SUPER MICRO COMPUTER, INC., 10-Q filed on 5/11/2026
Quarterly Report
v3.26.1
Cover - shares
9 Months Ended
Mar. 31, 2026
Apr. 30, 2026
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2026  
Document Transition Report false  
Entity File Number 001-33383  
Entity Registrant Name Super Micro Computer, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 77-0353939  
Entity Address, Address Line One 980 Rock Avenue  
Entity Address, City or Town San Jose  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 95131  
City Area Code 408  
Local Phone Number 503-8000  
Title of 12(b) Security Common Stock, $0.001 par value per share  
Trading Symbol SMCI  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Smaller Reporting Company false  
Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   601,418,482
Entity Central Index Key 0001375365  
Current Fiscal Year End Date --06-30  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q3  
Amendment Flag false  
v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2026
Jun. 30, 2025
Current assets:    
Cash and cash equivalents $ 1,290,324 $ 5,169,911
Accounts receivable, net of allowance for credit losses of $488 and $0 at March 31, 2026 and June 30, 2025, respectively (including accounts receivable from related parties of $633 and $393 at March 31, 2026 and June 30, 2025, respectively) 8,413,396 2,203,942
Inventories 11,103,376 4,680,375
Prepaid expenses and other current assets (including receivables from related parties of $28,714 and $13,745 at March 31, 2026 and June 30, 2025, respectively) 761,190 247,426
Total current assets 21,568,286 12,301,654
Property, plant and equipment, net 607,659 504,488
Deferred income taxes, net 632,715 607,416
Other assets 643,369 604,871
Total assets 23,452,029 14,018,429
Current liabilities:    
Accounts payable (including amounts due to related parties of $134,052 and $129,752 at March 31, 2026 and June 30, 2025, respectively) 3,686,991 1,281,977
Accrued liabilities (including amounts due to related parties of $1,330 and $1,044 at March 31, 2026 and June 30, 2025, respectively) 830,007 565,637
Income taxes payable 38,333 53,381
Lines of credit and term loans 2,095,069 75,060
Deferred revenue 1,472,235 368,737
Total current liabilities 8,122,635 2,344,792
Deferred revenue, non-current 663,410 362,645
Lines of credit and term loans, non-current 2,018,675 37,415
Convertible notes 4,659,357 4,645,178
Other long-term liabilities (including amounts due to related parties of $494 and $608 at March 31, 2026 and June 30, 2025, respectively) 412,361 326,528
Total liabilities 15,876,438 7,716,558
Commitments and contingencies (Note 14)
Stockholders’ equity:    
Common stock and additional paid-in capital, $0.001 par value, Authorized shares: 1,000,000; Issued and outstanding shares: 601,378 and 594,137 at March 31, 2026 and June 30, 2025, respectively 3,087,963 2,866,449
Accumulated other comprehensive income 692 705
Retained earnings 4,486,775 3,434,539
Total Super Micro Computer, Inc. stockholders’ equity 7,575,430 6,301,693
Non-controlling interest 161 178
Total stockholders’ equity 7,575,591 6,301,871
Total liabilities and stockholders’ equity $ 23,452,029 $ 14,018,429
v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2026
Jun. 30, 2025
Current assets:    
Accounts receivable, allowance for credit loss $ 488 $ 0
Accounts receivable, after allowance for credit loss, current 8,413,396 2,203,942
Receivable from related parties 761,190 247,426
Current liabilities:    
Accounts payable, related parties 3,686,991 1,281,977
Accrued liabilities, current 830,007 565,637
Other long-term liabilities $ 412,361 $ 326,528
Stockholders’ equity:    
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 1,000,000,000 1,000,000,000
Common stock, shares issued (in shares) 601,378,000 594,137,000
Common stock, shares outstanding (in shares) 601,378,000 594,137,000
Related Party    
Current assets:    
Accounts receivable, after allowance for credit loss, current $ 633 $ 393
Receivable from related parties 28,714 13,745
Current liabilities:    
Accounts payable, related parties 134,052 129,752
Accrued liabilities, current 1,330 1,044
Other long-term liabilities $ 494 $ 608
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]        
Net sales (including related party sales of $4,879 and $7,647 in the three months ended March 31, 2026 and 2025, respectively, and $23,940 and $33,799 in the nine months ended March 31, 2026 and 2025, respectively) $ 10,243,014 $ 4,599,913 $ 27,943,295 $ 16,215,131
Cost of sales (including related party purchases of $202,840 and $115,519 in the three months ended March 31, 2026 and 2025, respectively, and $549,962 and $491,680 in the nine months ended March 31, 2026 and 2025, respectively) 9,224,334 4,159,695 25,658,675 14,329,311
Gross profit 1,018,680 440,218 2,284,620 1,885,820
Operating expenses:        
Research and development 215,659 162,857 569,734 453,329
Sales and marketing 89,510 59,978 210,516 208,400
General and administrative 87,643 70,603 221,948 199,488
Total operating expenses 392,812 293,438 1,002,198 861,217
Income from operations 625,868 146,780 1,282,422 1,024,603
Other income (expense), net 4,147 (32,967) 4,243 (29,558)
Interest income 45,437 14,654 147,835 31,437
Interest expense (64,483) (13,402) (114,772) (37,291)
Income before income tax provision 610,969 115,065 1,319,728 989,191
Income tax provision (126,887) (5,843) (266,199) (137,544)
Share of (loss) income from equity investee, net of taxes (695) (445) (1,293) 2,053
Net income $ 483,387 $ 108,777 $ 1,052,236 $ 853,700
Net income per common share:        
Basic (in dollars per share) $ 0.81 $ 0.18 $ 1.76 $ 1.44
Diluted (in dollars per share) $ 0.72 $ 0.17 $ 1.59 $ 1.37
Weighted-average shares used in the calculation of net income per common share:        
Basic (in shares) 600,205 595,041 597,928 592,349
Diluted (in shares) 692,189 621,809 673,598 625,272
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Net sales $ 10,243,014 $ 4,599,913 $ 27,943,295 $ 16,215,131
Cost of sales 9,224,334 4,159,695 25,658,675 14,329,311
Related Party        
Net sales 4,879 7,647 23,940 33,799
Cost of sales $ 202,840 $ 115,519 $ 549,962 $ 491,680
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Statement of Comprehensive Income [Abstract]        
Net income $ 483,387 $ 108,777 $ 1,052,236 $ 853,700
Other comprehensive (loss) income, net of tax:        
Foreign currency translation (loss) gain, net of tax (3) 11 (13) (43)
Total other comprehensive (loss) income, net of tax (3) 11 (13) (43)
Total comprehensive income $ 483,384 $ 108,788 $ 1,052,223 $ 853,657
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock and Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Non-controlling Interest
Shares outstanding, beginning balance (in shares) at Jun. 30, 2024   588,087,410      
Stockholders' equity, beginning balance at Jun. 30, 2024 $ 5,417,370 $ 2,830,820 $ 706 $ 2,585,680 $ 164
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   1,330,560      
Exercise of stock options 6,527 $ 6,527      
Release of shares of common stock upon vesting of restricted stock units (in shares)   2,264,940      
Shares withheld for withholding taxes related to settlement of equity awards (in shares)   (685,850)      
Shares withheld for withholding taxes related to settlement of equity awards (35,537) $ (35,537)      
Stock-based compensation 64,137 $ 64,137      
Other comprehensive (loss) income 94   94    
Net income (loss) 424,326     424,327 (1)
Shares outstanding, ending balance (in shares) at Sep. 30, 2024   590,997,060      
Stockholders' equity, ending balance at Sep. 30, 2024 5,876,917 $ 2,865,947 800 3,010,007 163
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   1,597,044      
Exercise of stock options 342 $ 342      
Release of shares of common stock upon vesting of restricted stock units (in shares)   2,320,260      
Shares withheld for withholding taxes related to settlement of equity awards (in shares)   (1,433,012)      
Shares withheld for withholding taxes related to settlement of equity awards (41,499) $ (41,499)      
Stock-based compensation 82,262 $ 82,262      
Other comprehensive (loss) income (148)   (148)    
Net income (loss) 320,592     320,596 (4)
Shares outstanding, ending balance (in shares) at Dec. 31, 2024   593,481,352      
Stockholders' equity, ending balance at Dec. 31, 2024 6,238,466 $ 2,907,052 652 3,330,603 159
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   1,250,287      
Exercise of stock options 7,584 $ 7,584      
Release of shares of common stock upon vesting of restricted stock units (in shares)   3,028,380      
Shares withheld for withholding taxes related to settlement of equity awards (in shares)   (994,893)      
Shares withheld for withholding taxes related to settlement of equity awards (41,925) $ (41,925)      
Stock-based compensation 84,922 84,922      
Tax impact of amendment to capped call transactions (18,357) $ (18,357)      
Other comprehensive (loss) income 11   11    
Net income (loss) 108,778     108,777 1
Shares outstanding, ending balance (in shares) at Mar. 31, 2025   596,765,126      
Stockholders' equity, ending balance at Mar. 31, 2025 $ 6,379,479 $ 2,939,276 663 3,439,380 160
Shares outstanding, beginning balance (in shares) at Jun. 30, 2025 594,137,000 594,136,852      
Stockholders' equity, beginning balance at Jun. 30, 2025 $ 6,301,871 $ 2,866,449 705 3,434,539 178
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   631,240      
Exercise of stock options 7,922 $ 7,922      
Release of shares of common stock upon vesting of restricted stock units (in shares)   2,994,432      
Shares withheld for withholding taxes related to settlement of equity awards (in shares)   (925,181)      
Shares withheld for withholding taxes related to settlement of equity awards (43,642) $ (43,642)      
Stock-based compensation 89,139 $ 89,139      
Other comprehensive (loss) income (7)   (7)    
Net income (loss) 168,277     168,285 (8)
Shares outstanding, ending balance (in shares) at Sep. 30, 2025   596,837,343      
Stockholders' equity, ending balance at Sep. 30, 2025 $ 6,523,560 $ 2,919,868 698 3,602,824 170
Shares outstanding, beginning balance (in shares) at Jun. 30, 2025 594,137,000 594,136,852      
Stockholders' equity, beginning balance at Jun. 30, 2025 $ 6,301,871 $ 2,866,449 705 3,434,539 178
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares) 1,630,182        
Shares outstanding, ending balance (in shares) at Mar. 31, 2026 601,378,000 601,377,832      
Stockholders' equity, ending balance at Mar. 31, 2026 $ 7,575,591 $ 3,087,963 692 4,486,775 161
Shares outstanding, beginning balance (in shares) at Sep. 30, 2025   596,837,343      
Stockholders' equity, beginning balance at Sep. 30, 2025 6,523,560 $ 2,919,868 698 3,602,824 170
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   501,518      
Exercise of stock options 5,003 $ 5,003      
Release of shares of common stock upon vesting of restricted stock units (in shares)   2,211,116      
Shares withheld for withholding taxes related to settlement of equity awards (in shares)   (624,086)      
Shares withheld for withholding taxes related to settlement of equity awards (27,424) $ (27,424)      
Stock-based compensation 90,485 $ 90,485      
Other comprehensive (loss) income (3)   (3)    
Net income (loss) 400,556     400,564 (8)
Shares outstanding, ending balance (in shares) at Dec. 31, 2025   598,925,891      
Stockholders' equity, ending balance at Dec. 31, 2025 6,992,177 $ 2,987,932 695 4,003,388 162
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   497,424      
Exercise of stock options 5,422 $ 5,422      
Release of shares of common stock upon vesting of restricted stock units (in shares)   2,911,986      
Shares withheld for withholding taxes related to settlement of equity awards (in shares)   (957,469)      
Shares withheld for withholding taxes related to settlement of equity awards (31,325) $ (31,325)      
Stock-based compensation 125,934 $ 125,934      
Other comprehensive (loss) income (3)   (3)    
Net income (loss) $ 483,386     483,387 (1)
Shares outstanding, ending balance (in shares) at Mar. 31, 2026 601,378,000 601,377,832      
Stockholders' equity, ending balance at Mar. 31, 2026 $ 7,575,591 $ 3,087,963 $ 692 $ 4,486,775 $ 161
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
OPERATING ACTIVITIES:    
Net income $ 1,052,236 $ 853,700
Reconciliation of net income to net cash (used in) provided by operating activities:    
Depreciation and amortization 38,959 29,467
Amortization of right-of-use (“ROU”) assets 26,997 10,241
Amortization of debt discount and issuance costs 17,162 6,367
Inventory valuation adjustment write-down 239,255 159,050
Stock-based compensation expense 305,558 230,840
Impairment loss 13,747 0
Share of loss (income) from equity investee 1,293 (2,053)
Unrealized foreign currency exchange (gain) loss (4,428) 2,742
Loss on extinguishment of convertible notes 0 30,251
Deferred income taxes, net (30,920) (134,401)
Other non-cash income, net (8,302) (790)
Changes in operating assets and liabilities:    
Accounts receivable, net (including changes in related party balances of $(240) and $5,878 during the nine months ended March 31, 2026 and 2025, respectively) (6,209,831) 94,782
Inventories (6,669,560) 298,847
Prepaid expenses and other assets (including changes in related party balances of $(15,028) and $(2,782) during the nine months ended March 31, 2026 and 2025, respectively) (381,738) (284,356)
Accounts payable (including changes in related party balances of $4,300 and $(49,991) during the nine months ended March 31, 2026 and 2025, respectively) 2,406,930 (811,690)
Accrued liabilities (including changes in related party balances of $286 and $571 during the nine months ended March 31, 2026 and 2025, respectively) 232,916 52,714
Income taxes payable (11,576) 5,365
Deferred revenue 1,404,262 249,421
Other long-term liabilities (including changes in related party balances of $(114) and $729 during the nine months ended March 31, 2026 and 2025, respectively) 20,193 5,414
Net cash (used in) provided by operating activities (7,556,847) 795,911
INVESTING ACTIVITIES:    
Purchases of property, plant, and equipment (including payments to related parties of $9,366 and $10,508 during the nine months ended March 31, 2026 and 2025, respectively) (133,769) (104,536)
Investment in equity securities (42,000) 0
Net cash used in investing activities (175,769) (104,536)
FINANCING ACTIVITIES:    
Proceeds from lines of credit and term loans 4,235,265 1,357,991
Repayment of lines of credit and term loans (225,068) (1,731,366)
Payment of debt issuance costs (23,483) 0
Proceeds from exercise of stock options 18,347 14,452
Payment for withholding taxes related to settlement of equity awards (102,391) (118,960)
Debt issuance costs in connection with amended 2029 Convertibles Notes 0 (31,217)
Proceeds related to Receivables Purchase Agreement, net 4,191 0
Other (26) 22
Net cash provided by financing activities 3,906,835 174,618
Effect of exchange rate fluctuations on cash (6,554) 826
Net (decrease) increase in cash, cash equivalents and restricted cash (3,832,335) 866,819
Cash, cash equivalents and restricted cash at the beginning of the period 5,172,301 1,670,273
Cash, cash equivalents and restricted cash at the end of the period 1,339,966 2,537,092
Supplemental disclosure of cash flow information:    
Cash paid for interest 81,293 24,046
Cash paid for taxes, net of refunds 270,394 270,392
Non-cash investing and financing activities:    
Unpaid property, plant and equipment purchases (including due to related parties of $2,591 and $7,111 as of March 31, 2026 and 2025, respectively) 16,778 18,283
ROU assets obtained in exchange for operating lease commitments 94,907 128,617
Transfer of inventory to property, plant and equipment 7,304 4,889
2028 Convertible Notes    
FINANCING ACTIVITIES:    
Proceeds from issuance of 2028 Convertible Notes, net of issuance costs of $16,304 $ 0 $ 683,696
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)
$ in Thousands
9 Months Ended
Mar. 31, 2025
USD ($)
Non-cash investing and financing activities:  
Accounts receivable, net, related party $ 94,782
Prepaid expenses and other assets, related party (284,356)
Accounts payable, related party (811,690)
Accrued liabilities, related party 52,714
Changes in other long-term liabilities 5,414
Cash payment for property, plant, and equipment 104,536
Unpaid property, plant, and equipment 18,283
2028 Convertible Notes  
Non-cash investing and financing activities:  
Debt issuance costs 16,304
Related Party  
Non-cash investing and financing activities:  
Accounts receivable, net, related party 5,878
Prepaid expenses and other assets, related party (2,782)
Accounts payable, related party (49,991)
Accrued liabilities, related party 571
Changes in other long-term liabilities 729
Cash payment for property, plant, and equipment 10,508
Unpaid property, plant, and equipment $ 7,111
v3.26.1
Organization and Summary of Significant Accounting Policies
9 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Summary of Significant Accounting Policies
Note 1. Organization and Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this Quarterly Report on Form 10-Q should be read in conjunction with the consolidated financial statements and accompanying notes included in the Annual Report on Form 10-K for the fiscal year ended June 30, 2025, of Super Micro Computer, Inc., a Delaware corporation, and its consolidated entities (collectively, the “Company”). The condensed consolidated balance sheet as of June 30, 2025 included herein was derived from the audited financial statements as of that date but does not include all disclosures including notes required by U.S. GAAP.

The unaudited condensed consolidated financial statements included herein reflect all adjustments, including normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the consolidated financial condition, results of operations, and cash flows for the periods presented. All intercompany balances and transactions have been eliminated. Interim results are not necessarily indicative of the results for the full year ending June 30, 2026.

Significant Accounting Policies

Revenue Recognition

We generate revenues from the sale of server and storage systems, subsystems, accessories and services.

Product sales. We recognize revenue from sales of products as control is transferred to customers, which generally happens at the point of shipment or upon delivery, unless customer acceptance is required. Determining the point in time that control transfers to the customer requires judgment. Products sold by us are shipped from our facilities or drop shipped from our vendors. We may use distributors or channel partners to sell products to end customers. Revenue from distributors is recognized when the distributor obtains control of the product, which generally happens at the point of shipment or upon delivery.

We apply judgment in determining the transaction price as our contracts may include forms of variable consideration, including customer rebates, returns, and cash discounts for prompt payment. Variable consideration is estimated using either the expected value or most likely amount method, depending on which method better predicts the amount of consideration to which we expect to be entitled. We include estimated variable consideration in the transaction price only to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. Estimates of variable consideration are reassessed each reporting period and recorded as an adjustment to revenue, as applicable.

Services sales. Our sale of services mainly consists of extended warranty and on-site services as well as system rack installation and integration services. Revenue related to extended warranty commences upon the expiration of the standard warranty period and is recognized ratably over the contractual period as we stand ready to perform any required warranty service. Revenue related to on-site services commences upon recognition of the product sale and is recognized ratably over the contractual period as the on-site services are made available to the customer. These service contracts are typically one to five years in length. Revenue related to system rack installation and integration services is recognized when we perform the services and the customer receives and consumes the benefits.
Contracts with multiple promised goods and services. Certain of our contracts contain multiple promised goods and services. We assess whether each promised good or service is distinct for the purpose of identifying the performance obligations in the contract. This assessment requires management to make judgments about the individual promised goods or services and whether such goods or services are separable from the other aspects of the contractual relationship. Performance obligations in a contract are identified based on the promised goods or services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract. If these criteria are not met, the promised goods and services are accounted for as a combined performance obligation.

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. For contracts that contain multiple performance obligations, we allocate the transaction price for each customer contract to each performance obligation based on the relative Stand-alone Selling Price ("SSP") for each performance obligation within each contract. We recognize the amount of transaction price allocated to each performance obligation within a customer contract as revenue at the time the related performance obligation is satisfied by transferring control of the promised good or service to a customer. Determining the relative SSP for contracts that contain multiple performance obligations requires significant judgment. We determine SSP based on the price at which the performance obligation is sold separately. If the SSP is not observable through past transactions, we apply judgment to estimate the SSP. For all performance obligations, we are able to establish the SSP by maximizing the use of observable inputs. We typically establish an SSP range for our products and services, which is reassessed on a periodic basis or when facts and circumstances change. SSP for our products and services can evolve over time due to changes in our pricing practices, internally approved pricing guidelines with respect to geographies, customer type, internal costs, and gross margin objectives for the related performance obligations which can also be influenced by intense competition, changes in demand for our products and services, economic and other factors.

Our credit terms are predominantly short-term in nature; however, we also grant extended payment terms for certain customers. For the contracts with the extended payment terms in which the financing component is determined to be significant to the contract, the contract transaction price is adjusted for the effect of a financing component.

When we receive consideration from a customer prior to transferring goods or services to the customer, we record a contract liability (deferred revenue). We also recognize deferred revenue when we have an unconditional right to consideration (i.e., a receivable) before transfer of control of goods or services to a customer.

Shipping and handling fees collected from customers are included in net sales when control of the product is transferred to the customer, and the related shipping and handling costs are included in cost of sales. We have elected to account for shipping and handling activities that occur after the customer has obtained control of a good as a fulfillment cost rather than as an additional promised service. Taxes imposed by governmental authorities on our revenue producing activities with customers, such as sales taxes and value added taxes, are excluded from net sales.

For our other significant accounting policies, refer to our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.

Concentration of Credit Risk and Significant Customers

Financial instruments that potentially subject us to a significant concentration of credit risk consist of cash and cash equivalents, restricted cash, and accounts receivable. Cash and cash equivalents are maintained with high-quality financial institutions, the composition and maturities of which are regularly monitored by management.
We believe that the concentration of credit risk in our trade receivables is substantially mitigated by our credit evaluation process, relatively short collection terms and the high level of credit worthiness of our customers. For customers including distributors and direct customers, we perform ongoing credit evaluations of their financial conditions and limit the amount of credit extended when deemed necessary based upon payment history and their current credit worthiness, but we generally require no collateral other than the products that we deliver to them, in which we sometimes hold a purchase money security interest under our standard terms. We regularly review the allowance for credit losses by considering factors such as historical experience, credit quality, reasonable and supportable forecasts, age of the accounts receivable balances and current economic conditions that may affect a customer’s ability to pay.

Significant customer information is as follows:

March 31, 2026June 30, 2025
Percentage of accounts receivable:
Customer A32.2%*
Customer B16.8%33.4%
Customer C13.2%13.6%
Customer D12.9%*

^The customer references of A-D above may represent different customers than those reported in a previous period.
*Below 10%

Accounting Pronouncements Recently Adopted

In March 2024, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2024-02 which removes references to the FASB’s concepts statements from the FASB Accounting Standards Codification. The ASU is part of the FASB’s standing project to make “Codification updates for technical corrections such as conforming amendments, clarifications to guidance, simplifications to wording or the structure of guidance, and other minor improvements.” The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2024. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2025. We adopted ASU 2024-02 on July 1, 2025, which did not have a material impact on our condensed consolidated financial statements and related disclosures.

Recent Accounting Pronouncements Not Yet Adopted

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The standard is effective for annual periods beginning after December 15, 2024. Early adoption is permitted and should be applied prospectively, with retrospective application permitted. The ASU is effective for our fiscal year beginning July 1, 2025. We are currently assessing the effect of the adoption of this standard on our disclosures that will be included in our Form 10-K for the fiscal year ending June 30, 2026.

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40), which requires disaggregated disclosure of income statement expenses for public business entities. The ASU does not change the expense captions an entity presents on the face of the income statement, but it requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. In January 2025, the FASB issued ASU 2025-01, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40), which was issued to clarify the initial effective date for entities that do not have an annual reporting period that ends on December 31 (referred to as non-calendar year-end entities). The update clarified that ASU 2024-03 shall be effective for public business entities for annual reporting periods beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The ASU is effective for our fiscal year beginning July 1, 2027. We do not expect this ASU to have a material impact on our condensed consolidated financial statements other than additional disclosures.
In May 2025, the FASB issued ASU 2025-03, Business Combinations (Topic 805) and Consolidation (Topic 810): Determining the Accounting Acquirer in the Acquisition of a Variable Interest Entity, which revises current guidance for determining the accounting acquirer for a transaction effected primarily by exchanging equity interests in which the legal acquiree is a variable interest entity that meets the definition of a business. The amendments require that an entity consider the same factors that are currently required for determining which entity is the accounting acquirer in other acquisition transactions. The ASU is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within those annual reporting periods. Early adoption is permitted. The ASU is effective for our fiscal year beginning July 1, 2027. We do not expect this ASU to have a material impact on our condensed consolidated financial statements and disclosures.

In July 2025, the FASB issued ASU 2025-05, Financial Instruments–Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides all entities with a practical expedient and entities other than public business entities with an accounting policy election when applying the guidance in Topic 326, Financial Instruments–Credit Losses, to current accounts receivable and current contract assets arising from transactions accounted for under Topic 606, Revenue from Contracts with Customers. The ASU is effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted. The ASU is effective for our fiscal year beginning July 1, 2026. We do not expect this ASU to have a material impact on our condensed consolidated financial statements and disclosures.

In November 2025, the FASB issued ASU 2025-08, Financial Instruments–Credit Losses (Topic 326): Purchased Loans, which expands the population of acquired financial assets subject to the gross-up approach in Topic 326. The ASU is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within those annual reporting periods. Early adoption is permitted. The ASU is effective for our fiscal year beginning July 1, 2027. We do not expect this ASU to have a material impact on our condensed consolidated financial statements and disclosures.

In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-scope Improvements. This update makes targeted, narrow-scope improvements to the interim reporting guidance in Topic 270 to clarify application and improve consistency in practice. The amendments do not change the underlying principles of interim reporting. The ASU is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The ASU is effective for interim reporting periods beginning in our fiscal year beginning July 1, 2028. We are currently evaluating the effects of ASU on our condensed consolidated financial statements and disclosures.

In December 2025, the FASB issued ASU 2025-12, Codification Improvements, which includes 33 technical corrections, clarifications, and minor refinements across multiple ASC Topics intended to improve consistency and usability of U.S. GAAP. Transition is applied on an issue-by-issue basis: the EPS clarification (ASC 260, Issue 4) is applied retrospectively to all prior periods presented, while all other amendments may be applied prospectively or retrospectively, with appropriate disclosures about the nature/reason for the change (and additional disclosures if applied retrospectively). The ASU is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within those annual reporting periods. Early adoption is permitted. The ASU is effective for our fiscal year beginning July 1, 2027. We are currently evaluating the effects of ASU on our condensed consolidated financial statements and disclosures.

Reclassification

Certain prior period amounts have been reclassified to conform to the current period presentation. Such reclassifications did not result in net changes to condensed consolidated balance sheets, statements of operations, or statements of cash flows.
v3.26.1
Segment Information
9 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Segment Information
Note 2. Segment Information

We operate in one operating segment that develops and provides high-performance server solutions based upon an innovative, modular and open-standard architecture. Our Chief Executive Officer is the chief operating decision maker (“CODM”) and is responsible for assessing our performance. Our organizational structure is based on functional lines, with department heads and shared resources reporting either directly to the CODM or to a direct report of the CODM. The CODM reviews financial information presented on a consolidated basis and uses net income for purposes of evaluating financial performance and making operating decisions for us.

The CODM reviews significant operating expenses as components of net income, including research and development expenses, sales and marketing expenses, and general and administrative expenses, which are each separately disclosed and presented in the condensed consolidated statements of operations.

Additionally, the CODM reviews significant segment expenses including the inventory valuation adjustment write-downs, recorded to cost of sales, which is separately disclosed in Note 6, “Balance Sheet Components”, and stock-based compensation, which is separately disclosed in Note 12, “Stock-based Compensation and Stockholders’ Equity” in the notes to the condensed consolidated financial statements.

The measure of segment assets is reported on the condensed consolidated balance sheets as total consolidated assets. The accounting policies of our consolidated segment are the same as those described in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.

Disaggregation of Revenue

Total revenue recognized from all services and software for the three months ended March 31, 2026 and 2025 was $140.5 million and $71.8 million, respectively. Of this, revenue related to services recognized on an over time basis during the contract term was $104.4 million and $57.2 million for the three months ended March 31, 2026 and 2025, respectively.

Total revenue recognized from all service and software for the nine months ended March 31, 2026 and 2025 was $368.5 million and $244.5 million, respectively. Of this, revenue related to services recognized on an over time basis during the contract term was $280.4 million and $161.8 million for the nine months ended March 31, 2026 and 2025, respectively.

International net sales are based on the country to which the products were shipped. The following is a summary of net sales by geographic region (in thousands):

 Three Months Ended March 31,Nine Months Ended March 31,
 2026
% of Total
2025
% of Total
2026% of Total2025% of Total
United States$7,033,882 68.7 %$2,768,181 60.2 %$19,797,305 70.8 %$10,856,490 67.0 %
Other (1)
3,209,132 31.3 %1,831,732 39.8 %8,145,990 29.2 %5,358,641 33.0 %
Total$10,243,014 100.0 %$4,599,913 100.0 %$27,943,295 100.0 %$16,215,131 100.0 %

(1) all other countries were individually less than 10%.
Concentration of Customer Risk

Significant customer information is as follows:

Three Months Ended
March 31,
Nine Months Ended
March 31,
2026202520262025
Percentage of total net sales:
Customer A27.0%*38.5%15.1%
Customer B*22.5%*23.5%
Customer C*14.1%**
Customer D10.3%**13.5%

^The customer references of A-D above may represent different customers than those reported in a previous period.
*Below 10%

Contract Balances

Generally, the payment terms of our offerings range from 30 to 60 days, however occasionally we might offer longer payment terms to certain customers. In certain instances, customers may prepay for products and services in advance of delivery. Receivables represent our unconditional right to consideration for performance obligations that are either partially or fully completed.

Contract assets are rights to consideration in exchange for goods or services that we have transferred to a customer when such right is conditional on something other than the passage of time. Such contract assets have not been material to our condensed consolidated financial statements.

Contract liabilities consist of deferred revenue and relate to amounts invoiced to or advance consideration received from customers, which precede our satisfaction of the associated performance obligations. Our deferred revenue primarily results from customer payments received upfront for extended warranties and on-site services because these performance obligations are satisfied over time. Additionally, at times, deferred revenue may fluctuate due to the timing of non-refundable advance consideration received from non-cancelable contracts relating to the sale of future products. Revenue recognized during the three and nine months ended March 31, 2026, which was included in the opening deferred revenue balance as of June 30, 2025 of $731.4 million, was $57.0 million and $302.8 million, respectively. Revenue recognized during the three and nine months ended March 31, 2025, which was included in the opening deferred revenue balance as of June 30, 2024 of $416.4 million, was $38.5 million and $154.0 million, respectively.

Transaction Price Allocated to the Remaining Performance Obligations

Remaining performance obligations represent in aggregate the amount of transaction price that has been allocated to performance obligations not delivered, or only partially delivered, as of the end of the reporting period. We apply the exemption to not disclose information about remaining performance obligations that are part of a contract that has an original expected duration of one year or less. The remaining performance obligations excluded from this disclosure primarily relate to short-term backlog contracts expected to be fulfilled within one year, including on-site services, integration services, extended warranty services, and for product where control has not been transferred. The value of the transaction price allocated to the remaining performance obligations as of March 31, 2026 was approximately $2,135.6 million. We expect to recognize approximately 69% of such value in the next 12 months, and the remainder thereafter.
v3.26.1
Financial Instruments and Fair Value Measurements
9 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Financial Instruments and Fair Value Measurements
Note 3. Financial Instruments and Fair Value Measurements

We classify our financial instruments, except for our investment in an auction rate security and other investments in privately held companies, within Level 1 or Level 2 in the fair value hierarchy because we use quoted prices in active markets or alternative pricing sources and models using market observable inputs to determine their fair value.
Financial Instruments Measured at Fair Value on a Recurring Basis

Cash and cash equivalents, certificates of deposit, investment in an auction rate security, and marketable securities, included in prepaid expenses and other current assets and other assets in the condensed consolidated balance sheets, are carried at fair value.

The following table sets forth our financial instruments as of March 31, 2026 and June 30, 2025, which are measured at fair value on a recurring basis by level within the fair value hierarchy. These are classified based on the lowest level of input that is significant to the fair value measurement (in thousands):

As of March 31, 2026
As of June 30, 2025
Level 1Level 2Level 3Asset at Fair ValueLevel 1Level 2Level 3Asset at Fair Value
Assets
Money market funds (1)
$19 $— $— $19 $44 $— $— $44 
Certificates of deposit— 47,494 — 47,494 — 519 — 519 
Marketable equity security14,709 — — 14,709 6,239 — — 6,239 
Available-for-Sale Investment:
Auction rate security (2)
— — — — — — 1,750 1,750 
Total assets$14,728 $47,494 $— $62,222 $6,283 $519 $1,750 $8,552 

(1) All of the money market funds are included in cash and cash equivalents in the condensed consolidated balance sheets as of March 31, 2026 and June 30, 2025, respectively.
(2) The fair value of our auction rate security was immaterial as of March 31, 2026.

The investment in marketable equity security is carried at fair value using values available on a public exchange, is based on a Level 1 input, and is recorded in prepaid expenses and other current assets in the condensed consolidated balance sheets. The unrealized gains and losses of the investment are included in other income (expense), net in our condensed consolidated statements of operations. For the three and nine months ended March 31, 2026, an unrealized loss of $0.5 million and an unrealized gain of $8.5 million, respectively, were recorded in other income (expense), net in the condensed consolidated statements of operations. For the three and nine months ended March 31, 2025, an unrealized loss of $1.3 million and an unrealized loss of $0.2 million, respectively, were recorded in other income (expense), net in the condensed consolidated statements of operations.

On a quarterly basis, we also evaluate the current expected credit loss by considering factors such as historical experience, market data, issuer-specific factors, current economic conditions, and reasonable economic forecasts that affect collectability. For the three and nine months ended March 31, 2026 and 2025, the credit losses related to our investments were not material.

There were no transfers between Level 1, Level 2, or Level 3 financial instruments during the three and nine months ended March 31, 2026 and 2025.

Financial Instruments Not Recorded at Fair Value

Accounts receivable, accounts payable, and accrued liabilities are carried at cost, which approximates fair value due to the short maturity of these instruments. We estimate the fair value of outstanding debt, including our 3.50% Convertible Senior Notes due 2029 (“2029 Convertible Notes”), 2.25% Convertible Senior Notes due 2028 (“2028 Convertible Notes”), and 0.00% Convertible Senior Notes due 2030 (“2030 Convertible Notes”), for disclosure purposes on a recurring basis. Non-current accounts receivable, included in other assets in the condensed consolidated balance sheets, are carried at amortized cost, and bear interest at rates that approximate current market rates for similar credit. We believe the carrying amounts approximate fair value because there have been no significant changes in market rates or credit risk.
As of March 31, 2026 and June 30, 2025, our total lines of credit and term loans of $4,113.7 million and $112.5 million, respectively, are reported at amortized cost. The carrying value of our outstanding lines of credit and term loans approximates fair value because the borrowings primarily bear interest at variable rates based on current market rates or have short-term maturities. These fair value measurements are classified within Level 2 of the fair value hierarchy based on observable market inputs.

The estimated fair values as of March 31, 2026 of the 2029 Convertible Notes, the 2028 Convertible Notes, and the 2030 Convertible Notes were $1,381.7 million, $601.9 million, and $1,684.3 million, respectively. The estimated fair values as of June 30, 2025 of the 2029 Convertible Notes, the 2028 Convertible Notes, and the 2030 Convertible Notes were $1,801.9 million, $818.5 million, and $2,576.6 million. The estimated fair values of the 2029 Convertible Notes, the 2028 Convertible Notes, and the 2030 Convertible Notes was determined based on level 2 inputs of quoted market prices.
v3.26.1
Non-marketable Equity Securities
9 Months Ended
Mar. 31, 2026
Investments, Debt and Equity Securities [Abstract]  
Non-marketable Equity Securities
Note 4. Non-marketable Equity Securities

Our non-marketable equity securities, included in other assets in the condensed consolidated balance sheets, consist of investments in privately held companies without readily determinable fair values. The following table shows our non-marketable equity securities that were measured using the measurement alternative and equity method (in thousands):

March 31, 2026June 30, 2025
Non-marketable equity securities:
Opening gross investment balance (as of July 1, 2025 and July 1, 2024)$122,217 $66,217 
Investments made during the period42,000 56,000 
Cumulative impairment adjustments(23,600)(11,600)
Total carrying value - before the adjustments under equity method
140,617 110,617 
Securities under equity method - cumulative adjustment(1,027)— 
Total carrying value (as of March 31, 2026 and June 30, 2025)
$139,590 $110,617 

Our non-marketable equity securities include $92.5 million invested in an unrelated party (the “Sub-licensee”) to which we have subleased the entire space in Vernon, California. The Sub-licensee does not meet the criteria of a related party. Additionally, the Sub-licensee has been a customer of ours, and we concluded that equity investment agreements and sub-licensing agreements are separate from revenue contracts as all transactions have been recorded at the respective fair values. Please refer to Note 10, “Leases” for further discussion.

During the nine months ended March 31, 2026, we recognized an impairment loss of $12.0 million. No impairment loss was recorded during the three months ended March 31, 2026.
v3.26.1
Net Income per Common Share
9 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Net Income per Common Share
Note 5. Net Income per Common Share

The following table shows the computation of basic and diluted net income per common share for the three and nine months ended March 31, 2026 and 2025 (in thousands, except per share amounts):

 Three Months Ended
March 31,
Nine Months Ended
March 31,
 2026202520262025
Numerator:
Net income - basic$483,387 $108,777 $1,052,236 $853,700 
Convertible notes interest charge, net of tax17,888 — 16,472 1,777 
Net income - diluted $501,275 $108,777 $1,068,708 $855,477 
Denominator:
Weighted-average shares outstanding - basic600,205 595,041 597,928 592,349 
Effect of dilutive convertible notes73,803 — 53,130 1,673 
Effect of dilutive securities18,181 26,768 22,540 31,250 
Weighted-average shares outstanding - diluted692,189 621,809 673,598 625,272 
Net income per common share - basic$0.81 $0.18 $1.76 $1.44 
Net income per common share - diluted$0.72 $0.17 $1.59 $1.37 
Anti-dilutive shares excluded from diluted net income per share:
Stock-based awards28,653 16,245 20,203 9,278 
Convertible notes— 32,138 20,673 20,673 
v3.26.1
Balance Sheet Components
9 Months Ended
Mar. 31, 2026
Balance Sheet Related Disclosures [Abstract]  
Balance Sheet Components
Note 6. Balance Sheet Components

The following tables provide details of the selected balance sheet items (in thousands):

Cash, Cash Equivalents, and Restricted Cash

 March 31, 2026June 30, 2025
Cash and cash equivalents$1,290,324 $5,169,911 
Restricted cash included in prepaid expenses and other current assets and other assets49,642 2,390 
Total cash, cash equivalents and restricted cash$1,339,966 $5,172,301 

Inventories

March 31, 2026June 30, 2025
Finished goods$8,154,074 $3,465,352 
Work in process1,991,524 674,613 
Purchased parts and raw materials957,778 540,410 
Total inventories$11,103,376 $4,680,375 
During the three months ended March 31, 2026 and 2025, we recorded write down adjustments for excess and obsolete inventory and lower of cost and net realizable value adjustments to cost of sales totaling $70.2 million and $125.1 million, respectively, and recorded adjustments totaling $239.3 million and $159.0 million, respectively, during the nine months ended March 31, 2026 and 2025.

Property, Plant, and Equipment, net

 March 31, 2026June 30, 2025
Land$193,417 $162,848 
Buildings186,860 182,466 
Machinery and equipment141,458 111,331 
Building and leasehold improvements136,018 121,665 
Construction in progress55,705 1,038 
Furniture and fixtures42,607 36,268 
Software7,419 7,117 
Property, plant, and equipment, gross763,484 622,733 
Accumulated depreciation and amortization(155,825)(118,245)
Property, plant, and equipment, net$607,659 $504,488 

Depreciation expense for the three months ended March 31, 2026 and 2025 was $13.5 million and $10.9 million, respectively, and for the nine months ended March 31, 2026 and 2025 was $38.4 million and $29.4 million, respectively.

Other Assets

 March 31, 2026June 30, 2025
Operating lease ROU asset
$361,437 $293,692 
Long-term investments139,593 112,367 
Tariff receivable*64,539 — 
Non-current accounts receivable23,194 166,405 
Deferred service costs, non-current11,164 10,713 
Deposits3,896 4,980 
Restricted cash, non-current2,642 2,390 
Other36,904 14,324 
Total other assets$643,369 $604,871 

*Represents receivables related to the Company’s claims under Section 232 of the Trade Expansion Act of 1962. Refer to Note 14 for additional disclosures related to the Supreme Court decision related to tariff under the International Emergency Economic Powers Act (IEEPA).
Accrued Liabilities

March 31, 2026June 30, 2025
Customer deposits$203,570 $260,131 
Customer-related liabilities139,08432,858 
Accrued payroll and related expenses122,98382,156 
Import tax and tariff liabilities56,32320,883 
Accrued cooperative marketing expenses51,93926,775 
Input tax payable45,49339,161 
Accrued interest - lines of credit and term loans35,606146 
Accrued withholding tax38,653
Operating lease liability32,70321,189 
Accrued warranty costs15,3639,753 
Accrued professional fees11,6948,098 
Accrued interest - convertible notes
8,35627,701 
Other68,24036,780 
Total accrued liabilities$830,007 $565,637 

Product Warranties

Three Months Ended
March 31,
Nine Months Ended
March 31,
 2026202520262025
Balance, beginning of the period$23,012 $18,288 $16,954 $17,815 
Provision for warranty17,043 25,253 88,258 53,949 
Costs utilized(16,895)(24,277)(82,430)(51,131)
Change in estimated liability for pre-existing warranties607 (337)985 (1,706)
Balance, end of the period$23,767 $18,927 $23,767 $18,927 
Current portion$15,363 $10,740 $15,363 $10,740 
Non-current portion$8,404 $8,187 $8,404 $8,187 

The portion of the accrued warranty costs expected to be incurred within the next 12 months is included within accrued liabilities, while the remaining balance is included within other long-term liabilities on the condensed consolidated balance sheets.
v3.26.1
Receivables Purchase Agreement
9 Months Ended
Mar. 31, 2026
Transfers and Servicing [Abstract]  
Receivables Purchase Agreement
Note 7. Receivables Purchase Agreement

On July 16, 2025, we entered into a Receivables Purchase Agreement (as amended, supplemented or otherwise modified from time to time, the “Receivables Purchase Agreement”), by and among, us, as seller and guarantor, MUFG Bank, Ltd. (“MUFG”), Crédit Agricole Corporate and Investment Bank, and certain other entities from time to time party thereto as purchasers (the “Purchasers”), and MUFG as administrative agent (in such capacity, the “Administrative Agent”).
Pursuant to the Receivables Purchase Agreement, we may, subject to the terms and conditions set out therein, sell certain of our accounts receivable and related rights to the Purchasers (the “Purchased Receivables”). The Receivables Purchase Agreement provides for an uncommitted facility with an initial aggregate facility limit of $1,790.0 million. The Purchasers may elect in their sole direction to purchase eligible accounts receivable offered by us under the Receivables Purchase Agreement at the applicable purchase discount. The purchase price for any Purchased Receivable will be the net invoice amount of the Purchased Receivable, minus the applicable discount, which is set at Term Secured Overnight Financing Rate (“SOFR”) (as defined in the Receivables Purchase Agreement) plus a specified discount assigned to each account debtor in the range of 1.15% - 2.80%, and calculated on the basis of a specified discount period. In the event the purchase of such Purchased Receivables is not characterized as a sale, we will be deemed to have granted a security interest in such Purchased Receivables and the proceeds thereof in favor of the Purchasers.

Trade receivables sold and discount on trade receivables sold under this program were as follows (in thousands):

Three Months Ended
March 31,
Nine Months Ended
March 31,
 20262026
Trade receivables sold$831,674 $831,674 
Discount on trade receivables (1)
$5,737 $5,737 

(1) Included in general and administrative expenses in the condensed consolidated statements of operations.

Trade receivables sold under the Receivables Purchase Agreement and subject to servicing by us that remained outstanding and uncollected, and collected as of March 31, 2026, are as follows (in thousands):

 March 31, 2026
Outstanding and uncollected$123,628 
Outstanding and collected (1)
$4,191 

(1) Amount collected but not yet remitted to purchasers as of March 31, 2026 is classified in accrued liabilities on the condensed consolidated balance sheet.
v3.26.1
Lines of Credit, Revolving Credit Facilities, and Term Loans
9 Months Ended
Mar. 31, 2026
Debt Disclosure [Abstract]  
Lines of Credit, Revolving Credit Facilities, and Term Loans
Note 8. Lines of Credit, Revolving Credit Facilities, and Term Loans

Short-term and long-term loan obligations with respect to lines of credit and term loans as of March 31, 2026 and June 30, 2025 consisted of the following (in thousands):
 
 March 31,June 30,
 20262025
Lines of credit:
CTBC Credit Lines$181,305 $— 
Chang Hwa Bank Credit Lines25,005 — 
E.SUN Bank Credit Lines50,000 30,000 
Mega Bank Credit Lines30,000 — 
First Bank Credit Lines19,935 — 
JP Morgan Revolving Credit Facility2,000,000 — 
CTBC Revolving Credit Facilities1,762,970 — 
Total lines of credit4,069,215 30,000 
Term loan facilities:
Chang Hwa Bank Credit Facility due October 15, 20264,562 11,399 
CTBC Term Loan Facility, due June 4, 203022,343 28,822 
CTBC Term Loan Facility, due August 15, 2026603 1,846 
E.SUN Bank Term Loan Facility, due September 15, 20265,005 13,678 
E.SUN Bank Term Loan Facility, due August 15, 20275,760 9,632 
Mega Bank Term Loan Facility, due October 3, 20266,256 17,098 
Total term loans44,529 82,475 
Total lines of credit and term loans$4,113,744 $112,475 
Lines of credit and term loans, current$2,095,069 $75,060 
Lines of credit and term loans, non-current$2,018,675 $37,415 
Activities under Lines of Credit, Revolving Credit Facilities, and Term Loans

Available borrowings and interest rates as of March 31, 2026 and June 30, 2025 consisted of the following (in thousands except for percentages):

 March 31, 2026June 30, 2025
Available borrowingsInterest rateAvailable borrowingsInterest rate
Lines of credit:
CTBC Credit Lines$3,695 
2.26% - 4.62%
$185,000 
2.63% - 5.79%
Chang Hwa Bank Credit Lines$1,714 
1.88% - 4.40%
$30,259 
1.88% - 5.16%
E.SUN Bank Credit Lines$10,000 
2.02% - 4.67%
$30,000 
2.02% - 5.12%
Mega Bank Credit Lines$3,744 
2.23% - 4.48%
$50,000 
1.90% - 5.26%
First Bank Credit Lines$65 
2.03% - 4.49%
$— 
n/a
JP Morgan Revolving Credit Facility$— 
3.67% - 3.67%
$— 
n/a
CTBC Revolving Credit Facilities$— 
2.86% - 5.11%
$— 
n/a
Term loan facilities:
Chang Hwa Bank Credit Facility due October 15, 2026$— 2.08%$— 2.08%
CTBC Term Loan Facility, due June 4, 2030$— 
1.33% - 1.83%
$— 
1.33% - 1.83%
CTBC Term Loan Facility, due August 15, 2026$— 
2.03%
$— 
1.53% - 2.03%
E.SUN Bank Term Loan Facility, due September 15, 2026$— 
2.22%
$— 2.22%
E.SUN Bank Term Loan Facility, due August 15, 2027$— 2.22%$— 1.92%
Mega Bank Term Loan Facility, due October 3, 2026$— 
 2.02%
$— 
2.02%
See Note 7, “Lines of Credit and Term Loans” of our Annual Report on Form 10-K for the fiscal year ended June 30, 2025 for a more complete description of our credit facilities.

Principal payments on lines of credit and term loans are due as follows (in thousands):

 Fiscal Year:
 Principal Payments
Remainder of 2026$291,545 
20271,805,882 
20286,039 
20295,362 
20304,916 
2031 and thereafter2,000,000
Total lines of credit and term loans$4,113,744 

As of March 31, 2026, we were in compliance with all the covenants for the lines of credit and term loans on our condensed consolidated balance sheets.
We entered into new agreements, or extensions of previous agreements, during the nine months ended March 31, 2026, with the following terms:

CTBC Bank Credit Lines

2025 CTBC Facility Letter

On February 13, 2026, our Taiwan subsidiary received a facility extension letter to extend the maturity date, originally set to expire on February 28, 2026, to March 31, 2027.

As of March 31, 2026, the outstanding borrowings under the 2025 CTBC Bank Credit Lines was $181.3 million.

Mega Bank

Mega Bank Credit Facilities

On February 4, 2026, our Taiwan subsidiary renewed the facility from Mega Bank. The renewed facility continues to provide up to $50.0 million including sub-item of NTD 600.0 million in total credit capacity. The maturity date is January 8, 2027.

As of March 31, 2026, the outstanding borrowings under this facility was $30.0 million.

First Bank

On July 18, 2025, our Taiwan subsidiary renewed the Credit Agreement and the Foreign Currency Agreement with First Commercial Bank Co., Ltd. (“First Bank”). The credit lines are $20.0 million, including a sub-item credit limit of NTD 600.0 million designed for short-term working capital loans. Subsequently on February 26, 2026, we renewed the Credit Agreement and the new maturity date is March 9, 2027.

As of March 31, 2026, the outstanding borrowings under the First Bank credit line was $19.9 million.

JP Morgan Revolving Credit Facility

On December 29, 2025, we entered into a credit agreement (the “Credit Agreement”) with JPMorgan Chase Bank, N.A., (“JP Morgan”) as administrative agent and collateral agent, and a syndicate of lenders, which provides for a revolving credit facility of up to $2,000.0 million (the “Revolving Credit Facility”), including a $200.0 million letter of credit sub-limit and a $150.0 million same-day borrowing sub-limit, with an option to increase total commitments by up to $1,000.0 million subject to certain conditions. Borrowings under the Revolving Credit Facility may be used for working capital and other general corporate purposes. The upfront fees totaling $9.8 million incurred in connection with the credit agreement were capitalized as deferred cost and recorded as a non-current asset included within other assets on the condensed consolidated balance sheet as of issuance of the credit facility. These deferred financing costs are being amortized to interest expense over the term of the Revolving Credit Facility and not material.

As of March 31, 2026, we had $2,000.0 million outstanding under the Revolving Credit Facility.
Borrowings under the Revolving Credit Facility bear interest, at our option, at either an alternate base rate (“ABR”) or a term rate, in each case plus an applicable margin. The applicable margin varies based on (i) during a non-investment grade period, our leverage ratio (ranging from 1.25% to 2.00% for term rate loans and 0.25% to 1.00% for ABR loans), or (ii) during an investment grade period, our corporate family rating (ranging from 1.13% to 1.38% for term rate loans and 0.13% to 0.38% for ABR loans). We also pay a quarterly commitment fee on unused commitments ranging from 0.15% to 0.30% during a non-investment grade period (or 0.12% to 0.15% during an investment grade period). Investment grade period refers to the period beginning on the date (no earlier than September 30, 2026) when we attain an investment grade corporate family rating from at least two of Moody’s (Baa3 or higher), S&P (BBB- or higher), and Fitch (BBB- or higher), in each case with a stable or better outlook, and delivers an officer’s certificate to the administrative agent confirming such ratings, and continuing until the occurrence of a subsequent non-investment grade trigger event. The Revolving Credit Facility matures on December 29, 2030.

During any non-investment grade period, the Revolving Credit Facility is guaranteed by us and certain qualifying domestic subsidiaries (subject to customary exclusions) and is secured by a first-priority lien on substantially all assets of the applicable loan parties (subject to customary exclusions). The Credit Agreement includes customary restrictive covenants (some of which are not applicable during an investment grade period), including limitations on indebtedness, investments, and restricted payments, and a maximum total net leverage ratio covenant of 4.00:1.00 for the first four full fiscal quarters after inception, stepping down to 3.50:1.00 for the next four full fiscal quarters, and 3.00:1.00 thereafter. The Credit Agreement contains customary events of default (including change of control), which upon occurrence may result in the acceleration of amounts outstanding and termination of lender commitments.

CTBC Revolving Credit Facilities

On January 21, 2026, we entered into a facilities agreement (the “Credit Agreement”) with a group of lenders led by CTBC Bank Co., Ltd., along with Credit Agricole Corporate and Investment Bank, Taipei Branch and E.Sun Commercial Bank, Ltd. as mandated lead arrangers and bookrunners (with CTBC Bank Co., Ltd. also acting as administrative agent under the Credit Agreement). The agreement provides for two revolving credit facilities totaling $710.0 million (the “CTBC Revolving Credit Facilities”), comprised of Facility A1 ($350.0 million) and Facility A2 ($360.0 million), with an option to increase total commitments to up to $2,000.0 million, subject to certain conditions. On January 30, 2026, we entered into an increased facilities letter under the Credit Agreement, providing for additional revolving credit facilities in an aggregate amount of $1,055.0 million. As a result, the total lender commitments under the Credit Agreement increased to $1,765.0 million.

The proceeds of the CTBC Revolving Credit Facilities may be applied to procure certain components and/or raw materials, subject to specified invoice and purchase order documentation and related timing requirements. We may request loans under the CTBC Revolving Credit Facilities at any time until and including the date falling one month prior to the maturity date. We intend to use the proceeds under the Credit Agreement for general corporate purposes, including to fund working capital for growth and business expansion, subject to the foregoing conditions.

Borrowings under Facility A1 denominated in USD accrue interest at the US dollar offered rate of the Taipei Forex Trading Center (“TAIFX3”) (subject to a zero floor) plus a margin of 1.0% per annum, and borrowings under Facility A2 denominated in USD accrue interest at Term SOFR (subject to a zero floor) plus a margin of 1.2% per annum. Borrowings under Facility A1 and Facility A2 denominated in NTD accrue interest at the Taipei Interbank Offered Rate (“TAIBOR”) (subject to a zero floor) plus a margin of 1.0% per annum; provided that the interest rate applicable to any loan denominated in NTD will never be less than 1.7%. We pay a commitment fee on unused and available commitments under the CTBC Revolving Credit Facilities on each day of the availability period that the daily average utilization amount of the CTBC Revolving Credit Facilities is less than 50% of total commitments at a rate of 0.15% per annum, payable quarterly in arrears. A 0.10% fee is payable if the maturity of the CTBC Revolving Credit Facilities is extended. Each prepayment of a loan under the CTBC Revolving Credit Facilities on a date other than the last day of the applicable interest period and any cancellation of commitments under the CTBC Revolving Credit Facilities is subject to a fee of 0.15% of the relevant prepaid amount and/or cancelled amount.
The CTBC Revolving Credit Facilities mature on the first anniversary of the date of initial utilization; if no utilization is made within six months following the signing date of the Credit Agreement, the date of initial utilization will be deemed to be the first day following the completion of such six-month period. We may extend the maturity of the CTBC Revolving Credit Facilities on no more than two occasions, in each case by an additional year. The Credit Agreement is governed by the laws of Taiwan, and disputes are subject to the non-exclusive jurisdiction of the courts of Taiwan. The upfront fees totaling $13.7 million incurred in connection with the credit agreement were capitalized as deferred cost and recorded as a current asset included within prepaid expenses and other current assets on the condensed consolidated balance sheet as of issuance of the credit facilities. These deferred financing costs are being amortized to interest expense over the term of the Revolving Credit Facility and not material.

As of March 31, 2026, we had $1,763.0 million outstanding under the CTBC Revolving Credit Facilities.
Note 9. Convertible Notes

The following table summarizes our convertible notes as of March 31, 2026:

 
Issuance Date
Principal (in millions)
Coupon Interest
MaturityConversion price
Carrying Value (in millions)
Effective Interest Rate
2028 Convertible Notes
2/20/2025$700.0 2.25 %7/15/2028$61.06 $688.9 2.97 %
2029 Convertible Notes
2/27/2024$1,725.0 3.50 %3/1/2029$83.44 $1,707.8 3.86 %
2030 Convertible Notes
6/23/2025$2,300.0 0.00 %6/15/2030$55.20 $2,262.7 0.39 %

All notes are senior unsecured obligations ranking equally in right of payment with one another and senior to any future subordinated indebtedness. Each series is convertible, at our election, into cash, shares of our common stock, or a combination thereof, and none were eligible for early conversion as of March 31, 2026.

2029 Convertible Notes

We issued $1,725.0 million of 0.00% Convertible Senior Notes due 2029 (“Original 2029 Notes”) in February 2024. On February 20, 2025, we executed privately negotiated subscription and supplemental indenture agreements to amend the Original 2029 Notes (the “2029 Amendments”). Key changes included (i) establishing a 3.50% annual coupon, payable semi-annually on March 1 and September 1 beginning September 2025, and (ii) adjusting the conversion rate to 11.9842 shares per $1,000 principal amount, equivalent to a conversion price of approximately $83.44 per share. All other material terms remained substantially unchanged.

The amendment was accounted for as an extinguishment of the original debt and issuance of new debt under Accounting Standards Codification (“ASC”) 470-50, resulting in a $30.3 million extinguishment loss recorded in other income (expense), net, during the quarter ended March 31, 2025. Debt issuance costs are amortized to interest expense using the effective interest method.

Holders may convert their notes upon the occurrence of certain conditions, including: (1) if our stock price exceeds 130% of the conversion price for 20 of 30 consecutive trading days; (2) if the trading price of the notes is below 98% of the product of the stock price and conversion rate; (3) upon certain corporate events or distributions; (4) if we call the notes for redemption; or (5) at any time from and after September 1, 2028 until the second scheduled trading day before maturity. The notes are redeemable, in whole or in part, at our option beginning March 1, 2027 if our stock price exceeds 130% of the conversion price for a specified period, at a price equal to the principal amount plus accrued and unpaid interest.

As of March 31, 2026 and June 30, 2025, unamortized issuance costs are $17.2 million and $21.3 million, respectively. The interest expense for the three months ended March 31, 2026 and 2025 totaled $16.5 million and $8.2 million, respectively, including $1.4 million and $0.8 million, respectively, from the amortization of debt issuance costs. Interest expense for the nine months ended March 31, 2026 and 2025 totaled $49.4 million and $8.2 million, respectively, including $4.1 million and $0.8 million, respectively, from the amortization of debt issuance costs.
In connection with the issuance, we entered into 2029 Capped Call Transactions with certain financial institutions to reduce potential dilution upon conversion or offset cash payments exceeding principal. The capped calls were initially structured with a $134.14 strike price and $195.10 cap price and were amended in February 2025 to reflect the updated conversion rate. The amended cap price is $94.17 per share. These instruments are equity-classified under ASC 815-40, and no incremental value was recorded upon amendment.

2028 Convertible Notes

On February 20, 2025, we issued $700.0 million aggregate principal amount of 2028 Convertible Notes under an indenture with U.S. Bank Trust Company, N.A., as trustee. The notes were issued concurrently with the amended 2029 Convertible Notes and are convertible, at our election, into cash, shares of common stock, or a combination of both. The initial conversion rate is 16.3784 shares per $1,000 principal amount, equivalent to a conversion price of approximately $61.06 per share.

Holders may convert their 2028 Convertible Notes at their option only in the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on June 30, 2025, if the last reported sale price per share of our common stock exceeds 130% of the conversion price for each of at least 20 trading days (whether or not consecutive) during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2) during the five consecutive business days immediately after any five consecutive trading day period (such five consecutive trading day period, the “2028 Convertible Note measurement period”) in which the trading price per $1,000 principal amount of 2028 Convertible Notes for each trading day of the 2028 Convertible Note measurement period was less than 98% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day; (3) upon the occurrence of certain corporate events or distributions on our common stock, as described in the 2028 Convertible Notes Indenture; (4) if we call the 2028 Convertible Notes for redemption; and (5) at any time from, and including, January 15, 2028 until the close of business on the second scheduled trading day immediately before the maturity date irrespective of the circumstances in (1) - (4) above.

Interest accrues from February 20, 2025, and is payable semi-annually on January 15 and July 15, beginning July 15, 2025. The notes mature on July 15, 2028, unless earlier converted, redeemed, or repurchased. Redemption may occur on or after March 1, 2026, if the stock price exceeds 150% of the conversion price for a specified period.

The notes include customary provisions for conversion, redemption, and repurchase following a fundamental change. Upon such an event, holders may require us to repurchase all or part of their notes for cash equal to 100% of principal plus accrued interest, and the conversion rate may be increased for holders converting in connection with a qualifying corporate event or redemption.

We accounted for the 2028 Convertible Notes as a single liability measured at amortized cost, as no embedded features required bifurcation as derivatives. As of March 31, 2026 and June 30, 2025, unamortized issuance costs are $11.1 million and $14.6 million, respectively. Interest expense for the three months ended March 31, 2026 and 2025 totaled $5.1 million and $1.8 million, respectively, including $1.2 million and $0.5 million, respectively, from the amortization of debt issuance costs. Interest expense for the nine months ended March 31, 2026 and 2025 totaled $15.3 million and $1.8 million, respectively, including $3.5 million and $0.5 million, respectively, from the amortization of debt issuance costs.

2030 Convertible Notes

On June 23, 2025, we issued $2,300 million aggregate principal amount of 2030 Convertible Notes, including the $300.0 million overallotment option. Net proceeds were approximately $2,256.0 million after issuance costs.

The 2030 Convertible Notes are convertible at an initial rate of 18.1154 shares per $1,000 principal amount, equivalent to a conversion price of approximately $55.20 per share. Conversion prior to December 17, 2029 is permitted only if specified conditions are met (similar to those of the 2028 Convertible Notes and the 2029 Convertible Notes). After that date, the notes become convertible at any time up to two trading days before maturity.
Holders may convert their 2030 Convertible Notes upon the occurrence of certain conditions, including: (1) during any calendar quarter commencing after the calendar quarter ending on September 30, 2025, if our stock price exceeds 130% of the conversion price for 20 of 30 consecutive trading days; (2) during the five consecutive business days immediately after any five consecutive trading day period (such five consecutive trading day period, the “measurement period”) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day; (3) upon certain corporate events or distributions on our common stock, as described in the Indenture; (4) if we call the notes for redemption; or (5) at any time from and after December 17, 2029 until the second scheduled trading day before maturity. The notes are redeemable, in whole or in part, beginning June 15, 2028 if our stock price exceeds 130% of the conversion price for a specified period, at a price equal to the principal amount plus accrued and unpaid interest.

As of March 31, 2026 and June 30, 2025, unamortized issuance costs are $37.3 million and $43.9 million, respectively. Interest expense for the three and nine months ended March 31, 2026 totaled $2.2 million and $6.6 million, respectively, all of which are amortization of debt issuance costs.

We entered into 2030 Capped Call Transactions with certain counterparties to mitigate dilution or cash outflows above principal upon conversion. The capped calls have an initial cap price of $81.78 per share, representing a 100% premium to the $40.89 share price on the issuance date. These instruments are equity-classified under ASC 815-40.
v3.26.1
Convertible Notes
9 Months Ended
Mar. 31, 2026
Debt Disclosure [Abstract]  
Convertible Notes
Note 8. Lines of Credit, Revolving Credit Facilities, and Term Loans

Short-term and long-term loan obligations with respect to lines of credit and term loans as of March 31, 2026 and June 30, 2025 consisted of the following (in thousands):
 
 March 31,June 30,
 20262025
Lines of credit:
CTBC Credit Lines$181,305 $— 
Chang Hwa Bank Credit Lines25,005 — 
E.SUN Bank Credit Lines50,000 30,000 
Mega Bank Credit Lines30,000 — 
First Bank Credit Lines19,935 — 
JP Morgan Revolving Credit Facility2,000,000 — 
CTBC Revolving Credit Facilities1,762,970 — 
Total lines of credit4,069,215 30,000 
Term loan facilities:
Chang Hwa Bank Credit Facility due October 15, 20264,562 11,399 
CTBC Term Loan Facility, due June 4, 203022,343 28,822 
CTBC Term Loan Facility, due August 15, 2026603 1,846 
E.SUN Bank Term Loan Facility, due September 15, 20265,005 13,678 
E.SUN Bank Term Loan Facility, due August 15, 20275,760 9,632 
Mega Bank Term Loan Facility, due October 3, 20266,256 17,098 
Total term loans44,529 82,475 
Total lines of credit and term loans$4,113,744 $112,475 
Lines of credit and term loans, current$2,095,069 $75,060 
Lines of credit and term loans, non-current$2,018,675 $37,415 
Activities under Lines of Credit, Revolving Credit Facilities, and Term Loans

Available borrowings and interest rates as of March 31, 2026 and June 30, 2025 consisted of the following (in thousands except for percentages):

 March 31, 2026June 30, 2025
Available borrowingsInterest rateAvailable borrowingsInterest rate
Lines of credit:
CTBC Credit Lines$3,695 
2.26% - 4.62%
$185,000 
2.63% - 5.79%
Chang Hwa Bank Credit Lines$1,714 
1.88% - 4.40%
$30,259 
1.88% - 5.16%
E.SUN Bank Credit Lines$10,000 
2.02% - 4.67%
$30,000 
2.02% - 5.12%
Mega Bank Credit Lines$3,744 
2.23% - 4.48%
$50,000 
1.90% - 5.26%
First Bank Credit Lines$65 
2.03% - 4.49%
$— 
n/a
JP Morgan Revolving Credit Facility$— 
3.67% - 3.67%
$— 
n/a
CTBC Revolving Credit Facilities$— 
2.86% - 5.11%
$— 
n/a
Term loan facilities:
Chang Hwa Bank Credit Facility due October 15, 2026$— 2.08%$— 2.08%
CTBC Term Loan Facility, due June 4, 2030$— 
1.33% - 1.83%
$— 
1.33% - 1.83%
CTBC Term Loan Facility, due August 15, 2026$— 
2.03%
$— 
1.53% - 2.03%
E.SUN Bank Term Loan Facility, due September 15, 2026$— 
2.22%
$— 2.22%
E.SUN Bank Term Loan Facility, due August 15, 2027$— 2.22%$— 1.92%
Mega Bank Term Loan Facility, due October 3, 2026$— 
 2.02%
$— 
2.02%
See Note 7, “Lines of Credit and Term Loans” of our Annual Report on Form 10-K for the fiscal year ended June 30, 2025 for a more complete description of our credit facilities.

Principal payments on lines of credit and term loans are due as follows (in thousands):

 Fiscal Year:
 Principal Payments
Remainder of 2026$291,545 
20271,805,882 
20286,039 
20295,362 
20304,916 
2031 and thereafter2,000,000
Total lines of credit and term loans$4,113,744 

As of March 31, 2026, we were in compliance with all the covenants for the lines of credit and term loans on our condensed consolidated balance sheets.
We entered into new agreements, or extensions of previous agreements, during the nine months ended March 31, 2026, with the following terms:

CTBC Bank Credit Lines

2025 CTBC Facility Letter

On February 13, 2026, our Taiwan subsidiary received a facility extension letter to extend the maturity date, originally set to expire on February 28, 2026, to March 31, 2027.

As of March 31, 2026, the outstanding borrowings under the 2025 CTBC Bank Credit Lines was $181.3 million.

Mega Bank

Mega Bank Credit Facilities

On February 4, 2026, our Taiwan subsidiary renewed the facility from Mega Bank. The renewed facility continues to provide up to $50.0 million including sub-item of NTD 600.0 million in total credit capacity. The maturity date is January 8, 2027.

As of March 31, 2026, the outstanding borrowings under this facility was $30.0 million.

First Bank

On July 18, 2025, our Taiwan subsidiary renewed the Credit Agreement and the Foreign Currency Agreement with First Commercial Bank Co., Ltd. (“First Bank”). The credit lines are $20.0 million, including a sub-item credit limit of NTD 600.0 million designed for short-term working capital loans. Subsequently on February 26, 2026, we renewed the Credit Agreement and the new maturity date is March 9, 2027.

As of March 31, 2026, the outstanding borrowings under the First Bank credit line was $19.9 million.

JP Morgan Revolving Credit Facility

On December 29, 2025, we entered into a credit agreement (the “Credit Agreement”) with JPMorgan Chase Bank, N.A., (“JP Morgan”) as administrative agent and collateral agent, and a syndicate of lenders, which provides for a revolving credit facility of up to $2,000.0 million (the “Revolving Credit Facility”), including a $200.0 million letter of credit sub-limit and a $150.0 million same-day borrowing sub-limit, with an option to increase total commitments by up to $1,000.0 million subject to certain conditions. Borrowings under the Revolving Credit Facility may be used for working capital and other general corporate purposes. The upfront fees totaling $9.8 million incurred in connection with the credit agreement were capitalized as deferred cost and recorded as a non-current asset included within other assets on the condensed consolidated balance sheet as of issuance of the credit facility. These deferred financing costs are being amortized to interest expense over the term of the Revolving Credit Facility and not material.

As of March 31, 2026, we had $2,000.0 million outstanding under the Revolving Credit Facility.
Borrowings under the Revolving Credit Facility bear interest, at our option, at either an alternate base rate (“ABR”) or a term rate, in each case plus an applicable margin. The applicable margin varies based on (i) during a non-investment grade period, our leverage ratio (ranging from 1.25% to 2.00% for term rate loans and 0.25% to 1.00% for ABR loans), or (ii) during an investment grade period, our corporate family rating (ranging from 1.13% to 1.38% for term rate loans and 0.13% to 0.38% for ABR loans). We also pay a quarterly commitment fee on unused commitments ranging from 0.15% to 0.30% during a non-investment grade period (or 0.12% to 0.15% during an investment grade period). Investment grade period refers to the period beginning on the date (no earlier than September 30, 2026) when we attain an investment grade corporate family rating from at least two of Moody’s (Baa3 or higher), S&P (BBB- or higher), and Fitch (BBB- or higher), in each case with a stable or better outlook, and delivers an officer’s certificate to the administrative agent confirming such ratings, and continuing until the occurrence of a subsequent non-investment grade trigger event. The Revolving Credit Facility matures on December 29, 2030.

During any non-investment grade period, the Revolving Credit Facility is guaranteed by us and certain qualifying domestic subsidiaries (subject to customary exclusions) and is secured by a first-priority lien on substantially all assets of the applicable loan parties (subject to customary exclusions). The Credit Agreement includes customary restrictive covenants (some of which are not applicable during an investment grade period), including limitations on indebtedness, investments, and restricted payments, and a maximum total net leverage ratio covenant of 4.00:1.00 for the first four full fiscal quarters after inception, stepping down to 3.50:1.00 for the next four full fiscal quarters, and 3.00:1.00 thereafter. The Credit Agreement contains customary events of default (including change of control), which upon occurrence may result in the acceleration of amounts outstanding and termination of lender commitments.

CTBC Revolving Credit Facilities

On January 21, 2026, we entered into a facilities agreement (the “Credit Agreement”) with a group of lenders led by CTBC Bank Co., Ltd., along with Credit Agricole Corporate and Investment Bank, Taipei Branch and E.Sun Commercial Bank, Ltd. as mandated lead arrangers and bookrunners (with CTBC Bank Co., Ltd. also acting as administrative agent under the Credit Agreement). The agreement provides for two revolving credit facilities totaling $710.0 million (the “CTBC Revolving Credit Facilities”), comprised of Facility A1 ($350.0 million) and Facility A2 ($360.0 million), with an option to increase total commitments to up to $2,000.0 million, subject to certain conditions. On January 30, 2026, we entered into an increased facilities letter under the Credit Agreement, providing for additional revolving credit facilities in an aggregate amount of $1,055.0 million. As a result, the total lender commitments under the Credit Agreement increased to $1,765.0 million.

The proceeds of the CTBC Revolving Credit Facilities may be applied to procure certain components and/or raw materials, subject to specified invoice and purchase order documentation and related timing requirements. We may request loans under the CTBC Revolving Credit Facilities at any time until and including the date falling one month prior to the maturity date. We intend to use the proceeds under the Credit Agreement for general corporate purposes, including to fund working capital for growth and business expansion, subject to the foregoing conditions.

Borrowings under Facility A1 denominated in USD accrue interest at the US dollar offered rate of the Taipei Forex Trading Center (“TAIFX3”) (subject to a zero floor) plus a margin of 1.0% per annum, and borrowings under Facility A2 denominated in USD accrue interest at Term SOFR (subject to a zero floor) plus a margin of 1.2% per annum. Borrowings under Facility A1 and Facility A2 denominated in NTD accrue interest at the Taipei Interbank Offered Rate (“TAIBOR”) (subject to a zero floor) plus a margin of 1.0% per annum; provided that the interest rate applicable to any loan denominated in NTD will never be less than 1.7%. We pay a commitment fee on unused and available commitments under the CTBC Revolving Credit Facilities on each day of the availability period that the daily average utilization amount of the CTBC Revolving Credit Facilities is less than 50% of total commitments at a rate of 0.15% per annum, payable quarterly in arrears. A 0.10% fee is payable if the maturity of the CTBC Revolving Credit Facilities is extended. Each prepayment of a loan under the CTBC Revolving Credit Facilities on a date other than the last day of the applicable interest period and any cancellation of commitments under the CTBC Revolving Credit Facilities is subject to a fee of 0.15% of the relevant prepaid amount and/or cancelled amount.
The CTBC Revolving Credit Facilities mature on the first anniversary of the date of initial utilization; if no utilization is made within six months following the signing date of the Credit Agreement, the date of initial utilization will be deemed to be the first day following the completion of such six-month period. We may extend the maturity of the CTBC Revolving Credit Facilities on no more than two occasions, in each case by an additional year. The Credit Agreement is governed by the laws of Taiwan, and disputes are subject to the non-exclusive jurisdiction of the courts of Taiwan. The upfront fees totaling $13.7 million incurred in connection with the credit agreement were capitalized as deferred cost and recorded as a current asset included within prepaid expenses and other current assets on the condensed consolidated balance sheet as of issuance of the credit facilities. These deferred financing costs are being amortized to interest expense over the term of the Revolving Credit Facility and not material.

As of March 31, 2026, we had $1,763.0 million outstanding under the CTBC Revolving Credit Facilities.
Note 9. Convertible Notes

The following table summarizes our convertible notes as of March 31, 2026:

 
Issuance Date
Principal (in millions)
Coupon Interest
MaturityConversion price
Carrying Value (in millions)
Effective Interest Rate
2028 Convertible Notes
2/20/2025$700.0 2.25 %7/15/2028$61.06 $688.9 2.97 %
2029 Convertible Notes
2/27/2024$1,725.0 3.50 %3/1/2029$83.44 $1,707.8 3.86 %
2030 Convertible Notes
6/23/2025$2,300.0 0.00 %6/15/2030$55.20 $2,262.7 0.39 %

All notes are senior unsecured obligations ranking equally in right of payment with one another and senior to any future subordinated indebtedness. Each series is convertible, at our election, into cash, shares of our common stock, or a combination thereof, and none were eligible for early conversion as of March 31, 2026.

2029 Convertible Notes

We issued $1,725.0 million of 0.00% Convertible Senior Notes due 2029 (“Original 2029 Notes”) in February 2024. On February 20, 2025, we executed privately negotiated subscription and supplemental indenture agreements to amend the Original 2029 Notes (the “2029 Amendments”). Key changes included (i) establishing a 3.50% annual coupon, payable semi-annually on March 1 and September 1 beginning September 2025, and (ii) adjusting the conversion rate to 11.9842 shares per $1,000 principal amount, equivalent to a conversion price of approximately $83.44 per share. All other material terms remained substantially unchanged.

The amendment was accounted for as an extinguishment of the original debt and issuance of new debt under Accounting Standards Codification (“ASC”) 470-50, resulting in a $30.3 million extinguishment loss recorded in other income (expense), net, during the quarter ended March 31, 2025. Debt issuance costs are amortized to interest expense using the effective interest method.

Holders may convert their notes upon the occurrence of certain conditions, including: (1) if our stock price exceeds 130% of the conversion price for 20 of 30 consecutive trading days; (2) if the trading price of the notes is below 98% of the product of the stock price and conversion rate; (3) upon certain corporate events or distributions; (4) if we call the notes for redemption; or (5) at any time from and after September 1, 2028 until the second scheduled trading day before maturity. The notes are redeemable, in whole or in part, at our option beginning March 1, 2027 if our stock price exceeds 130% of the conversion price for a specified period, at a price equal to the principal amount plus accrued and unpaid interest.

As of March 31, 2026 and June 30, 2025, unamortized issuance costs are $17.2 million and $21.3 million, respectively. The interest expense for the three months ended March 31, 2026 and 2025 totaled $16.5 million and $8.2 million, respectively, including $1.4 million and $0.8 million, respectively, from the amortization of debt issuance costs. Interest expense for the nine months ended March 31, 2026 and 2025 totaled $49.4 million and $8.2 million, respectively, including $4.1 million and $0.8 million, respectively, from the amortization of debt issuance costs.
In connection with the issuance, we entered into 2029 Capped Call Transactions with certain financial institutions to reduce potential dilution upon conversion or offset cash payments exceeding principal. The capped calls were initially structured with a $134.14 strike price and $195.10 cap price and were amended in February 2025 to reflect the updated conversion rate. The amended cap price is $94.17 per share. These instruments are equity-classified under ASC 815-40, and no incremental value was recorded upon amendment.

2028 Convertible Notes

On February 20, 2025, we issued $700.0 million aggregate principal amount of 2028 Convertible Notes under an indenture with U.S. Bank Trust Company, N.A., as trustee. The notes were issued concurrently with the amended 2029 Convertible Notes and are convertible, at our election, into cash, shares of common stock, or a combination of both. The initial conversion rate is 16.3784 shares per $1,000 principal amount, equivalent to a conversion price of approximately $61.06 per share.

Holders may convert their 2028 Convertible Notes at their option only in the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on June 30, 2025, if the last reported sale price per share of our common stock exceeds 130% of the conversion price for each of at least 20 trading days (whether or not consecutive) during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2) during the five consecutive business days immediately after any five consecutive trading day period (such five consecutive trading day period, the “2028 Convertible Note measurement period”) in which the trading price per $1,000 principal amount of 2028 Convertible Notes for each trading day of the 2028 Convertible Note measurement period was less than 98% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day; (3) upon the occurrence of certain corporate events or distributions on our common stock, as described in the 2028 Convertible Notes Indenture; (4) if we call the 2028 Convertible Notes for redemption; and (5) at any time from, and including, January 15, 2028 until the close of business on the second scheduled trading day immediately before the maturity date irrespective of the circumstances in (1) - (4) above.

Interest accrues from February 20, 2025, and is payable semi-annually on January 15 and July 15, beginning July 15, 2025. The notes mature on July 15, 2028, unless earlier converted, redeemed, or repurchased. Redemption may occur on or after March 1, 2026, if the stock price exceeds 150% of the conversion price for a specified period.

The notes include customary provisions for conversion, redemption, and repurchase following a fundamental change. Upon such an event, holders may require us to repurchase all or part of their notes for cash equal to 100% of principal plus accrued interest, and the conversion rate may be increased for holders converting in connection with a qualifying corporate event or redemption.

We accounted for the 2028 Convertible Notes as a single liability measured at amortized cost, as no embedded features required bifurcation as derivatives. As of March 31, 2026 and June 30, 2025, unamortized issuance costs are $11.1 million and $14.6 million, respectively. Interest expense for the three months ended March 31, 2026 and 2025 totaled $5.1 million and $1.8 million, respectively, including $1.2 million and $0.5 million, respectively, from the amortization of debt issuance costs. Interest expense for the nine months ended March 31, 2026 and 2025 totaled $15.3 million and $1.8 million, respectively, including $3.5 million and $0.5 million, respectively, from the amortization of debt issuance costs.

2030 Convertible Notes

On June 23, 2025, we issued $2,300 million aggregate principal amount of 2030 Convertible Notes, including the $300.0 million overallotment option. Net proceeds were approximately $2,256.0 million after issuance costs.

The 2030 Convertible Notes are convertible at an initial rate of 18.1154 shares per $1,000 principal amount, equivalent to a conversion price of approximately $55.20 per share. Conversion prior to December 17, 2029 is permitted only if specified conditions are met (similar to those of the 2028 Convertible Notes and the 2029 Convertible Notes). After that date, the notes become convertible at any time up to two trading days before maturity.
Holders may convert their 2030 Convertible Notes upon the occurrence of certain conditions, including: (1) during any calendar quarter commencing after the calendar quarter ending on September 30, 2025, if our stock price exceeds 130% of the conversion price for 20 of 30 consecutive trading days; (2) during the five consecutive business days immediately after any five consecutive trading day period (such five consecutive trading day period, the “measurement period”) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day; (3) upon certain corporate events or distributions on our common stock, as described in the Indenture; (4) if we call the notes for redemption; or (5) at any time from and after December 17, 2029 until the second scheduled trading day before maturity. The notes are redeemable, in whole or in part, beginning June 15, 2028 if our stock price exceeds 130% of the conversion price for a specified period, at a price equal to the principal amount plus accrued and unpaid interest.

As of March 31, 2026 and June 30, 2025, unamortized issuance costs are $37.3 million and $43.9 million, respectively. Interest expense for the three and nine months ended March 31, 2026 totaled $2.2 million and $6.6 million, respectively, all of which are amortization of debt issuance costs.

We entered into 2030 Capped Call Transactions with certain counterparties to mitigate dilution or cash outflows above principal upon conversion. The capped calls have an initial cap price of $81.78 per share, representing a 100% premium to the $40.89 share price on the issuance date. These instruments are equity-classified under ASC 815-40.
v3.26.1
Leases
9 Months Ended
Mar. 31, 2026
Leases [Abstract]  
Leases
Note 10. Leases

We lease offices, warehouses and other premises, vehicles and certain equipment under non-cancelable operating leases. Operating lease expense recognized and supplemental cash flow information related to operating leases for the three and nine months ended March 31, 2026 and 2025 were as follows (in thousands):

Three Months Ended
March 31,
Nine Months Ended
March 31,
2026202520262025
Operating lease expense (including expense for lease agreements with related parties of $292 and $208 for the three months ended March 31, 2026 and 2025, respectively, and $758 and $538 for the nine months ended March 31, 2026 and 2025, respectively)
$15,098 $5,712 $43,117 $12,685 
Cash payments for operating leases (including payments to related parties of $297 and $202 for the three months ended March 31, 2026 and 2025, respectively, and $788 and $508 for the nine months ended March 31, 2026 and 2025, respectively)
$13,663 $5,380 $36,012 $11,959 
New operating lease assets obtained in exchange for operating lease liabilities $834 $110,145 $94,907 $128,617 

During the three and nine months ended March 31, 2026 and 2025, our costs related to short-term lease arrangements were immaterial. Variable lease payments expensed in the three and nine months ended March 31, 2026 and 2025 were immaterial.
ROU assets and lease liabilities are recorded in the condensed consolidated balance sheets as follows (in thousands):

March 31, 2026June 30, 2025
Other assets
$361,437 $293,692 
Accrued liabilities
$32,703 $21,189 
Other long-term liabilities
345,352 280,368 
Total lease liabilities$378,055 $301,557 
Weighted average remaining lease term
8.6 years
9.1 years
Weighted average discount rate (1)
5.8 %5.8 %

(1) As the interest rate in the lease contract is typically not readily available, we estimate the incremental borrowing rate considering credit notching approach based on information available at lease commencement.

In June 2024, we entered into a lease agreement for a 21 megawatt (“MW”) data center co-location space located in Vernon, California (the “Data Center Space”) that will expire on September 30, 2035. We do not have an option to extend (or to terminate) the lease. The lease agreement consists of three tranches, with the first tranche of 6 MW having commenced on January 24, 2025, the second tranche of 9 MW commenced on May 12, 2025, and the third tranche of 6 MW commenced on August 15, 2025. As of March 31, 2026, the ROU assets and lease liabilities related to all three tranches totaled $284.0 million and $294.9 million, respectively. Variable lease payments not dependent on a rate or index associated with our leases are recognized when the event, activity, or circumstance in the lease agreement on which those payments are assessed as probable. Variable lease payments are presented as operating expenses in the condensed consolidated statements of operations.

Simultaneously, we entered into a Sublicense agreement, the term of which coincides with our Data Center Space lease. We accounted for the lease as an operating lease and the Sublicense as a sublease under Accounting Standards Codification Topic 842, Leases. The Sublicense did not relieve our original obligation under the Data Center Space lease, and therefore we did not adjust the operating lease ROU asset and related liability. Sublicense income is recognized on a straight-line basis and the rental income is included in other income (expense), net on the condensed consolidated statements of operations.

Rental income is included in other income (expense), net on the condensed consolidated statements of operations (in thousands):

Three Months Ended
March 31,
Nine Months Ended
March 31,
2026202520262025
Sublease income$10,524 $1,300 $29,181 $1,300 
As of March 31, 2026, the future total minimum Sublicense receipts expected to be received are as follows (in thousands):

Fiscal Year:Future minimum Sublicense receipts
Remainder of 2026$9,492 
202738,348 
202839,499 
202940,684 
203041,904 
2031 and beyond241,533 
Total Sublicense receipts - Lessor$411,460 

Maturities of operating lease liabilities under non-cancelable operating lease arrangements as of March 31, 2026 are as follows (in thousands):

Fiscal Year:
Maturities of operating leases
Remainder of 2026$14,123 
202755,980 
202855,498 
202955,890 
203057,437 
2031 and beyond251,685 
Total future lease payments490,613 
Less: Imputed interest(112,558)
Present value of operating lease liabilities $378,055 
Current portion$32,703 
Long-term portion$345,352 

Related party leases

We have entered into lease agreements with related parties. See Note 11, “Related Party Transactions” for further discussion.
v3.26.1
Related Party Transactions
9 Months Ended
Mar. 31, 2026
Related Party Transactions [Abstract]  
Related Party Transactions
Note 11. Related Party Transactions

We have a variety of business relationships with Ablecom Technology Inc (“Ablecom”) and Compuware Technology Inc (“Compuware”), both of which are Taiwan-based corporations. Ablecom is a major contract manufacturer for us and its Chief Executive Officer, Steve Liang, is the brother of Charles Liang, our President, Chief Executive Officer and Chairman of the Board. As of March 31, 2026, Steve Liang and his family members owned approximately 35.0% of Ablecom’s stock. Charles Liang and his spouse, Sara Liu, who is also an officer and director for us, collectively owned approximately 10.5% of Ablecom’s capital stock as of March 31, 2026. Bill Liang, a brother of both Charles Liang and Steve Liang, is a member of the board of directors of Ablecom. Bill Liang is also the Chief Executive Officer of Compuware, Chairman of Compuware’s board of directors and a holder of equity interest in Compuware. Steve Liang is also a member of Compuware’s board of directors and is an equity holder of Compuware. Compuware is also a major contract manufacturer for us and a distributor of our products in limited geographic regions. Neither Charles Liang nor Sara Liu own any capital stock of Compuware.
In October 2018, our Chief Executive Officer, Charles Liang, personally borrowed approximately $12.9 million from Chien-Tsun Chang, the spouse of Steve Liang. The loan was unsecured, had no maturity date and bore interest at 0.80% per month for the first six months, increased to 0.85% per month through February 28, 2020, and reduced to 0.25% effective March 1, 2020. The loan was originally made at Mr. Liang's request to provide funds to repay margin loans to two financial institutions, which loans had been secured by shares of our common stock that he held. The lenders called the loans in October 2018, following the suspension of our common stock from trading on Nasdaq in August 2018 and the decline in the market price of our common stock in October 2018. As of March 31, 2026 and June 30, 2025, the amount due on the unsecured loan (including principal and accrued interest) was $0.0 million and approximately $16.8 million, respectively. On October 9, 2025, the outstanding loan principal and accrued interest through October 8, 2025, totaling $16.9 million was repaid in full.

Dealings with Ablecom

We have entered into a series of agreements with Ablecom, including, but not limited to, multiple product development, production and service agreements, credit agreements, product manufacturing agreements, manufacturing services agreements and lease agreements for warehouse space.

Under these agreements, we outsource to Ablecom a portion of our design activities and a significant part of our server chassis manufacturing as well as an immaterial portion of other components. Ablecom manufactured approximately 94.0% and 95.0% of the chassis purchased by us during the three months ended March 31, 2026 and 2025, respectively, and 95.5% and 95.2% of the chassis purchased by us during the nine months ended March 31, 2026 and 2025, respectively. With respect to design activities, Ablecom generally agrees to design certain agreed-upon products according to our specifications, and further agrees to build the tools needed to manufacture the products. We pay Ablecom for the design and engineering services, and further agree to pay Ablecom for the tooling. We retain full ownership of any intellectual property resulting from the design of these products and tooling.

During the third quarter ended March 31, 2026, we entered into an arrangement for Ablecom to resell certain products, to an end customer in Japan. The transaction was entered into in the ordinary course of business, and the related terms and conditions were consistent with those negotiated with other third-party resellers for similar transactions.

With respect to the manufacturing aspects of the relationship, Ablecom purchases most of the materials needed to manufacture the chassis from third parties and we provide certain components used in the manufacturing process (such as power supplies) to Ablecom through consignment or sales transactions. Ablecom uses these materials and components to manufacture the completed chassis and then sell them back to us. For the components purchased from us, Ablecom sells the components back to us at a price equal to the price at which we sold the components to Ablecom. There is no revenue recognized by us from these transactions. We and Ablecom frequently review and negotiate the prices of the chassis we purchase from Ablecom. In addition to inventory purchases, we also incur other costs associated with design services, tooling and other miscellaneous costs from Ablecom.

Our exposure to financial loss as a result of our involvement with Ablecom is limited to potential losses on our purchase orders in the event of an unforeseen decline in the market price and/or demand of our products such that we incur a loss on the sale or cannot sell the products. Non-cancelable purchase orders from us to Ablecom on March 31, 2026 and June 30, 2025 were $49.3 million and $30.6 million, respectively, effectively representing the exposure to financial loss. We do not directly or indirectly guarantee any obligations of Ablecom, or any losses that the equity holders of Ablecom may suffer. Since Ablecom manufactures substantially all the chassis that we incorporate into our products, if Ablecom were to suddenly be unable to manufacture chassis for us, our business could suffer if we are unable to quickly qualify substitute suppliers who can supply high-quality chassis to us in volume and at acceptable prices. We have extended a $10.0 million trade credit line with a net 30 days payment term to Ablecom through a credit agreement that outlines the terms and conditions governing their business dealings.
Dealings with Compuware

We appointed Compuware as a non-exclusive authorized distributor of our products in Taiwan, China, Australia, Malaysia, and U.S. Compuware assumes the responsibility of installing our products at the site of the end customer, if required, and administers customer support in exchange for a discount from our standard price for its purchases. From time to time, Compuware acts as a sales representative for us in exchange for a fee that is based on a percentage of net sales generated from customers introduced to us. The fee structure for Compuware is comparable to the fee structure offered to other sales representatives in the same geographic region.

We have entered into a series of agreements with Compuware, including multiple product development, production and service agreements, product manufacturing agreements, and lease agreements for office space. We extended a $200.0 million trade credit line on November 19, 2025, with a net 90 days payment term to Compuware through a credit agreement that outlines the terms and conditions governing their business dealings.

Under these agreements, we outsource a portion of our design activities, a significant part of our power supplies manufacturing and an immaterial portion of other components to Compuware. Compuware manufactured approximately 92.4% and 93.7% of the power supplies purchased by us during the three months ended March 31, 2026 and 2025, respectively, and 94.0% and 94.8% of the power supplies purchased by us during the nine months ended March 31, 2026 and 2025, respectively. With respect to design activities, Compuware generally agrees to design certain agreed-upon products according to our specifications and further agree to build the tools needed to manufacture the products. We pay Compuware for the design and engineering services and further agrees to pay Compuware for the tooling. We retain full ownership of any intellectual property resulting from the design of these products and tooling. With respect to the manufacturing aspects of the relationship, Compuware purchases most of the materials needed to manufacture the power supplies from third parties and uses these materials to manufacture the products and then sell those products to us. We and Compuware frequently review and negotiate the prices of the power supplies we purchase from Compuware.
Compuware also manufactures motherboards, backplanes and other components used on printed circuit boards for us. We sell to Compuware most of the components needed to manufacture the above products. Compuware uses the components to manufacture the products and then sells the products back to us at a purchase price equal to the price at which we sold the components to Compuware, plus a “manufacturing value added” fee and other miscellaneous material charges and costs, including overhead and labor. There is no revenue recognized by us from these transactions. We and Compuware frequently review and negotiate the amount of the “manufacturing value added” fee that will be included in the price of the products we purchase from Compuware. In addition to the inventory purchases, we also incur costs associated with design services, tooling assets, and miscellaneous costs.

Our exposure to financial loss as a result of our involvement with Compuware is limited to potential losses on our purchase orders in the event of an unforeseen decline in the market price and/or demand of our products such that we incur a loss on the sale or cannot sell the products. Non-cancelable purchase orders from us to Compuware on March 31, 2026 and June 30, 2025 were $179.3 million and $118.3 million, respectively, effectively representing the exposure to financial loss. We do not directly or indirectly guarantee any obligations of Compuware, or any losses that the equity holders of Compuware may suffer.
Dealings with Leadtek Research Inc.

In October 2023, Ablecom and Compuware acquired an approximately 30% interest in Leadtek Research Inc. (“Leadtek”), a Taiwan company specializing in providing professional graphics cards and workstation solutions (the “Leadtek Investment”). As of December 31, 2025, this interest came down to approximately 29%. Prior to the Leadtek Investment, none of our related parties had direct or indirect material interests in any transactions in which we were a participant with Leadtek. Commencing with the closing of the Leadtek Investment, Steve Liang and Bill Liang have served as two of the seven members of the Leadtek board of directors. We engaged in transactions whereby we sold servers worth $0.4 million and $0.2 million to Leadtek during the three months ended March 31, 2026 and 2025, respectively, and $1.2 million and $0.5 million to Leadtek during the nine months ended March 31, 2026 and 2025, respectively. We did not purchase any graphic cards from Leadtek during the three months ended March 31, 2026 and 2025, respectively. We purchased graphic cards worth $0.0 million and $0.5 million from Leadtek during the nine months ended March 31, 2026 and 2025, respectively.

Dealings with Investment in a Corporate Venture

In October 2016, we entered into agreements pursuant to which we contributed certain technology rights in connection with an investment in a privately held company (the “Corporate Venture”) located in China to expand our presence in China. The Corporate Venture was 30% owned by us and 70% owned by another company in China. The agreement was signed in the third quarter of the fiscal year ended June 30, 2017, and the investment was accounted for using the equity method of accounting. The Corporate Venture was also a related party.

We monitor the investment for events or circumstances indicative of potential impairment and make appropriate reductions in carrying values if we determine that an impairment charge is required. As of June 30, 2025, we concluded the Corporate Venture would be divested in the fiscal year ending June 2026. We performed an impairment analysis on this investment and concluded the remaining carrying value of the equity investment of $6.7 million was impaired as of June 30, 2025. On November 25, 2025, the Equity Transfer Agreement was signed, and the divestiture of our 30% interest was completed on December 23, 2025, and the Corporate Venture ceased to be a related party as of December 23, 2025.

We sold products worth $4.2 million to the Corporate Venture during the three months ended March 31, 2025, and $8.1 million and $9.0 million to the Corporate Venture during the nine months ended March 31, 2026 and 2025, respectively. Our share of intra-entity profits on the products that remained unsold by the Corporate Venture had been eliminated and reduced the carrying value of our investment in the Corporate Venture due to prior impairment write-off as of December 31, 2025. To the extent that the elimination of intra-entity profits reduces the investment balance below zero, such amounts are recorded within accrued liabilities. We had $0.0 million and less than $0.1 million receivables due from the Corporate Venture in accounts receivable, net as of March 31, 2026 and June 30, 2025, respectively.
Other transactions

For the three months ended March 31, 2026, we had no sales to and immaterial purchases from Green Earth Liang’s Inc. (“Green Earth”), an entity affiliated with our Chief Executive Officer. For the three months ended March 31, 2025, we had no transactions from Green Earth Liang’s Inc. For the nine months ended March 31, 2026, we had no sales to and immaterial purchases from Green Earth Liang’s Inc. For the nine months ended March 31, 2025, we had immaterial expense reimbursement from Green Earth Liang's Inc. As of March 31, 2026 and June 30, 2025, there was no amount due to and from Green Earth.

We had the following balances related to transactions with our related parties as of March 31, 2026 and June 30, 2025 (in thousands):

Accounts receivable
Other receivables (1)
Other assetsAccounts payable
Accrued liabilities (2)
Other long-term liabilities (3)
Ablecom
As of March 31, 2026
$$1,344 $59 $88,323 $689 $251 
As of June 30, 2025
$$1,059 $— $55,460 $753 $114 
Compuware
As of March 31, 2026
$430 $27,370 $— $45,729 $641 $243 
As of June 30, 2025
$285 $12,686 $— $74,292 $291 $494 
Corporate Venture
As of March 31, 2026
$— $— $— $— $— $— 
As of June 30, 2025
$30 $— $— $— $— $— 
Leadtek
As of March 31, 2026
$202 $— $— $— $— $— 
As of June 30, 2025
$77 $— $— $— $— $— 
Total
As of March 31, 2026
$633 $28,714 $59 $134,052 $1,330 $494 
As of June 30, 2025
$393 $13,745 $— $129,752 $1,044 $608 

(1) Other receivables include receivables from vendors included in prepaid expenses and other current assets.
(2) Includes current portion of operating lease liabilities included in other current liabilities.
(3) Other long-term liabilities include non-current portion of lease liabilities.
Our results from transactions with our related parties for each of the three months ended March 31, 2026 and 2025, are as follows (in thousands):

Net salesCost of salesPurchase of fixed assetsResearch and DevelopmentSales and marketing
Ablecom
Three months ended March 31, 2026$315 $126,145 $4,444 $1,754 $— 
Three months ended March 31, 2025$$50,147 $7,777 $971 $— 
Compuware
Three months ended March 31, 2026$4,181 $76,695 $$445 $1,104 
Three months ended March 31, 2025$3,278 $65,372 $— $460 $— 
Corporate Venture
Three months ended March 31, 2026$— $— $— $— $— 
Three months ended March 31, 2025$4,201 $— $— $— $— 
Leadtek
Three months ended March 31, 2026$383 $— $— $— $— 
Three months ended March 31, 2025$165 $— $— $— $— 
Green Earth
Three months ended March 31, 2026$— $— $— $— $15 
Three months ended March 31, 2025$— $— $— $— $— 
Total
Three months ended March 31, 2026$4,879 $202,840 $4,450 $2,199 $1,119 
Three months ended March 31, 2025$7,647 $115,519 $7,777 $1,431 $— 

Our results from transactions with our related parties for each of the nine months ended March 31, 2026 and 2025, are as follows (in thousands):

Net salesCost of salesPurchase of fixed assetsResearch and DevelopmentSales and marketing
Ablecom
Nine months ended March 31, 2026$403 $307,907 $7,923 $4,161 $— 
Nine months ended March 31, 2025$10 $252,426 $14,908 $3,958 $— 
Compuware
Nine months ended March 31, 2026$14,184 $242,055 $155 $1,138 $1,739 
Nine months ended March 31, 2025$24,318 $238,720 $371 $1,120 $— 
Corporate Venture*
Nine months ended March 31, 2026$8,147 $— $— $— $— 
Nine months ended March 31, 2025$8,977 $— $— $— $— 
Leadtek
Nine months ended March 31, 2026$1,206 $— $— $— $— 
Nine months ended March 31, 2025$494 $534 $— $— $— 
Green Earth
Nine months ended March 31, 2026$— $— $— $— $76 
Nine months ended March 31, 2025$— $— $— $— $(6)
Total
Nine months ended March 31, 2026$23,940 $549,962 $8,078 $5,299 $1,815 
Nine months ended March 31, 2025$33,799 $491,680 $15,279 $5,078 $(6)

*The divestiture of our 30% interest was completed on December 23, 2025, after which the Corporate Venture ceased to be a related party. Accordingly, this disclosure covers only the six months ended December 31, 2025.
Our cash flow impact from transactions with our related parties for each of the nine months ended March 31, 2026 and 2025, are as follows (in thousands):

Changes in accounts receivableChanges in prepaid expenses and other assetsChanges in accounts payableChanges in accrued liabilitiesChanges in other long-term liabilitiesCash payment for property, plant, and equipmentUnpaid property, plant, and equipment
Ablecom
Nine months ended March 31, 2026$— $(344)$32,863 $(64)$137 $9,217 $2,584 
Nine months ended March 31, 2025$— $577 $(48,270)$487 $227 $10,137 $7,111 
Compuware
Nine months ended March 31, 2026$(145)$(14,684)$(28,563)$350 $(251)$149 $
Nine months ended March 31, 2025$48 $(3,359)$(1,491)$84 $502 $371 $— 
Corporate Venture*
Nine months ended March 31, 2026$30 $— $— $— $— $— $— 
Nine months ended March 31, 2025$4,990 $— $— $— $— $— $— 
Leadtek
Nine months ended March 31, 2026$(125)$— $— $— $— $— $— 
Nine months ended March 31, 2025$840 $— $(230)$— $— $— $— 
Total
Nine months ended March 31, 2026$(240)$(15,028)$4,300 $286 $(114)$9,366 $2,591 
Nine months ended March 31, 2025$5,878 $(2,782)$(49,991)$571 $729 $10,508 $7,111 

*The divestiture of our 30% interest was completed on December 23, 2025, after which the Corporate Venture ceased to be a related party. Accordingly, this disclosure covers only the six months ended December 31, 2025.
v3.26.1
Stock-based Compensation and Stockholders' Equity
9 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Stock-based Compensation and Stockholders' Equity
Note 12. Stock-based Compensation and Stockholders’ Equity

Preferred Stock

We have 10,000,000 shares of undesignated preferred stock, $0.001 par value per share, authorized but not issued with rights and preferences determined by our board of directors at the time of issuance of such shares. As of March 31, 2026 and June 30, 2025, there were no shares of preferred stock issued and outstanding.

Common Stock

We may issue up to 1,000,000,000 shares of common stock, $0.001 par value per share. The holders of our common stock are entitled to one vote for each share held of record on all matters submitted to a vote of stockholders.

Equity Incentive Plan

Our 2020 Equity and Incentive Compensation Plan (the “2020 Plan”) was approved by stockholders on June 5, 2020, authorizing 50,000,000 plus 10,450,000 shares carried over from the 2016 Equity Incentive Plan (the “2016 Plan”). No new awards may be granted under the 2016 Plan, though 72,460,000 shares remained reserved for outstanding awards at the time of adoption. Stockholders approved amendments to the 2020 Plan in May 2022, January 2024, and June 2025, increasing the share reserve by 20,000,000, 15,000,000, and 18,000,000 respectively. Awards under the 2020 Plan include stock options, restricted stock units, performance shares, and other equity-based awards. Stock options are granted at a price not less than fair value (110% for 10% stockholders) and generally expire ten years after the date of the grant. Stock options and RSUs generally vest over four years (25% after one year and quarterly thereafter).

As of March 31, 2026, we had 7,654,346 authorized shares available for future issuance under the 2020 Plan.
Determining Fair Value

We measure RSUs at the grant-date stock price and stock options using the Black-Scholes model, with inputs for expected term, volatility, zero dividend yield, and U.S. Treasury risk-free rates, amortized over the vesting period.

The weighted-average estimated fair value of employee stock options granted during the three and nine months ended March 31, 2026 was $21.70 and $33.98 per share, respectively, and three and nine months ended March 31, 2025 was $18.97 and $26.03, respectively, using the below assumptions.

The fair value of stock option grants for the three and nine months ended March 31, 2026 and 2025 was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions:

 Three Months Ended March 31,Nine Months Ended March 31,
 2026202520262025
Risk-free interest rate
3.92%
4.05% - 4.39%
3.68% - 4.00%
3.82% - 4.39%
Expected term
5.96 years
3.00 years - 5.98 years
3.44 years - 5.96 years
3.00 years - 5.98 years
Dividend yield—%—%—%—%
Volatility
77.64%
73.06% - 95.28%
76.16% - 92.16%
63.67% - 95.28%

The following table shows total stock-based compensation expense included in the condensed consolidated statements of operations for the three and nine months ended March 31, 2026 and 2025 (in thousands):
 
 Three Months Ended March 31,Nine Months Ended March 31,
 2026202520262025
Cost of sales$11,522 $7,060 $25,400 $17,713 
Research and development83,115 54,254 200,090 141,590 
Sales and marketing12,276 9,923 33,700 27,245 
General and administrative19,021 13,467 46,368 44,292 
Stock-based compensation expense before taxes125,934 84,704 305,558 230,840 
Income tax impact(28,713)(22,433)(70,373)(57,442)
Stock-based compensation expense, net$97,221 $62,271 $235,185 $173,398 

During the three and nine months ended March 31, 2026, there was no stock-based compensation expense capitalized to our condensed consolidated balance sheets. During the three and nine months ended March 31, 2025, stock-based compensation expense capitalized to our condensed consolidated balance sheets was $0.2 million and $0.5 million, respectively.

Stock Option Activity

2023 CEO Performance Award

In November 2023, the Compensation Committee granted the CEO a stock option for 5,000,000 shares at an exercise price of $45.00. Vesting occurs in five tranches upon achievement of specified stock price targets ($45.00 to $110.00 per share) and revenue-based operational milestones, subject to continued service. Shares exercised before November 14, 2026 must be held until that date, except for those sold to cover exercise costs and taxes.
The achievement status of the operational and stock price milestones as of March 31, 2026 was as follows:

Annualized Revenue Milestone
(in billions) (1)
Achievement Status
Stock Price Milestone (1)
Achievement Status
$13.0
Achieved (6)
$45.00
Achieved (2)
$15.0
Achieved (7)
$60.00
Achieved (3)
$17.0
Achieved (8)
$75.00
Achieved (4)
$19.0
Achieved (9)
$90.00
Achieved (5)
$21.0
Achieved (10)
$110.00Not yet achieved

(1)Under the terms of the 2023 CEO Performance Stock Option, the annualized revenue milestones and stock price milestones set forth in the table above must be achieved by December 31, 2028 and March 31, 2029, respectively.
(2)On March 2, 2024, the Compensation Committee certified achievement of the $45.00 stock price milestone based upon the 60 trading day average stock price from November 29, 2023 through February 26, 2024.
(3)On April 1, 2024, the Compensation Committee certified achievement of the $60.00 stock price milestone based upon the 60 trading day average stock price from December 15, 2023 through March 13, 2024.
(4)On April 1, 2024, the Compensation Committee certified achievement of the $75.00 stock price milestone based upon the 60 trading day average stock price from January 4, 2024 through April 1, 2024.
(5)On May 5, 2024, the Compensation Committee certified achievement of the $90.00 stock price milestone based upon the 60 trading day average stock price from January 31, 2024 through April 25, 2024.
(6)On February 27, 2025, the Compensation Committee certified achievement of the $13.0 billion revenue milestone based on our previous four consecutive fiscal quarters revenue as of June 30, 2024.
(7)On April 22, 2025, the Compensation Committee certified achievement of the $15.0 billion revenue milestone based on our previous four consecutive fiscal quarters revenue as of September 30, 2024.
(8)On April 22, 2025, the Compensation Committee certified achievement of the $17.0 billion revenue milestone based on our previous four consecutive fiscal quarters revenue as of September 30, 2024.
(9)On April 22, 2025, the Compensation Committee certified achievement of the $19.0 billion revenue milestone based on our previous four consecutive fiscal quarters revenue as of December 31, 2024.
(10)On August 26, 2025, the Compensation Committee certified achievement of the $21.0 billion revenue milestone based on our previous four consecutive fiscal quarters revenue as of March 31, 2025.

During the three and nine months ended March 31, 2026, we recognized compensation expense related to the 2023 CEO Performance Stock Option of $0.9 million and $2.9 million, respectively. During the three and nine months ended March 31, 2025, we recognized compensation expense related to the 2023 CEO Performance Stock Option of $0.9 million and $12.4 million, respectively. As of March 31, 2026, we had $2.6 million in unrecognized compensation cost related to the 2023 CEO Performance Stock Option. The unrecognized compensation cost as of March 31, 2026 is expected to be recognized over a period of 0.75 years.

The following table summarizes stock option activity (including CEO Performance Stock Options) during the nine months ended March 31, 2026 under all plans: 

Options
Outstanding
Weighted
Average
Exercise
Price per
Share
Weighted
Average
Grant Date Fair Value
Weighted
Average
Remaining
Contractual
Term (in Years)
Aggregate
Intrinsic
Value
(in thousands)
Balance as of June 30, 2025
34,848,133 $22.47 $— — $— 
Granted3,178,597 $49.37 $33.98 — $— 
Exercised(1,630,182)$8.17 $— — $— 
Forfeited/Cancelled(975,634)$37.45 $— — $— 
Balance as of March 31, 2026
35,420,914 $25.13 $— 6.49$322,574 
Options exercisable at March 31, 2026
24,885,340 $17.48 $— 5.63$309,416 
The total pretax intrinsic value of options exercised during the three and nine months ended March 31, 2026 was $10.8 million and $50.5 million, respectively. The total pretax intrinsic value of options exercised during the three and nine months ended March 31, 2025 was $46.8 million and $162.6 million, respectively.

As of March 31, 2026, $237.2 million of unrecognized compensation cost related to stock options is expected to be recognized over a weighted-average period of 2.59 years.

RSU Activity

The following table summarizes RSU activity during the nine months ended March 31, 2026 under all plans: 

Time-Based RSUs
Outstanding
Weighted
Average
Grant-Date Fair Value per Share
Balance as of June 30, 2025
20,428,647 $34.22 
Granted8,120,018 $45.07 
Released(8,117,534)$28.50 
Forfeited(1,402,029)$40.15 
Balance as of March 31, 2026
19,029,102 $40.85 

As of March 31, 2026, $689.4 million of unrecognized compensation cost related to unvested RSUs is expected to be recognized over a weighted-average period of 2.48 years.
v3.26.1
Income Taxes
9 Months Ended
Mar. 31, 2026
Income Tax Disclosure [Abstract]  
Income Taxes
Note 13. Income Taxes

We recorded a provision for income taxes of $126.9 million and $266.2 million for the three and nine months ended March 31, 2026, respectively, and provision of $5.8 million and $137.5 million for the three and nine months ended March 31, 2025, respectively. The effective tax rate was 20.8% and 20.2% for the three and nine months ended March 31, 2026, respectively, and 5.1% and 13.9% for the three and nine months ended March 31, 2025, respectively. The effective tax rates for the three and nine months ended March 31, 2026, were higher than that for the three and nine months ended March 31, 2025, primarily due to the significant decrease in tax deductions related to stock-based compensation and U.S. federal research tax credit, driven by a lower stock vesting price in the three and nine months ended March 31, 2026. The effective tax rates for the three and nine months ended March 31, 2026 were lower than the U.S. federal statutory rate of 21%, primarily due to tax benefits from the foreign-derived intangible income deduction, stock-based compensation, and the U.S. federal research tax credit.

On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted into law and contains several changes to key U.S. federal income tax laws, such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act, modifications to the international tax framework and the restoration of favorable tax treatment for certain business provisions. The legislation has multiple effective dates, with certain provisions effective in 2025 and others implemented through 2027. As of March 31, 2026, we have recognized the tax effects of certain OBBBA provisions. We will continue to evaluate the impact of the Act upon our future effective tax rate, tax liabilities, and cash taxes.

We believe that we have adequately provided reserves for all uncertain tax positions; however, amounts asserted by tax authorities could be greater or less than our current position. Accordingly, our provision on federal, state and foreign tax related matters to be recorded in the future may change as revised estimates are made or as the underlying matters are settled or otherwise resolved.
In general, the federal statute of limitations remains open for tax years ended June 30, 2023 through 2025. Various states’ statutes of limitations remain open in general for tax years ended June 30, 2022 through 2025. Certain statutes of limitations in major foreign jurisdictions remain open for the tax years ended June 30, 2020 through 2025. It is reasonably possible that our gross unrecognized tax benefits will decrease by approximately $4.1 million, in the next 12 months, due to the lapse of the statute of limitations. These adjustments, if recognized, would positively impact our effective tax rate, and would be recognized as additional tax benefits. As of March 31, 2026, we are under examination in certain tax jurisdictions, including the United States for fiscal year ended June 30, 2024, and India for tax years ended in 2024 and 2025.
v3.26.1
Commitments and Contingencies
9 Months Ended
Mar. 31, 2026
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Note 14. Commitments and Contingencies

Litigation and claims

On August 30, 2024, a putative class action complaint was filed against the Company, the Company’s Chief Executive Officer, and the Company’s Chief Financial Officer in the U.S. District Court for the Northern District of California (Averza v. Super Micro Computer, Inc., et al., No. 5:24-cv-06147). Additional putative class action complaints were filed in the same court on October 4, 2024 (Norfolk County Retirement System v. Super Micro Computer, Inc., et al., No. 5:24-cv-06980); on October 18, 2024 (Covey Financial Inc., et al. v. Super Micro Computer, Inc., et al., No. 5:24-cv-07274); and on March 25, 2026 (Bhuva v. Super Micro Computer, Inc. et al, No. 3:26-cv-02606). Another such complaint was filed on April 8, 2026 (City of Hialeah Employees Retirement System v. Super Micro Computer, Inc. et al, No. 5:26-cv-03018), which included a former director of the company as an additional defendant. The complaints contain similar allegations, claiming that (i) each of the defendants violated Section 10(b) of the Securities Exchange Act and Rule 10b-5 promulgated thereunder and (ii) each of the Company’s Chief Executive Officer and the Company’s Chief Financial Officer violated Section 20(a) of the Securities Exchange Act as controlling persons of the Company for the alleged violations under (i), due (in each case) to alleged misrepresentations and/or omissions in public statements regarding the Company’s financial results and its internal controls and procedures. The Court then appointed Universal-Investment-Gesellschaft mbH as the Lead Plaintiff, who thereafter filed a Consolidated Amended Complaint on September 22, 2025. The appointment of Lead Plaintiff has been appealed to the Supreme Court of California. Company filed its Motion to Dismiss on November 21, 2025. These matters are too preliminary to form a judgment as to whether the likelihood of an adverse outcome is probable and we are unable to estimate the possible loss or range of loss, if any.
On September 11, 2024, certain current and former directors and certain current officers of the Company were named as defendants in a putative derivative lawsuit filed in the U.S. District Court for the Northern District of California, captioned Hollin v. Liang, et al., Case No. 5:24-cv-06410 (the “Hollin Action”). Four additional putative derivative lawsuits have been filed in the same court, captioned Latypov v. Liang, et al., Case No. 5:24-cv-06779 (filed Sept. 26, 2024), Keritsis v. Liang, et al., Case No. 5:24-cv-07753 (filed Nov. 6, 2024), Roy v. Liang, et al., Case No. 5:24-cv-08006 (filed Nov. 14, 2024), and Jha v. Liang, et al., No. 5:24-cv-08792 (filed Dec. 5, 2024) (together with the Hollin Action, the “Federal Derivative Litigation”). On November 20, 2024, a similar putative derivative lawsuit was filed in the Superior Court of California, County of Santa Clara, captioned Spatz v. Liang, et al., Case No. 24CV452241 (the “Spatz Action”). Two additional putative derivative lawsuits have been filed in the same court, captioned Clark v. Liang, et al., Case No. 24CV454416 (filed Dec. 17, 2024) and Carter, et al. v. Liang, et al., Case No. 24CV454689 (filed Dec. 20, 2024) (together with the Spatz Action, the “State Court Derivative Litigation,” and together with the Federal Derivative Litigation, the “Derivative Litigation”). The Company was also named as a nominal defendant in the Derivative Litigation. The Federal Derivative Litigation purports to allege derivative claims for breaches of Sections 10(b), 14(a), and 20(a) of the Securities Exchange Act of 1934, as amended, and Rules 10b-5 and 14a-9 promulgated thereunder, breach of fiduciary duty, aiding and abetting breach of fiduciary duty, unjust enrichment, abuse of control, gross mismanagement, waste of corporate assets, and contribution arising out of allegations that the Company’s officers and directors caused the Company to issue materially false and misleading statements concerning the Company’s business operations and financial results. The State Court Derivative Litigation purports to allege claims for breach of fiduciary duty, aiding and abetting breach of fiduciary duty, waste of corporate assets, unjust enrichment, and insider trading arising out of similar allegations as the Federal Derivative Litigation. The plaintiffs in the Derivative Litigation seek unspecified money damages, in addition to punitive damages and other relief. The Court in the Hollin Action consolidated the five previously stayed Federal Derivative Litigation actions. The Court in the Spatz Action stayed all proceedings and consolidating the three State Court Derivative Litigation actions. On August 29, 2025, certain current and former directors and certain current officers of the Company were named as defendants in another putative derivative lawsuit filed in the Delaware Court of Chancery, captioned Anderson v. Liang, et al., C.A. No. 2025-0986-KSJM. On January 6, 2026, a substantially similar lawsuit was filed in the Delaware Court of Chancery, captioned Mathiyalagan v. Liang, et. al., C.A. No. 2026-0013-KSJM. On January 29, 2026, another substantially similar lawsuit was filed in Northern District of California by plaintiffs Employees’ Retirement System of the State of Rhode Island and Bucks County Employees’ Retirement System, Case No. 5:26-cv-00955-NC. These matters are too preliminary to form a judgment as to whether the likelihood of an adverse outcome is probable and we are unable to estimate the possible loss or range of loss, if any.

On November 19, 2024, the Company received a subpoena from the U.S. Securities and Exchange Commission Enforcement Staff in connection with an investigation entitled In the Matter of Super Micro Computer, Inc. The Company continues to produce documents in response to the subpoena. The Company received another subpoena on April 28, 2026. The matter is too preliminary to form a judgment as to whether the likelihood of an adverse outcome is probable and we are unable to estimate the possible loss or range of loss, if any.

Other legal proceedings and indemnifications

In the ordinary course of our business, we periodically receive subpoenas, civil investigative demands, and other formal requests for information from various courts, regulatory bodies, and government agencies. These requests typically seek documents or information related to our customers, products, or transactions in connection with matters that do not directly name or involve us as a party or target. Our general policy is to cooperate and respond fully to such requests as required by law. We are not aware of any such matters that, individually or in the aggregate, are expected to have a material adverse effect on the Company’s financial position.

We have entered into indemnification agreements with our current and former directors and executive officers. Under these agreements, we have agreed to indemnify such individuals to the fullest extent permitted by law against liabilities that arise by reason of their status as directors or officers and to advance expenses incurred by such individuals in connection with related legal proceedings. It is not possible to determine the maximum potential amount of payments we could be required to make under these agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each claim. However, we maintain directors and officers liability insurance coverage to reduce our exposure to such obligations.
Other matters

As a result of a Supreme Court ruling issued in February 2026, we may be entitled to a refund of tariffs previously paid on imported products under the IEEPA. As of March 31, 2026, we have not recognized an asset related to the potential refund. We will continue to evaluate new information and will recognize the refund when the right to receive the amount becomes realized or realizable.

On April 7, 2026, the Company announced that it had launched an independent investigation into the allegations described in the March 19, 2026, indictment from the U.S. Attorney’s Office for the Southern District of New York concerning three individuals either employed or associated with the Company at the time in connection with an alleged conspiracy to commit export control violations. The independent investigation is being led by the Lead Independent Director of the Company’s Board and the Chair of the Board’s Audit Committee, who will report their findings and conclusions to the other four independent members of the Board. The investigations are ongoing and no conclusion has been reached.

Purchase Commitments— We have agreements to purchase inventory and non-inventory items primarily through the next 12 months. As of March 31, 2026, these remaining non-cancelable commitments were $10.1 billion, including $228.6 million for related parties. We also review and assess the need for expected loss liabilities on a quarterly basis for all products we do not expect to sell but have committed purchases from suppliers. As of March 31, 2026, we recorded $4.1 million of loss liabilities. The loss liabilities are recorded in accrued liabilities in our condensed consolidated balance sheets. There were no loss liabilities recognized as of June 30, 2025.

Lease Commitments— See Note 10, “Leases”, for a discussion of our operating lease commitments.
v3.26.1
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2026
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.26.1
Organization and Summary of Significant Accounting Policies (Policies)
9 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this Quarterly Report on Form 10-Q should be read in conjunction with the consolidated financial statements and accompanying notes included in the Annual Report on Form 10-K for the fiscal year ended June 30, 2025, of Super Micro Computer, Inc., a Delaware corporation, and its consolidated entities (collectively, the “Company”). The condensed consolidated balance sheet as of June 30, 2025 included herein was derived from the audited financial statements as of that date but does not include all disclosures including notes required by U.S. GAAP.

The unaudited condensed consolidated financial statements included herein reflect all adjustments, including normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the consolidated financial condition, results of operations, and cash flows for the periods presented. All intercompany balances and transactions have been eliminated. Interim results are not necessarily indicative of the results for the full year ending June 30, 2026.
Revenue Recognition
Revenue Recognition

We generate revenues from the sale of server and storage systems, subsystems, accessories and services.

Product sales. We recognize revenue from sales of products as control is transferred to customers, which generally happens at the point of shipment or upon delivery, unless customer acceptance is required. Determining the point in time that control transfers to the customer requires judgment. Products sold by us are shipped from our facilities or drop shipped from our vendors. We may use distributors or channel partners to sell products to end customers. Revenue from distributors is recognized when the distributor obtains control of the product, which generally happens at the point of shipment or upon delivery.

We apply judgment in determining the transaction price as our contracts may include forms of variable consideration, including customer rebates, returns, and cash discounts for prompt payment. Variable consideration is estimated using either the expected value or most likely amount method, depending on which method better predicts the amount of consideration to which we expect to be entitled. We include estimated variable consideration in the transaction price only to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. Estimates of variable consideration are reassessed each reporting period and recorded as an adjustment to revenue, as applicable.

Services sales. Our sale of services mainly consists of extended warranty and on-site services as well as system rack installation and integration services. Revenue related to extended warranty commences upon the expiration of the standard warranty period and is recognized ratably over the contractual period as we stand ready to perform any required warranty service. Revenue related to on-site services commences upon recognition of the product sale and is recognized ratably over the contractual period as the on-site services are made available to the customer. These service contracts are typically one to five years in length. Revenue related to system rack installation and integration services is recognized when we perform the services and the customer receives and consumes the benefits.
Contracts with multiple promised goods and services. Certain of our contracts contain multiple promised goods and services. We assess whether each promised good or service is distinct for the purpose of identifying the performance obligations in the contract. This assessment requires management to make judgments about the individual promised goods or services and whether such goods or services are separable from the other aspects of the contractual relationship. Performance obligations in a contract are identified based on the promised goods or services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract. If these criteria are not met, the promised goods and services are accounted for as a combined performance obligation.

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. For contracts that contain multiple performance obligations, we allocate the transaction price for each customer contract to each performance obligation based on the relative Stand-alone Selling Price ("SSP") for each performance obligation within each contract. We recognize the amount of transaction price allocated to each performance obligation within a customer contract as revenue at the time the related performance obligation is satisfied by transferring control of the promised good or service to a customer. Determining the relative SSP for contracts that contain multiple performance obligations requires significant judgment. We determine SSP based on the price at which the performance obligation is sold separately. If the SSP is not observable through past transactions, we apply judgment to estimate the SSP. For all performance obligations, we are able to establish the SSP by maximizing the use of observable inputs. We typically establish an SSP range for our products and services, which is reassessed on a periodic basis or when facts and circumstances change. SSP for our products and services can evolve over time due to changes in our pricing practices, internally approved pricing guidelines with respect to geographies, customer type, internal costs, and gross margin objectives for the related performance obligations which can also be influenced by intense competition, changes in demand for our products and services, economic and other factors.

Our credit terms are predominantly short-term in nature; however, we also grant extended payment terms for certain customers. For the contracts with the extended payment terms in which the financing component is determined to be significant to the contract, the contract transaction price is adjusted for the effect of a financing component.

When we receive consideration from a customer prior to transferring goods or services to the customer, we record a contract liability (deferred revenue). We also recognize deferred revenue when we have an unconditional right to consideration (i.e., a receivable) before transfer of control of goods or services to a customer.

Shipping and handling fees collected from customers are included in net sales when control of the product is transferred to the customer, and the related shipping and handling costs are included in cost of sales. We have elected to account for shipping and handling activities that occur after the customer has obtained control of a good as a fulfillment cost rather than as an additional promised service. Taxes imposed by governmental authorities on our revenue producing activities with customers, such as sales taxes and value added taxes, are excluded from net sales.
Concentration of Credit Risk and Significant Customers
Concentration of Credit Risk and Significant Customers

Financial instruments that potentially subject us to a significant concentration of credit risk consist of cash and cash equivalents, restricted cash, and accounts receivable. Cash and cash equivalents are maintained with high-quality financial institutions, the composition and maturities of which are regularly monitored by management.
We believe that the concentration of credit risk in our trade receivables is substantially mitigated by our credit evaluation process, relatively short collection terms and the high level of credit worthiness of our customers. For customers including distributors and direct customers, we perform ongoing credit evaluations of their financial conditions and limit the amount of credit extended when deemed necessary based upon payment history and their current credit worthiness, but we generally require no collateral other than the products that we deliver to them, in which we sometimes hold a purchase money security interest under our standard terms. We regularly review the allowance for credit losses by considering factors such as historical experience, credit quality, reasonable and supportable forecasts, age of the accounts receivable balances and current economic conditions that may affect a customer’s ability to pay.
Accounting Pronouncements Recently Adopted and Recent Accounting Pronouncements Not Yet Adopted
Accounting Pronouncements Recently Adopted

In March 2024, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2024-02 which removes references to the FASB’s concepts statements from the FASB Accounting Standards Codification. The ASU is part of the FASB’s standing project to make “Codification updates for technical corrections such as conforming amendments, clarifications to guidance, simplifications to wording or the structure of guidance, and other minor improvements.” The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2024. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2025. We adopted ASU 2024-02 on July 1, 2025, which did not have a material impact on our condensed consolidated financial statements and related disclosures.

Recent Accounting Pronouncements Not Yet Adopted

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The standard is effective for annual periods beginning after December 15, 2024. Early adoption is permitted and should be applied prospectively, with retrospective application permitted. The ASU is effective for our fiscal year beginning July 1, 2025. We are currently assessing the effect of the adoption of this standard on our disclosures that will be included in our Form 10-K for the fiscal year ending June 30, 2026.

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40), which requires disaggregated disclosure of income statement expenses for public business entities. The ASU does not change the expense captions an entity presents on the face of the income statement, but it requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. In January 2025, the FASB issued ASU 2025-01, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40), which was issued to clarify the initial effective date for entities that do not have an annual reporting period that ends on December 31 (referred to as non-calendar year-end entities). The update clarified that ASU 2024-03 shall be effective for public business entities for annual reporting periods beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The ASU is effective for our fiscal year beginning July 1, 2027. We do not expect this ASU to have a material impact on our condensed consolidated financial statements other than additional disclosures.
In May 2025, the FASB issued ASU 2025-03, Business Combinations (Topic 805) and Consolidation (Topic 810): Determining the Accounting Acquirer in the Acquisition of a Variable Interest Entity, which revises current guidance for determining the accounting acquirer for a transaction effected primarily by exchanging equity interests in which the legal acquiree is a variable interest entity that meets the definition of a business. The amendments require that an entity consider the same factors that are currently required for determining which entity is the accounting acquirer in other acquisition transactions. The ASU is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within those annual reporting periods. Early adoption is permitted. The ASU is effective for our fiscal year beginning July 1, 2027. We do not expect this ASU to have a material impact on our condensed consolidated financial statements and disclosures.

In July 2025, the FASB issued ASU 2025-05, Financial Instruments–Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides all entities with a practical expedient and entities other than public business entities with an accounting policy election when applying the guidance in Topic 326, Financial Instruments–Credit Losses, to current accounts receivable and current contract assets arising from transactions accounted for under Topic 606, Revenue from Contracts with Customers. The ASU is effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted. The ASU is effective for our fiscal year beginning July 1, 2026. We do not expect this ASU to have a material impact on our condensed consolidated financial statements and disclosures.

In November 2025, the FASB issued ASU 2025-08, Financial Instruments–Credit Losses (Topic 326): Purchased Loans, which expands the population of acquired financial assets subject to the gross-up approach in Topic 326. The ASU is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within those annual reporting periods. Early adoption is permitted. The ASU is effective for our fiscal year beginning July 1, 2027. We do not expect this ASU to have a material impact on our condensed consolidated financial statements and disclosures.

In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-scope Improvements. This update makes targeted, narrow-scope improvements to the interim reporting guidance in Topic 270 to clarify application and improve consistency in practice. The amendments do not change the underlying principles of interim reporting. The ASU is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The ASU is effective for interim reporting periods beginning in our fiscal year beginning July 1, 2028. We are currently evaluating the effects of ASU on our condensed consolidated financial statements and disclosures.

In December 2025, the FASB issued ASU 2025-12, Codification Improvements, which includes 33 technical corrections, clarifications, and minor refinements across multiple ASC Topics intended to improve consistency and usability of U.S. GAAP. Transition is applied on an issue-by-issue basis: the EPS clarification (ASC 260, Issue 4) is applied retrospectively to all prior periods presented, while all other amendments may be applied prospectively or retrospectively, with appropriate disclosures about the nature/reason for the change (and additional disclosures if applied retrospectively). The ASU is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within those annual reporting periods. Early adoption is permitted. The ASU is effective for our fiscal year beginning July 1, 2027. We are currently evaluating the effects of ASU on our condensed consolidated financial statements and disclosures.
Reclassification
Reclassification

Certain prior period amounts have been reclassified to conform to the current period presentation. Such reclassifications did not result in net changes to condensed consolidated balance sheets, statements of operations, or statements of cash flows.
v3.26.1
Organization and Summary of Significant Accounting Policies (Tables)
9 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Accounts Receivable Concentration Risk Significant customer information is as follows:
March 31, 2026June 30, 2025
Percentage of accounts receivable:
Customer A32.2%*
Customer B16.8%33.4%
Customer C13.2%13.6%
Customer D12.9%*

^The customer references of A-D above may represent different customers than those reported in a previous period.
*Below 10%
Significant customer information is as follows:

Three Months Ended
March 31,
Nine Months Ended
March 31,
2026202520262025
Percentage of total net sales:
Customer A27.0%*38.5%15.1%
Customer B*22.5%*23.5%
Customer C*14.1%**
Customer D10.3%**13.5%

^The customer references of A-D above may represent different customers than those reported in a previous period.
*Below 10%
v3.26.1
Segment Information (Tables)
9 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Disaggregation of Revenue The following is a summary of net sales by geographic region (in thousands):
 Three Months Ended March 31,Nine Months Ended March 31,
 2026
% of Total
2025
% of Total
2026% of Total2025% of Total
United States$7,033,882 68.7 %$2,768,181 60.2 %$19,797,305 70.8 %$10,856,490 67.0 %
Other (1)
3,209,132 31.3 %1,831,732 39.8 %8,145,990 29.2 %5,358,641 33.0 %
Total$10,243,014 100.0 %$4,599,913 100.0 %$27,943,295 100.0 %$16,215,131 100.0 %
(1) all other countries were individually less than 10%.
Schedule of Total Net Sales Concentration Risk Significant customer information is as follows:
March 31, 2026June 30, 2025
Percentage of accounts receivable:
Customer A32.2%*
Customer B16.8%33.4%
Customer C13.2%13.6%
Customer D12.9%*

^The customer references of A-D above may represent different customers than those reported in a previous period.
*Below 10%
Significant customer information is as follows:

Three Months Ended
March 31,
Nine Months Ended
March 31,
2026202520262025
Percentage of total net sales:
Customer A27.0%*38.5%15.1%
Customer B*22.5%*23.5%
Customer C*14.1%**
Customer D10.3%**13.5%

^The customer references of A-D above may represent different customers than those reported in a previous period.
*Below 10%
v3.26.1
Financial Instruments and Fair Value Measurements (Tables)
9 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Schedule of Cash Equivalents and Long-Term Investments Measured at Fair value on a Recurring Basis
The following table sets forth our financial instruments as of March 31, 2026 and June 30, 2025, which are measured at fair value on a recurring basis by level within the fair value hierarchy. These are classified based on the lowest level of input that is significant to the fair value measurement (in thousands):

As of March 31, 2026
As of June 30, 2025
Level 1Level 2Level 3Asset at Fair ValueLevel 1Level 2Level 3Asset at Fair Value
Assets
Money market funds (1)
$19 $— $— $19 $44 $— $— $44 
Certificates of deposit— 47,494 — 47,494 — 519 — 519 
Marketable equity security14,709 — — 14,709 6,239 — — 6,239 
Available-for-Sale Investment:
Auction rate security (2)
— — — — — — 1,750 1,750 
Total assets$14,728 $47,494 $— $62,222 $6,283 $519 $1,750 $8,552 

(1) All of the money market funds are included in cash and cash equivalents in the condensed consolidated balance sheets as of March 31, 2026 and June 30, 2025, respectively.
(2) The fair value of our auction rate security was immaterial as of March 31, 2026.
v3.26.1
Non-marketable Equity Securities (Tables)
9 Months Ended
Mar. 31, 2026
Investments, Debt and Equity Securities [Abstract]  
Schedule of Non-marketable Equity Securities The following table shows our non-marketable equity securities that were measured using the measurement alternative and equity method (in thousands):
March 31, 2026June 30, 2025
Non-marketable equity securities:
Opening gross investment balance (as of July 1, 2025 and July 1, 2024)$122,217 $66,217 
Investments made during the period42,000 56,000 
Cumulative impairment adjustments(23,600)(11,600)
Total carrying value - before the adjustments under equity method
140,617 110,617 
Securities under equity method - cumulative adjustment(1,027)— 
Total carrying value (as of March 31, 2026 and June 30, 2025)
$139,590 $110,617 
v3.26.1
Net Income per Common Share (Tables)
9 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted Net Income Per Share
The following table shows the computation of basic and diluted net income per common share for the three and nine months ended March 31, 2026 and 2025 (in thousands, except per share amounts):

 Three Months Ended
March 31,
Nine Months Ended
March 31,
 2026202520262025
Numerator:
Net income - basic$483,387 $108,777 $1,052,236 $853,700 
Convertible notes interest charge, net of tax17,888 — 16,472 1,777 
Net income - diluted $501,275 $108,777 $1,068,708 $855,477 
Denominator:
Weighted-average shares outstanding - basic600,205 595,041 597,928 592,349 
Effect of dilutive convertible notes73,803 — 53,130 1,673 
Effect of dilutive securities18,181 26,768 22,540 31,250 
Weighted-average shares outstanding - diluted692,189 621,809 673,598 625,272 
Net income per common share - basic$0.81 $0.18 $1.76 $1.44 
Net income per common share - diluted$0.72 $0.17 $1.59 $1.37 
Anti-dilutive shares excluded from diluted net income per share:
Stock-based awards28,653 16,245 20,203 9,278 
Convertible notes— 32,138 20,673 20,673 
v3.26.1
Balance Sheet Components (Tables)
9 Months Ended
Mar. 31, 2026
Balance Sheet Related Disclosures [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash
The following tables provide details of the selected balance sheet items (in thousands):

Cash, Cash Equivalents, and Restricted Cash

 March 31, 2026June 30, 2025
Cash and cash equivalents$1,290,324 $5,169,911 
Restricted cash included in prepaid expenses and other current assets and other assets49,642 2,390 
Total cash, cash equivalents and restricted cash$1,339,966 $5,172,301 
Schedule of Inventories
Inventories

March 31, 2026June 30, 2025
Finished goods$8,154,074 $3,465,352 
Work in process1,991,524 674,613 
Purchased parts and raw materials957,778 540,410 
Total inventories$11,103,376 $4,680,375 
Schedule of Property, Plant, and Equipment, Net
Property, Plant, and Equipment, net

 March 31, 2026June 30, 2025
Land$193,417 $162,848 
Buildings186,860 182,466 
Machinery and equipment141,458 111,331 
Building and leasehold improvements136,018 121,665 
Construction in progress55,705 1,038 
Furniture and fixtures42,607 36,268 
Software7,419 7,117 
Property, plant, and equipment, gross763,484 622,733 
Accumulated depreciation and amortization(155,825)(118,245)
Property, plant, and equipment, net$607,659 $504,488 
Schedule of Other Assets
Other Assets

 March 31, 2026June 30, 2025
Operating lease ROU asset
$361,437 $293,692 
Long-term investments139,593 112,367 
Tariff receivable*64,539 — 
Non-current accounts receivable23,194 166,405 
Deferred service costs, non-current11,164 10,713 
Deposits3,896 4,980 
Restricted cash, non-current2,642 2,390 
Other36,904 14,324 
Total other assets$643,369 $604,871 
*Represents receivables related to the Company’s claims under Section 232 of the Trade Expansion Act of 1962. Refer to Note 14 for additional disclosures related to the Supreme Court decision related to tariff under the International Emergency Economic Powers Act (IEEPA).
Schedule of Accrued Liabilities
Accrued Liabilities

March 31, 2026June 30, 2025
Customer deposits$203,570 $260,131 
Customer-related liabilities139,08432,858 
Accrued payroll and related expenses122,98382,156 
Import tax and tariff liabilities56,32320,883 
Accrued cooperative marketing expenses51,93926,775 
Input tax payable45,49339,161 
Accrued interest - lines of credit and term loans35,606146 
Accrued withholding tax38,653
Operating lease liability32,70321,189 
Accrued warranty costs15,3639,753 
Accrued professional fees11,6948,098 
Accrued interest - convertible notes
8,35627,701 
Other68,24036,780 
Total accrued liabilities$830,007 $565,637 
Schedule of Product Warranties
Product Warranties

Three Months Ended
March 31,
Nine Months Ended
March 31,
 2026202520262025
Balance, beginning of the period$23,012 $18,288 $16,954 $17,815 
Provision for warranty17,043 25,253 88,258 53,949 
Costs utilized(16,895)(24,277)(82,430)(51,131)
Change in estimated liability for pre-existing warranties607 (337)985 (1,706)
Balance, end of the period$23,767 $18,927 $23,767 $18,927 
Current portion$15,363 $10,740 $15,363 $10,740 
Non-current portion$8,404 $8,187 $8,404 $8,187 
v3.26.1
Receivables Purchase Agreement (Tables)
9 Months Ended
Mar. 31, 2026
Transfers and Servicing [Abstract]  
Schedule of Transfer of Trade Receivables Accounted for as Sales
Trade receivables sold and discount on trade receivables sold under this program were as follows (in thousands):

Three Months Ended
March 31,
Nine Months Ended
March 31,
 20262026
Trade receivables sold$831,674 $831,674 
Discount on trade receivables (1)
$5,737 $5,737 

(1) Included in general and administrative expenses in the condensed consolidated statements of operations.

Trade receivables sold under the Receivables Purchase Agreement and subject to servicing by us that remained outstanding and uncollected, and collected as of March 31, 2026, are as follows (in thousands):

 March 31, 2026
Outstanding and uncollected$123,628 
Outstanding and collected (1)
$4,191 

(1) Amount collected but not yet remitted to purchasers as of March 31, 2026 is classified in accrued liabilities on the condensed consolidated balance sheet.
v3.26.1
Lines of Credit, Revolving Credit Facilities, and Term Loans (Tables)
9 Months Ended
Mar. 31, 2026
Debt Disclosure [Abstract]  
Schedule of Short-term and Long-term Debt Obligations
Short-term and long-term loan obligations with respect to lines of credit and term loans as of March 31, 2026 and June 30, 2025 consisted of the following (in thousands):
 
 March 31,June 30,
 20262025
Lines of credit:
CTBC Credit Lines$181,305 $— 
Chang Hwa Bank Credit Lines25,005 — 
E.SUN Bank Credit Lines50,000 30,000 
Mega Bank Credit Lines30,000 — 
First Bank Credit Lines19,935 — 
JP Morgan Revolving Credit Facility2,000,000 — 
CTBC Revolving Credit Facilities1,762,970 — 
Total lines of credit4,069,215 30,000 
Term loan facilities:
Chang Hwa Bank Credit Facility due October 15, 20264,562 11,399 
CTBC Term Loan Facility, due June 4, 203022,343 28,822 
CTBC Term Loan Facility, due August 15, 2026603 1,846 
E.SUN Bank Term Loan Facility, due September 15, 20265,005 13,678 
E.SUN Bank Term Loan Facility, due August 15, 20275,760 9,632 
Mega Bank Term Loan Facility, due October 3, 20266,256 17,098 
Total term loans44,529 82,475 
Total lines of credit and term loans$4,113,744 $112,475 
Lines of credit and term loans, current$2,095,069 $75,060 
Lines of credit and term loans, non-current$2,018,675 $37,415 
Available borrowings and interest rates as of March 31, 2026 and June 30, 2025 consisted of the following (in thousands except for percentages):
 March 31, 2026June 30, 2025
Available borrowingsInterest rateAvailable borrowingsInterest rate
Lines of credit:
CTBC Credit Lines$3,695 
2.26% - 4.62%
$185,000 
2.63% - 5.79%
Chang Hwa Bank Credit Lines$1,714 
1.88% - 4.40%
$30,259 
1.88% - 5.16%
E.SUN Bank Credit Lines$10,000 
2.02% - 4.67%
$30,000 
2.02% - 5.12%
Mega Bank Credit Lines$3,744 
2.23% - 4.48%
$50,000 
1.90% - 5.26%
First Bank Credit Lines$65 
2.03% - 4.49%
$— 
n/a
JP Morgan Revolving Credit Facility$— 
3.67% - 3.67%
$— 
n/a
CTBC Revolving Credit Facilities$— 
2.86% - 5.11%
$— 
n/a
Term loan facilities:
Chang Hwa Bank Credit Facility due October 15, 2026$— 2.08%$— 2.08%
CTBC Term Loan Facility, due June 4, 2030$— 
1.33% - 1.83%
$— 
1.33% - 1.83%
CTBC Term Loan Facility, due August 15, 2026$— 
2.03%
$— 
1.53% - 2.03%
E.SUN Bank Term Loan Facility, due September 15, 2026$— 
2.22%
$— 2.22%
E.SUN Bank Term Loan Facility, due August 15, 2027$— 2.22%$— 1.92%
Mega Bank Term Loan Facility, due October 3, 2026$— 
 2.02%
$— 
2.02%
Schedule of Maturities of Short-term and Long-term Debt Obligations
Principal payments on lines of credit and term loans are due as follows (in thousands):

 Fiscal Year:
 Principal Payments
Remainder of 2026$291,545 
20271,805,882 
20286,039 
20295,362 
20304,916 
2031 and thereafter2,000,000
Total lines of credit and term loans$4,113,744 
v3.26.1
Convertible Notes - (Tables)
9 Months Ended
Mar. 31, 2026
Debt Disclosure [Abstract]  
Schedule of Convertible Debt
The following table summarizes our convertible notes as of March 31, 2026:

 
Issuance Date
Principal (in millions)
Coupon Interest
MaturityConversion price
Carrying Value (in millions)
Effective Interest Rate
2028 Convertible Notes
2/20/2025$700.0 2.25 %7/15/2028$61.06 $688.9 2.97 %
2029 Convertible Notes
2/27/2024$1,725.0 3.50 %3/1/2029$83.44 $1,707.8 3.86 %
2030 Convertible Notes
6/23/2025$2,300.0 0.00 %6/15/2030$55.20 $2,262.7 0.39 %
v3.26.1
Leases (Tables)
9 Months Ended
Mar. 31, 2026
Leases [Abstract]  
Schedule of Operating Lease Expense Recognized and Supplemental Cash Flow Information Operating lease expense recognized and supplemental cash flow information related to operating leases for the three and nine months ended March 31, 2026 and 2025 were as follows (in thousands):
Three Months Ended
March 31,
Nine Months Ended
March 31,
2026202520262025
Operating lease expense (including expense for lease agreements with related parties of $292 and $208 for the three months ended March 31, 2026 and 2025, respectively, and $758 and $538 for the nine months ended March 31, 2026 and 2025, respectively)
$15,098 $5,712 $43,117 $12,685 
Cash payments for operating leases (including payments to related parties of $297 and $202 for the three months ended March 31, 2026 and 2025, respectively, and $788 and $508 for the nine months ended March 31, 2026 and 2025, respectively)
$13,663 $5,380 $36,012 $11,959 
New operating lease assets obtained in exchange for operating lease liabilities $834 $110,145 $94,907 $128,617 
Schedule of Assets and Liabilities, Lessee
ROU assets and lease liabilities are recorded in the condensed consolidated balance sheets as follows (in thousands):

March 31, 2026June 30, 2025
Other assets
$361,437 $293,692 
Accrued liabilities
$32,703 $21,189 
Other long-term liabilities
345,352 280,368 
Total lease liabilities$378,055 $301,557 
Weighted average remaining lease term
8.6 years
9.1 years
Weighted average discount rate (1)
5.8 %5.8 %

(1) As the interest rate in the lease contract is typically not readily available, we estimate the incremental borrowing rate considering credit notching approach based on information available at lease commencement.
Schedule of Operating Lease, Lease Income
Rental income is included in other income (expense), net on the condensed consolidated statements of operations (in thousands):

Three Months Ended
March 31,
Nine Months Ended
March 31,
2026202520262025
Sublease income$10,524 $1,300 $29,181 $1,300 
Schedule of Future Total Minimum Sublicence Receipts
As of March 31, 2026, the future total minimum Sublicense receipts expected to be received are as follows (in thousands):

Fiscal Year:Future minimum Sublicense receipts
Remainder of 2026$9,492 
202738,348 
202839,499 
202940,684 
203041,904 
2031 and beyond241,533 
Total Sublicense receipts - Lessor$411,460 
Schedule of Future Minimum Lease Payments Under Noncancelable Operating Lease Arrangements
Maturities of operating lease liabilities under non-cancelable operating lease arrangements as of March 31, 2026 are as follows (in thousands):

Fiscal Year:
Maturities of operating leases
Remainder of 2026$14,123 
202755,980 
202855,498 
202955,890 
203057,437 
2031 and beyond251,685 
Total future lease payments490,613 
Less: Imputed interest(112,558)
Present value of operating lease liabilities $378,055 
Current portion$32,703 
Long-term portion$345,352 
v3.26.1
Related Party Transactions (Tables)
9 Months Ended
Mar. 31, 2026
Related Party Transactions [Abstract]  
Schedule of Related Party Transactions
We had the following balances related to transactions with our related parties as of March 31, 2026 and June 30, 2025 (in thousands):

Accounts receivable
Other receivables (1)
Other assetsAccounts payable
Accrued liabilities (2)
Other long-term liabilities (3)
Ablecom
As of March 31, 2026
$$1,344 $59 $88,323 $689 $251 
As of June 30, 2025
$$1,059 $— $55,460 $753 $114 
Compuware
As of March 31, 2026
$430 $27,370 $— $45,729 $641 $243 
As of June 30, 2025
$285 $12,686 $— $74,292 $291 $494 
Corporate Venture
As of March 31, 2026
$— $— $— $— $— $— 
As of June 30, 2025
$30 $— $— $— $— $— 
Leadtek
As of March 31, 2026
$202 $— $— $— $— $— 
As of June 30, 2025
$77 $— $— $— $— $— 
Total
As of March 31, 2026
$633 $28,714 $59 $134,052 $1,330 $494 
As of June 30, 2025
$393 $13,745 $— $129,752 $1,044 $608 

(1) Other receivables include receivables from vendors included in prepaid expenses and other current assets.
(2) Includes current portion of operating lease liabilities included in other current liabilities.
(3) Other long-term liabilities include non-current portion of lease liabilities.
Our results from transactions with our related parties for each of the three months ended March 31, 2026 and 2025, are as follows (in thousands):

Net salesCost of salesPurchase of fixed assetsResearch and DevelopmentSales and marketing
Ablecom
Three months ended March 31, 2026$315 $126,145 $4,444 $1,754 $— 
Three months ended March 31, 2025$$50,147 $7,777 $971 $— 
Compuware
Three months ended March 31, 2026$4,181 $76,695 $$445 $1,104 
Three months ended March 31, 2025$3,278 $65,372 $— $460 $— 
Corporate Venture
Three months ended March 31, 2026$— $— $— $— $— 
Three months ended March 31, 2025$4,201 $— $— $— $— 
Leadtek
Three months ended March 31, 2026$383 $— $— $— $— 
Three months ended March 31, 2025$165 $— $— $— $— 
Green Earth
Three months ended March 31, 2026$— $— $— $— $15 
Three months ended March 31, 2025$— $— $— $— $— 
Total
Three months ended March 31, 2026$4,879 $202,840 $4,450 $2,199 $1,119 
Three months ended March 31, 2025$7,647 $115,519 $7,777 $1,431 $— 

Our results from transactions with our related parties for each of the nine months ended March 31, 2026 and 2025, are as follows (in thousands):

Net salesCost of salesPurchase of fixed assetsResearch and DevelopmentSales and marketing
Ablecom
Nine months ended March 31, 2026$403 $307,907 $7,923 $4,161 $— 
Nine months ended March 31, 2025$10 $252,426 $14,908 $3,958 $— 
Compuware
Nine months ended March 31, 2026$14,184 $242,055 $155 $1,138 $1,739 
Nine months ended March 31, 2025$24,318 $238,720 $371 $1,120 $— 
Corporate Venture*
Nine months ended March 31, 2026$8,147 $— $— $— $— 
Nine months ended March 31, 2025$8,977 $— $— $— $— 
Leadtek
Nine months ended March 31, 2026$1,206 $— $— $— $— 
Nine months ended March 31, 2025$494 $534 $— $— $— 
Green Earth
Nine months ended March 31, 2026$— $— $— $— $76 
Nine months ended March 31, 2025$— $— $— $— $(6)
Total
Nine months ended March 31, 2026$23,940 $549,962 $8,078 $5,299 $1,815 
Nine months ended March 31, 2025$33,799 $491,680 $15,279 $5,078 $(6)

*The divestiture of our 30% interest was completed on December 23, 2025, after which the Corporate Venture ceased to be a related party. Accordingly, this disclosure covers only the six months ended December 31, 2025.
Our cash flow impact from transactions with our related parties for each of the nine months ended March 31, 2026 and 2025, are as follows (in thousands):

Changes in accounts receivableChanges in prepaid expenses and other assetsChanges in accounts payableChanges in accrued liabilitiesChanges in other long-term liabilitiesCash payment for property, plant, and equipmentUnpaid property, plant, and equipment
Ablecom
Nine months ended March 31, 2026$— $(344)$32,863 $(64)$137 $9,217 $2,584 
Nine months ended March 31, 2025$— $577 $(48,270)$487 $227 $10,137 $7,111 
Compuware
Nine months ended March 31, 2026$(145)$(14,684)$(28,563)$350 $(251)$149 $
Nine months ended March 31, 2025$48 $(3,359)$(1,491)$84 $502 $371 $— 
Corporate Venture*
Nine months ended March 31, 2026$30 $— $— $— $— $— $— 
Nine months ended March 31, 2025$4,990 $— $— $— $— $— $— 
Leadtek
Nine months ended March 31, 2026$(125)$— $— $— $— $— $— 
Nine months ended March 31, 2025$840 $— $(230)$— $— $— $— 
Total
Nine months ended March 31, 2026$(240)$(15,028)$4,300 $286 $(114)$9,366 $2,591 
Nine months ended March 31, 2025$5,878 $(2,782)$(49,991)$571 $729 $10,508 $7,111 

*The divestiture of our 30% interest was completed on December 23, 2025, after which the Corporate Venture ceased to be a related party. Accordingly, this disclosure covers only the six months ended December 31, 2025.
v3.26.1
Stock-based Compensation and Stockholders' Equity (Tables)
9 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Assumptions Used to Estimate Fair Value of Stock Options Granted Using Black-Scholes Option Pricing Model
The fair value of stock option grants for the three and nine months ended March 31, 2026 and 2025 was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions:

 Three Months Ended March 31,Nine Months Ended March 31,
 2026202520262025
Risk-free interest rate
3.92%
4.05% - 4.39%
3.68% - 4.00%
3.82% - 4.39%
Expected term
5.96 years
3.00 years - 5.98 years
3.44 years - 5.96 years
3.00 years - 5.98 years
Dividend yield—%—%—%—%
Volatility
77.64%
73.06% - 95.28%
76.16% - 92.16%
63.67% - 95.28%
Schedule of Stock-based Compensation Expense
The following table shows total stock-based compensation expense included in the condensed consolidated statements of operations for the three and nine months ended March 31, 2026 and 2025 (in thousands):
 
 Three Months Ended March 31,Nine Months Ended March 31,
 2026202520262025
Cost of sales$11,522 $7,060 $25,400 $17,713 
Research and development83,115 54,254 200,090 141,590 
Sales and marketing12,276 9,923 33,700 27,245 
General and administrative19,021 13,467 46,368 44,292 
Stock-based compensation expense before taxes125,934 84,704 305,558 230,840 
Income tax impact(28,713)(22,433)(70,373)(57,442)
Stock-based compensation expense, net$97,221 $62,271 $235,185 $173,398 
Schedule of Operational and Stock Price Milestones
The achievement status of the operational and stock price milestones as of March 31, 2026 was as follows:

Annualized Revenue Milestone
(in billions) (1)
Achievement Status
Stock Price Milestone (1)
Achievement Status
$13.0
Achieved (6)
$45.00
Achieved (2)
$15.0
Achieved (7)
$60.00
Achieved (3)
$17.0
Achieved (8)
$75.00
Achieved (4)
$19.0
Achieved (9)
$90.00
Achieved (5)
$21.0
Achieved (10)
$110.00Not yet achieved

(1)Under the terms of the 2023 CEO Performance Stock Option, the annualized revenue milestones and stock price milestones set forth in the table above must be achieved by December 31, 2028 and March 31, 2029, respectively.
(2)On March 2, 2024, the Compensation Committee certified achievement of the $45.00 stock price milestone based upon the 60 trading day average stock price from November 29, 2023 through February 26, 2024.
(3)On April 1, 2024, the Compensation Committee certified achievement of the $60.00 stock price milestone based upon the 60 trading day average stock price from December 15, 2023 through March 13, 2024.
(4)On April 1, 2024, the Compensation Committee certified achievement of the $75.00 stock price milestone based upon the 60 trading day average stock price from January 4, 2024 through April 1, 2024.
(5)On May 5, 2024, the Compensation Committee certified achievement of the $90.00 stock price milestone based upon the 60 trading day average stock price from January 31, 2024 through April 25, 2024.
(6)On February 27, 2025, the Compensation Committee certified achievement of the $13.0 billion revenue milestone based on our previous four consecutive fiscal quarters revenue as of June 30, 2024.
(7)On April 22, 2025, the Compensation Committee certified achievement of the $15.0 billion revenue milestone based on our previous four consecutive fiscal quarters revenue as of September 30, 2024.
(8)On April 22, 2025, the Compensation Committee certified achievement of the $17.0 billion revenue milestone based on our previous four consecutive fiscal quarters revenue as of September 30, 2024.
(9)On April 22, 2025, the Compensation Committee certified achievement of the $19.0 billion revenue milestone based on our previous four consecutive fiscal quarters revenue as of December 31, 2024.
(10)On August 26, 2025, the Compensation Committee certified achievement of the $21.0 billion revenue milestone based on our previous four consecutive fiscal quarters revenue as of March 31, 2025.
Schedule of Stock Option Activity
The following table summarizes stock option activity (including CEO Performance Stock Options) during the nine months ended March 31, 2026 under all plans: 

Options
Outstanding
Weighted
Average
Exercise
Price per
Share
Weighted
Average
Grant Date Fair Value
Weighted
Average
Remaining
Contractual
Term (in Years)
Aggregate
Intrinsic
Value
(in thousands)
Balance as of June 30, 2025
34,848,133 $22.47 $— — $— 
Granted3,178,597 $49.37 $33.98 — $— 
Exercised(1,630,182)$8.17 $— — $— 
Forfeited/Cancelled(975,634)$37.45 $— — $— 
Balance as of March 31, 2026
35,420,914 $25.13 $— 6.49$322,574 
Options exercisable at March 31, 2026
24,885,340 $17.48 $— 5.63$309,416 
Schedule of Restricted Stock Unit Activity
The following table summarizes RSU activity during the nine months ended March 31, 2026 under all plans: 

Time-Based RSUs
Outstanding
Weighted
Average
Grant-Date Fair Value per Share
Balance as of June 30, 2025
20,428,647 $34.22 
Granted8,120,018 $45.07 
Released(8,117,534)$28.50 
Forfeited(1,402,029)$40.15 
Balance as of March 31, 2026
19,029,102 $40.85 
v3.26.1
Organization and Summary of Significant Accounting Policies (Details) - Accounts Receivable - Customer Concentration Risk
9 Months Ended 12 Months Ended
Mar. 31, 2026
Jun. 30, 2025
Customer A    
Concentration Risk [Line Items]    
Concentration risk percentage 32.20%  
Customer B    
Concentration Risk [Line Items]    
Concentration risk percentage 16.80% 33.40%
Customer C    
Concentration Risk [Line Items]    
Concentration risk percentage 13.20% 13.60%
Customer D    
Concentration Risk [Line Items]    
Concentration risk percentage 12.90%  
v3.26.1
Segment Information - Narrative (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2026
USD ($)
Mar. 31, 2025
USD ($)
Mar. 31, 2026
USD ($)
segment
Mar. 31, 2025
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Disaggregation of Revenue [Line Items]            
Number of operating segments | segment     1      
Number of reportable segments | segment     1      
Net sales $ 10,243,014 $ 4,599,913 $ 27,943,295 $ 16,215,131    
Contract liabilities         $ 731,400 $ 416,400
Contract with customer liability, revenue recognized in the period 57,000 38,500 302,800 154,000    
Remaining revenue performance obligation, amount $ 2,135,600   $ 2,135,600      
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-04-01            
Disaggregation of Revenue [Line Items]            
Remaining revenue performance obligation, percent to be recognized 69.00%   69.00%      
Remaining performance obligation, expected timing of satisfaction, period 12 months   12 months      
Minimum            
Disaggregation of Revenue [Line Items]            
Payment terms     30 days      
Maximum            
Disaggregation of Revenue [Line Items]            
Payment terms     60 days      
Service and Software            
Disaggregation of Revenue [Line Items]            
Net sales $ 140,500 71,800 $ 368,500 244,500    
Service            
Disaggregation of Revenue [Line Items]            
Net sales $ 104,400 $ 57,200 $ 280,400 $ 161,800    
v3.26.1
Segment Information - Schedule of Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Disaggregation of Revenue [Line Items]        
Net sales $ 10,243,014 $ 4,599,913 $ 27,943,295 $ 16,215,131
Net Sales | Geographic Concentration Risk        
Disaggregation of Revenue [Line Items]        
Concentration risk percentage 100.00% 100.00% 100.00% 100.00%
United States        
Disaggregation of Revenue [Line Items]        
Net sales $ 7,033,882 $ 2,768,181 $ 19,797,305 $ 10,856,490
United States | Net Sales | Geographic Concentration Risk        
Disaggregation of Revenue [Line Items]        
Concentration risk percentage 68.70% 60.20% 70.80% 67.00%
Other        
Disaggregation of Revenue [Line Items]        
Net sales $ 3,209,132 $ 1,831,732 $ 8,145,990 $ 5,358,641
Other | Net Sales | Geographic Concentration Risk        
Disaggregation of Revenue [Line Items]        
Concentration risk percentage 31.30% 39.80% 29.20% 33.00%
v3.26.1
Segment Information - Schedule of Total Net Sales Concentration Risk (Details) - Net Sales - Customer Concentration Risk
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Customer A        
Disaggregation of Revenue [Line Items]        
Concentration risk percentage 27.00%   38.50% 15.10%
Customer B        
Disaggregation of Revenue [Line Items]        
Concentration risk percentage   22.50%   23.50%
Customer C        
Disaggregation of Revenue [Line Items]        
Concentration risk percentage   14.10%    
Customer D        
Disaggregation of Revenue [Line Items]        
Concentration risk percentage 10.30%     13.50%
v3.26.1
Financial Instruments and Fair Value Measurements - Schedule of Cash Equivalents and Long-Term Investments Measured at Fair value on a Recurring Basis (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Jun. 30, 2025
Assets    
Marketable equity security $ 14,709 $ 6,239
Available-for-Sale Investment:    
Auction rate security 0 1,750
Total assets 62,222 8,552
Money market funds    
Assets    
Cash and cash equivalents 19 44
Certificates of deposit    
Assets    
Cash and cash equivalents 47,494 519
Level 1    
Assets    
Marketable equity security 14,709 6,239
Available-for-Sale Investment:    
Auction rate security 0 0
Total assets 14,728 6,283
Level 1 | Money market funds    
Assets    
Cash and cash equivalents 19 44
Level 1 | Certificates of deposit    
Assets    
Cash and cash equivalents 0 0
Level 2    
Assets    
Marketable equity security 0 0
Available-for-Sale Investment:    
Auction rate security 0 0
Total assets 47,494 519
Level 2 | Money market funds    
Assets    
Cash and cash equivalents 0 0
Level 2 | Certificates of deposit    
Assets    
Cash and cash equivalents 47,494 519
Level 3    
Assets    
Marketable equity security 0 0
Available-for-Sale Investment:    
Auction rate security 0 1,750
Total assets 0 1,750
Level 3 | Money market funds    
Assets    
Cash and cash equivalents 0 0
Level 3 | Certificates of deposit    
Assets    
Cash and cash equivalents $ 0 $ 0
v3.26.1
Financial Instruments and Fair Value Measurements - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Jun. 30, 2025
Jun. 23, 2025
Feb. 20, 2025
2029 Convertible Notes | Convertible Notes Payable              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Coupon Interest 3.50%   3.50%       3.50%
2028 Convertible Notes | Convertible Notes Payable              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Coupon Interest 2.25%   2.25%       2.25%
2030 Convertible Notes | Convertible Notes Payable              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Coupon Interest 0.00%   0.00%     0.00%  
Level 1 | Marketable equity security              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Unrealized (loss) gain on investments $ (0.5) $ (1.3) $ 8.5 $ (0.2)      
Level 3 | Auction Rate Security              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Investments credit loss 0.0 $ 0.0 0.0 $ 0.0      
Level 2              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Fair value of debt outstanding 4,113.7   4,113.7   $ 112.5    
Level 2 | 2029 Convertible Notes | Convertible Notes Payable              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Fair value of convertible debt 1,381.7   1,381.7   1,801.9    
Level 2 | 2028 Convertible Notes | Convertible Notes Payable              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Fair value of convertible debt 601.9   601.9   818.5    
Level 2 | 2030 Convertible Notes | Convertible Notes Payable              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Fair value of convertible debt $ 1,684.3   $ 1,684.3   $ 2,576.6    
v3.26.1
Non-marketable Equity Securities - Schedule of Non-marketable Equity Securities (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Jun. 30, 2025
Jun. 30, 2024
Investments, Debt and Equity Securities [Abstract]      
Opening gross investment balance (as of July 1, 2025 and July 1, 2024)   $ 122,217 $ 66,217
Investments made during the period $ 42,000 56,000  
Cumulative impairment adjustments (23,600) (11,600)  
Total carrying value - before the adjustments under equity method 140,617 110,617  
Securities under equity method - cumulative adjustment (1,027) 0  
Total carrying value (as of March 31, 2026 and June 30, 2025) $ 139,590 $ 110,617  
v3.26.1
Non-marketable Equity Securities - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2026
Jun. 30, 2025
Equity Securities without Readily Determinable Fair Value [Line Items]      
Total carrying value - before the adjustments under equity method $ 140,617,000 $ 140,617,000 $ 110,617,000
Impairment loss 0 12,000,000.0  
Sublessor      
Equity Securities without Readily Determinable Fair Value [Line Items]      
Total carrying value - before the adjustments under equity method $ 92,500,000 $ 92,500,000  
v3.26.1
Net Income per Common Share - Schedule of Computation of Basic and Diluted Net Income Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Numerator:        
Net income - basic $ 483,387 $ 108,777 $ 1,052,236 $ 853,700
Convertible notes interest charge, net of tax 17,888 0 16,472 1,777
Net income - diluted $ 501,275 $ 108,777 $ 1,068,708 $ 855,477
Denominator:        
Weighted-average shares outstanding - basic (in shares) 600,205 595,041 597,928 592,349
Effect of dilutive convertible notes (in shares) 73,803 0 53,130 1,673
Effect of dilutive securities (in shares) 18,181 26,768 22,540 31,250
Weighted-average shares outstanding - diluted (in shares) 692,189 621,809 673,598 625,272
Net income per common share - basic (in dollars per share) $ 0.81 $ 0.18 $ 1.76 $ 1.44
Net income per common share - diluted (in dollars per share) $ 0.72 $ 0.17 $ 1.59 $ 1.37
Stock-based awards        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive outstanding equity awards (in shares) 28,653 16,245 20,203 9,278
Convertible notes        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive outstanding equity awards (in shares) 0 32,138 20,673 20,673
v3.26.1
Balance Sheet Components - Schedule of Cash, Cash Equivalents, Restricted Cash (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Balance Sheet Related Disclosures [Abstract]        
Cash and cash equivalents $ 1,290,324 $ 5,169,911    
Restricted cash included in prepaid expenses and other current assets and other assets 49,642 2,390    
Total cash, cash equivalents and restricted cash $ 1,339,966 $ 5,172,301 $ 2,537,092 $ 1,670,273
v3.26.1
Balance Sheet Components - Schedule of Inventories (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Jun. 30, 2025
Inventory, Net [Abstract]    
Finished goods $ 8,154,074 $ 3,465,352
Work in process 1,991,524 674,613
Purchased parts and raw materials 957,778 540,410
Total inventories $ 11,103,376 $ 4,680,375
v3.26.1
Balance Sheet Components - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Balance Sheet Related Disclosures [Abstract]        
Net provision for excess and obsolete inventory to cost of sales $ 70.2 $ 125.1 $ 239.3 $ 159.0
Depreciation and amortization expense $ 13.5 $ 10.9 $ 38.4 $ 29.4
v3.26.1
Balance Sheet Components - Schedule of Property, Plant, and Equipment, Net (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Jun. 30, 2025
Property, Plant and Equipment [Line Items]    
Property, plant, and equipment, gross $ 763,484 $ 622,733
Accumulated depreciation and amortization (155,825) (118,245)
Property, plant, and equipment, net 607,659 504,488
Land    
Property, Plant and Equipment [Line Items]    
Property, plant, and equipment, gross 193,417 162,848
Buildings    
Property, Plant and Equipment [Line Items]    
Property, plant, and equipment, gross 186,860 182,466
Machinery and equipment    
Property, Plant and Equipment [Line Items]    
Property, plant, and equipment, gross 141,458 111,331
Building and leasehold improvements    
Property, Plant and Equipment [Line Items]    
Property, plant, and equipment, gross 136,018 121,665
Construction in progress    
Property, Plant and Equipment [Line Items]    
Property, plant, and equipment, gross 55,705 1,038
Furniture and fixtures    
Property, Plant and Equipment [Line Items]    
Property, plant, and equipment, gross 42,607 36,268
Software    
Property, Plant and Equipment [Line Items]    
Property, plant, and equipment, gross $ 7,419 $ 7,117
v3.26.1
Balance Sheet Components - Other Assets (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Jun. 30, 2025
Balance Sheet Related Disclosures [Abstract]    
Operating lease ROU asset $ 361,437 $ 293,692
Long-term investments 139,593 112,367
Tariff receivable 64,539 0
Non-current accounts receivable 23,194 166,405
Deferred service costs, non-current 11,164 10,713
Deposits 3,896 4,980
Restricted cash, non-current 2,642 2,390
Other 36,904 14,324
Total other assets $ 643,369 $ 604,871
v3.26.1
Balance Sheet Components - Schedule of Accrued Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Jun. 30, 2025
Short-term Debt [Line Items]    
Customer deposits $ 203,570 $ 260,131
Customer-related liabilities 139,084 32,858
Accrued payroll and related expenses 122,983 82,156
Import tax and tariff liabilities 56,323 20,883
Accrued cooperative marketing expenses 51,939 26,775
Input tax payable 45,493 39,161
Accrued withholding tax 38,653 6
Operating lease liability 32,703 21,189
Accrued warranty costs 15,363 9,753
Accrued professional fees 11,694 8,098
Other 68,240 36,780
Total accrued liabilities 830,007 565,637
Lines of Credit and Term Loans    
Short-term Debt [Line Items]    
Accrued interest 35,606 146
Convertible Notes Payable    
Short-term Debt [Line Items]    
Accrued interest $ 8,356 $ 27,701
v3.26.1
Balance Sheet Components - Schedule of Product Warranties (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Product Warranties:        
Balance, beginning of the period $ 23,012 $ 18,288 $ 16,954 $ 17,815
Provision for warranty 17,043 25,253 88,258 53,949
Costs utilized (16,895) (24,277) (82,430) (51,131)
Change in estimated liability for pre-existing warranties 607 (337) 985 (1,706)
Balance, end of the period 23,767 18,927 23,767 18,927
Total product warranty 23,767 18,927 23,767 18,927
Current portion 15,363 10,740 15,363 10,740
Non-current portion $ 8,404 $ 8,187 $ 8,404 $ 8,187
v3.26.1
Receivables Purchase Agreement - Narrative (Details) - Receivables Purchase Agreement
$ in Millions
Jul. 16, 2025
USD ($)
Transfer of Financial Assets Accounted for as Sales [Line Items]  
Credit facility, maximum borrowing capacity $ 1,790.0
Minimum  
Transfer of Financial Assets Accounted for as Sales [Line Items]  
Discount percentage 1.15%
Maximum  
Transfer of Financial Assets Accounted for as Sales [Line Items]  
Discount percentage 2.80%
v3.26.1
Receivables Purchase Agreement - Schedule of Trade receivables Sold and Discount on Trade Receivables Sold (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2026
Transfers and Servicing [Abstract]    
Trade receivables sold $ 831,674 $ 831,674
Discount on trade receivables $ 5,737 $ 5,737
v3.26.1
Receivables Purchase Agreement - Schedule of Trade Receivables that Remained Outstanding and Uncollected (Details)
$ in Thousands
Mar. 31, 2026
USD ($)
Transfers and Servicing [Abstract]  
Outstanding and uncollected $ 123,628
Outstanding and collected $ 4,191
v3.26.1
Lines of Credit, Revolving Credit Facilities, and Term Loans - Schedule of Short-term and Long-term Debt (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Jun. 30, 2025
Short-term Debt [Line Items]    
Total lines of credit and term loans $ 4,113,744 $ 112,475
Lines of credit and term loans, current 2,095,069 75,060
Lines of credit and term loans, non-current 2,018,675 37,415
Secured Debt | Term Loan    
Short-term Debt [Line Items]    
Total term loans 44,529 82,475
Secured Debt | Chang Hwa Bank Credit Facility due October 15, 2026 | Term Loan    
Short-term Debt [Line Items]    
Total term loans 4,562 11,399
Secured Debt | CTBC Term Loan Facility, due June 4, 2030 | Term Loan    
Short-term Debt [Line Items]    
Total term loans 22,343 28,822
Secured Debt | CTBC Term Loan Facility, due August 15, 2026 | Term Loan    
Short-term Debt [Line Items]    
Total term loans 603 1,846
Secured Debt | E.SUN Bank Term Loan Facility, due September 15, 2026 | Term Loan    
Short-term Debt [Line Items]    
Total term loans 5,005 13,678
Secured Debt | E.SUN Bank Term Loan Facility, due August 15, 2027 | Term Loan    
Short-term Debt [Line Items]    
Total term loans 5,760 9,632
Secured Debt | Mega Bank Term Loan Facility, due October 3, 2026 | Term Loan    
Short-term Debt [Line Items]    
Total term loans 6,256 17,098
Lines of Credit | Revolving Credit Facility    
Short-term Debt [Line Items]    
Total lines of credit 4,069,215 30,000
Lines of Credit | Revolving Credit Facility | CTBC Credit Lines    
Short-term Debt [Line Items]    
Total lines of credit 181,305 0
Lines of Credit | Revolving Credit Facility | Chang Hwa Bank Credit Lines    
Short-term Debt [Line Items]    
Total lines of credit 25,005 0
Lines of Credit | Revolving Credit Facility | E.SUN Bank Credit Lines    
Short-term Debt [Line Items]    
Total lines of credit 50,000 30,000
Lines of Credit | Revolving Credit Facility | Mega Bank Credit Lines    
Short-term Debt [Line Items]    
Total lines of credit 30,000 0
Lines of Credit | Revolving Credit Facility | First Bank Credit Lines    
Short-term Debt [Line Items]    
Total lines of credit 19,935 0
Lines of Credit | Revolving Credit Facility | JP Morgan Revolving Credit Facility    
Short-term Debt [Line Items]    
Total lines of credit 2,000,000 0
Lines of Credit | Revolving Credit Facility | CTBC Revolving Credit Facilities    
Short-term Debt [Line Items]    
Total lines of credit $ 1,762,970 $ 0
v3.26.1
Lines of Credit, Revolving Credit Facilities, and Term Loans - Schedule of Available Borrowings and Interest Rates for Short-term and Long-term Debt (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Jun. 30, 2025
Secured Debt | Chang Hwa Bank Credit Facility due October 15, 2026 | Term Loan    
Short-term Debt [Line Items]    
Available borrowings $ 0 $ 0
Interest rate 2.08% 2.08%
Secured Debt | CTBC Term Loan Facility, due June 4, 2030 | Term Loan    
Short-term Debt [Line Items]    
Available borrowings $ 0 $ 0
Secured Debt | CTBC Term Loan Facility, due June 4, 2030 | Minimum | Term Loan    
Short-term Debt [Line Items]    
Interest rate 1.33% 1.33%
Secured Debt | CTBC Term Loan Facility, due June 4, 2030 | Maximum | Term Loan    
Short-term Debt [Line Items]    
Interest rate 1.83% 1.83%
Secured Debt | CTBC Term Loan Facility, due August 15, 2026 | Term Loan    
Short-term Debt [Line Items]    
Available borrowings $ 0 $ 0
Interest rate 2.03%  
Secured Debt | CTBC Term Loan Facility, due August 15, 2026 | Minimum | Term Loan    
Short-term Debt [Line Items]    
Interest rate   1.53%
Secured Debt | CTBC Term Loan Facility, due August 15, 2026 | Maximum | Term Loan    
Short-term Debt [Line Items]    
Interest rate   2.03%
Secured Debt | E.SUN Bank Term Loan Facility, due September 15, 2026 | Term Loan    
Short-term Debt [Line Items]    
Available borrowings $ 0 $ 0
Interest rate 2.22% 2.22%
Secured Debt | E.SUN Bank Term Loan Facility, due August 15, 2027 | Term Loan    
Short-term Debt [Line Items]    
Available borrowings $ 0 $ 0
Interest rate 2.22% 1.92%
Secured Debt | Mega Bank Term Loan Facility, due October 3, 2026    
Short-term Debt [Line Items]    
Interest rate   2.02%
Secured Debt | Mega Bank Term Loan Facility, due October 3, 2026 | Term Loan    
Short-term Debt [Line Items]    
Available borrowings $ 0 $ 0
Interest rate 2.02%  
Lines of Credit | Revolving Credit Facility | CTBC Credit Lines    
Short-term Debt [Line Items]    
Available borrowings $ 3,695 $ 185,000
Lines of Credit | Revolving Credit Facility | CTBC Credit Lines | Minimum    
Short-term Debt [Line Items]    
Interest rate 2.26% 2.63%
Lines of Credit | Revolving Credit Facility | CTBC Credit Lines | Maximum    
Short-term Debt [Line Items]    
Interest rate 4.62% 5.79%
Lines of Credit | Revolving Credit Facility | Chang Hwa Bank Credit Lines    
Short-term Debt [Line Items]    
Available borrowings $ 1,714 $ 30,259
Lines of Credit | Revolving Credit Facility | Chang Hwa Bank Credit Lines | Minimum    
Short-term Debt [Line Items]    
Interest rate 1.88% 1.88%
Lines of Credit | Revolving Credit Facility | Chang Hwa Bank Credit Lines | Maximum    
Short-term Debt [Line Items]    
Interest rate 4.40% 5.16%
Lines of Credit | Revolving Credit Facility | E.SUN Bank Credit Lines    
Short-term Debt [Line Items]    
Available borrowings $ 10,000 $ 30,000
Lines of Credit | Revolving Credit Facility | E.SUN Bank Credit Lines | Minimum    
Short-term Debt [Line Items]    
Interest rate 2.02% 2.02%
Lines of Credit | Revolving Credit Facility | E.SUN Bank Credit Lines | Maximum    
Short-term Debt [Line Items]    
Interest rate 4.67% 5.12%
Lines of Credit | Revolving Credit Facility | Mega Bank Credit Lines    
Short-term Debt [Line Items]    
Available borrowings $ 3,744 $ 50,000
Lines of Credit | Revolving Credit Facility | Mega Bank Credit Lines | Minimum    
Short-term Debt [Line Items]    
Interest rate 2.23% 1.90%
Lines of Credit | Revolving Credit Facility | Mega Bank Credit Lines | Maximum    
Short-term Debt [Line Items]    
Interest rate 4.48% 5.26%
Lines of Credit | Revolving Credit Facility | First Bank Credit Lines    
Short-term Debt [Line Items]    
Available borrowings $ 65 $ 0
Lines of Credit | Revolving Credit Facility | First Bank Credit Lines | Minimum    
Short-term Debt [Line Items]    
Interest rate 2.03%  
Lines of Credit | Revolving Credit Facility | First Bank Credit Lines | Maximum    
Short-term Debt [Line Items]    
Interest rate 4.49%  
Lines of Credit | Revolving Credit Facility | JP Morgan Revolving Credit Facility    
Short-term Debt [Line Items]    
Available borrowings $ 0 0
Lines of Credit | Revolving Credit Facility | JP Morgan Revolving Credit Facility | Minimum    
Short-term Debt [Line Items]    
Interest rate 3.67%  
Lines of Credit | Revolving Credit Facility | JP Morgan Revolving Credit Facility | Maximum    
Short-term Debt [Line Items]    
Interest rate 3.67%  
Lines of Credit | Revolving Credit Facility | CTBC Revolving Credit Facilities    
Short-term Debt [Line Items]    
Available borrowings $ 0 $ 0
Lines of Credit | Revolving Credit Facility | CTBC Revolving Credit Facilities | Minimum    
Short-term Debt [Line Items]    
Interest rate 2.86%  
Lines of Credit | Revolving Credit Facility | CTBC Revolving Credit Facilities | Maximum    
Short-term Debt [Line Items]    
Interest rate 5.11%  
v3.26.1
Lines of Credit, Revolving Credit Facilities, and Term Loans - Schedule of Maturities of Revolving Lines of Credit and Term Loans (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Jun. 30, 2025
Debt Disclosure [Abstract]    
Remainder of 2026 $ 291,545  
2027 1,805,882  
2028 6,039  
2029 5,362  
2030 4,916  
2031 and thereafter 2,000,000  
Total lines of credit and term loans $ 4,113,744 $ 112,475
v3.26.1
Lines of Credit, Revolving Credit Facilities, and Term Loans - CTBC Bank Credit Lines, Mega Bank Credit Facilities and First Bank (Details)
$ in Millions, $ in Millions
Mar. 31, 2026
USD ($)
Feb. 04, 2026
USD ($)
Feb. 04, 2026
TWD ($)
Jul. 18, 2025
USD ($)
Jul. 18, 2025
TWD ($)
CTBC Bank Credit Lines | CTBC Bank | Lines of Credit          
Short-term Debt [Line Items]          
Line of credit $ 181.3        
Mega Bank Credit Facilities | Mega Bank | Lines of Credit          
Short-term Debt [Line Items]          
Line of credit 30.0        
Mega Bank Credit Facilities | Mega Bank | Lines of Credit | Revolving Credit Facility          
Short-term Debt [Line Items]          
Credit facility, maximum borrowing capacity   $ 50.0 $ 600.0    
First Bank Credit Lines, Foreign Currency Working Capital Loan | First Bank | Lines of Credit | Revolving Credit Facility          
Short-term Debt [Line Items]          
Line of credit $ 19.9        
Credit facility, maximum borrowing capacity       $ 20.0 $ 600.0
v3.26.1
Lines of Credit, Revolving Credit Facilities, and Term Loans - JP Morgan Revolving Credit Facility (Details) - JPMorgan Chase Bank Credit Facility
$ in Millions
Dec. 29, 2025
USD ($)
Mar. 31, 2026
USD ($)
Lines of Credit    
Short-term Debt [Line Items]    
Upfront fees $ 9.8  
Covenant, leverage ratio, maximum 4.00  
Covenant, liquidity ratio required, minimum 3.50  
Covenant, liquidity ratio required, thereafter 3.00  
Revolving Credit Facility    
Short-term Debt [Line Items]    
Line of credit   $ 2,000.0
Revolving Credit Facility | Lines of Credit    
Short-term Debt [Line Items]    
Credit facility, maximum borrowing capacity $ 2,000.0  
Revolving Credit Facility | Lines of Credit | Minimum | Internal Noninvestment Grade    
Short-term Debt [Line Items]    
Commitment fee percentage 0.15%  
Revolving Credit Facility | Lines of Credit | Minimum | Internal Investment Grade    
Short-term Debt [Line Items]    
Commitment fee percentage 0.12%  
Revolving Credit Facility | Lines of Credit | Maximum | Internal Noninvestment Grade    
Short-term Debt [Line Items]    
Commitment fee percentage 0.30%  
Revolving Credit Facility | Lines of Credit | Maximum | Internal Investment Grade    
Short-term Debt [Line Items]    
Commitment fee percentage 0.15%  
Revolving Credit Facility | Term Loan | Minimum | Internal Noninvestment Grade    
Short-term Debt [Line Items]    
Debt Instrument, basis spread on variable rate 1.25%  
Revolving Credit Facility | Term Loan | Minimum | Internal Investment Grade    
Short-term Debt [Line Items]    
Debt Instrument, basis spread on variable rate 1.13%  
Revolving Credit Facility | Term Loan | Maximum | Internal Noninvestment Grade    
Short-term Debt [Line Items]    
Debt Instrument, basis spread on variable rate 2.00%  
Revolving Credit Facility | Term Loan | Maximum | Internal Investment Grade    
Short-term Debt [Line Items]    
Debt Instrument, basis spread on variable rate 1.38%  
Revolving Credit Facility | ABR Loans | Minimum | Internal Noninvestment Grade    
Short-term Debt [Line Items]    
Debt Instrument, basis spread on variable rate 0.25%  
Revolving Credit Facility | ABR Loans | Minimum | Internal Investment Grade    
Short-term Debt [Line Items]    
Debt Instrument, basis spread on variable rate 0.13%  
Revolving Credit Facility | ABR Loans | Maximum | Internal Noninvestment Grade    
Short-term Debt [Line Items]    
Debt Instrument, basis spread on variable rate 1.00%  
Revolving Credit Facility | ABR Loans | Maximum | Internal Investment Grade    
Short-term Debt [Line Items]    
Debt Instrument, basis spread on variable rate 0.38%  
Letter of Credit | Lines of Credit    
Short-term Debt [Line Items]    
Credit facility, maximum borrowing capacity $ 200.0  
Accordion feature, increase limit 1,000.0  
Same-Day Borrowing Sub-Limit | Lines of Credit    
Short-term Debt [Line Items]    
Credit facility, maximum borrowing capacity $ 150.0  
v3.26.1
Lines of Credit, Revolving Credit Facilities, and Term Loans - CTBC Revolving Credit Facilities (Details) - Revolving Credit Facility - Lines of Credit
Jan. 21, 2026
USD ($)
revolvingCreditFacility
Mar. 31, 2026
USD ($)
Jan. 30, 2026
USD ($)
CTBC Credit Agreement, Initial Two Facilities      
Short-term Debt [Line Items]      
Number of revolving credit facilities | revolvingCreditFacility 2    
CTBC Revolving Credit Facility      
Short-term Debt [Line Items]      
Credit facility, maximum borrowing capacity $ 710,000,000.0    
Credit facility, maximum borrowing capacity option, subject to certain conditions $ 2,000,000,000    
Accordion feature, increase limit     $ 1,055,000,000
Interest rate, stated percentage 0.00%    
Debt Instrument, basis spread on variable rate 1.00%    
Commitment fee percentage 0.15%    
Maturity extension fee percentage 0.0010    
Prepayment and cancellation fee percentage 0.0015    
Upfront fees $ 13,700,000    
Line of credit   $ 1,763,000,000  
CTBC Revolving Credit Facility | Minimum      
Short-term Debt [Line Items]      
Interest rate, stated percentage 1.70%    
CTBC Revolving Credit Facility | Maximum      
Short-term Debt [Line Items]      
Usage percentage 0.50    
CTBC A1 Revolving Credit Facility      
Short-term Debt [Line Items]      
Credit facility, maximum borrowing capacity $ 350,000,000.0    
Interest rate, stated percentage 0.00%    
Debt Instrument, basis spread on variable rate 1.00%    
CTBC A2 Revolving Credit Facility      
Short-term Debt [Line Items]      
Credit facility, maximum borrowing capacity $ 360,000,000.0    
Interest rate, stated percentage 0.00%    
Debt Instrument, basis spread on variable rate 1.20%    
CTBC Revolving Credit Facilities, With Accordion Feature      
Short-term Debt [Line Items]      
Credit facility, maximum borrowing capacity     $ 1,765,000,000
v3.26.1
Convertible Notes - Schedule of Convertible Debt (Details) - Convertible Notes Payable - USD ($)
$ / shares in Units, $ in Millions
9 Months Ended
Mar. 31, 2026
Jun. 23, 2025
Feb. 20, 2025
Feb. 27, 2024
2028 Convertible Notes        
Debt Instrument [Line Items]        
Principal (in millions) $ 700.0   $ 700.0  
Coupon Interest 2.25%   2.25%  
Conversion price $ 61.06   $ 61.06  
Carrying Value (in millions) $ 688.9      
Effective Interest Rate 2.97%      
2029 Convertible Notes        
Debt Instrument [Line Items]        
Principal (in millions) $ 1,725.0     $ 1,725.0
Coupon Interest 3.50%   3.50%  
Conversion price $ 83.44   $ 83.44  
Carrying Value (in millions) $ 1,707.8      
Effective Interest Rate 3.86%      
2030 Convertible Notes        
Debt Instrument [Line Items]        
Principal (in millions) $ 2,300.0 $ 2,300.0    
Coupon Interest 0.00% 0.00%    
Conversion price $ 55.20 $ 55.20    
Carrying Value (in millions) $ 2,262.7      
Effective Interest Rate 0.39%      
v3.26.1
Convertible Notes - Narrative (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Jun. 23, 2025
USD ($)
day
$ / shares
Feb. 20, 2025
USD ($)
day
$ / shares
Feb. 29, 2024
day
$ / shares
Mar. 31, 2026
USD ($)
$ / shares
Mar. 31, 2025
USD ($)
Mar. 31, 2026
USD ($)
$ / shares
Mar. 31, 2025
USD ($)
Jun. 30, 2025
USD ($)
Feb. 28, 2025
$ / shares
Feb. 27, 2024
USD ($)
Debt Instrument [Line Items]                    
Loss on extinguishment of debt           $ 0 $ 30,251      
2029 Convertible Notes | Convertible Notes Payable                    
Debt Instrument [Line Items]                    
Principal (in millions)       $ 1,725,000   $ 1,725,000       $ 1,725,000
Interest rate, stated percentage                   0.00%
Coupon interest   3.50%   3.50%   3.50%        
Conversion price ratio   0.0119842                
Conversion price | $ / shares   $ 83.44   $ 83.44   $ 83.44        
Loss on extinguishment of debt         $ 30,300          
Convertible conversion percentage     130.00%              
Unamortized issuance costs       $ 17,200   $ 17,200   $ 21,300    
Interest expense       16,500 8,200 49,400 8,200      
Amortization of debt issuance costs       1,400 800 4,100 800      
Capped call initial strike price (in dollars per share) | $ / shares     $ 134.14              
Capped call strike price (in dollars per share) | $ / shares     $ 195.10              
Cap price (in dollars per share) | $ / shares                 $ 94.17  
2029 Convertible Notes | Convertible Notes Payable | Debt Covenant, Redemption Option One                    
Debt Instrument [Line Items]                    
Trading days | day     20              
Convertible, threshold consecutive trading days | day     30              
2029 Convertible Notes | Convertible Notes Payable | Debt Covenant, Redemption Option Two                    
Debt Instrument [Line Items]                    
Convertible conversion percentage     98.00%              
2028 Convertible Notes | Convertible Notes Payable                    
Debt Instrument [Line Items]                    
Principal (in millions)   $ 700,000   $ 700,000   $ 700,000        
Coupon interest   2.25%   2.25%   2.25%        
Conversion price ratio   0.0163784                
Conversion price | $ / shares   $ 61.06   $ 61.06   $ 61.06        
Convertible conversion percentage   150.00%                
Unamortized issuance costs       $ 11,100   $ 11,100   14,600    
Interest expense       5,100 1,800 15,300 1,800      
Amortization of debt issuance costs       1,200 $ 500 3,500 $ 500      
Percentage of principal repaid upon request following fundamental change   100.00%                
2028 Convertible Notes | Convertible Notes Payable | Debt Covenant, Redemption Option One                    
Debt Instrument [Line Items]                    
Convertible conversion percentage   130.00%                
Trading days | day   20                
Convertible, threshold consecutive trading days | day   30                
2028 Convertible Notes | Convertible Notes Payable | Debt Covenant, Redemption Option Two                    
Debt Instrument [Line Items]                    
Convertible conversion percentage   98.00%                
Trading days | day   5                
Convertible, threshold consecutive trading days | day   5                
2030 Convertible Notes | Convertible Notes Payable                    
Debt Instrument [Line Items]                    
Principal (in millions) $ 2,300,000     $ 2,300,000   $ 2,300,000        
Coupon interest 0.00%     0.00%   0.00%        
Conversion price ratio 0.0181154                  
Conversion price | $ / shares $ 55.20     $ 55.20   $ 55.20        
Unamortized issuance costs       $ 37,300   $ 37,300   $ 43,900    
Amortization of debt issuance costs       $ 2,200   $ 6,600        
Capped call strike price (in dollars per share) | $ / shares $ 81.78                  
Proceeds from convertible debt $ 2,256,000                  
Premium of capped call 100.00%                  
Share price milestone (in dollars per share) | $ / shares $ 40.89                  
2030 Convertible Notes | Convertible Notes Payable | Debt Covenant, Redemption Option One                    
Debt Instrument [Line Items]                    
Convertible conversion percentage 130.00%                  
Trading days | day 20                  
Convertible, threshold consecutive trading days | day 30                  
2030 Convertible Notes | Convertible Notes Payable | Debt Covenant, Redemption Option Two                    
Debt Instrument [Line Items]                    
Convertible conversion percentage 98.00%                  
Convertible, threshold consecutive trading days | day 5                  
Convertible Senior Notes Due 2030, Overallotment Option | Convertible Notes Payable                    
Debt Instrument [Line Items]                    
Principal (in millions) $ 300,000                  
v3.26.1
Leases - Schedule of Lease Costs and Cash Flow Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Related Party Transaction [Line Items]        
Operating lease expense (including expense for lease agreements with related parties of $292 and $208 for the three months ended March 31, 2026 and 2025, respectively, and $758 and $538 for the nine months ended March 31, 2026 and 2025, respectively) $ 15,098 $ 5,712 $ 43,117 $ 12,685
Cash payments for operating leases (including payments to related parties of $297 and $202 for the three months ended March 31, 2026 and 2025, respectively, and $788 and $508 for the nine months ended March 31, 2026 and 2025, respectively) 13,663 5,380 36,012 11,959
New operating lease assets obtained in exchange for operating lease liabilities 834 110,145 94,907 128,617
Related Party        
Related Party Transaction [Line Items]        
Operating lease expense (including expense for lease agreements with related parties of $292 and $208 for the three months ended March 31, 2026 and 2025, respectively, and $758 and $538 for the nine months ended March 31, 2026 and 2025, respectively) 292 208 758 538
Cash payments for operating leases (including payments to related parties of $297 and $202 for the three months ended March 31, 2026 and 2025, respectively, and $788 and $508 for the nine months ended March 31, 2026 and 2025, respectively) $ 297 $ 202 $ 788 $ 508
v3.26.1
Leases - Schedule of ROU Assets and Lease Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Jun. 30, 2025
Leases [Abstract]    
Other assets $ 361,437 $ 293,692
Accrued liabilities 32,703 21,189
Other long-term liabilities 345,352 280,368
Present value of operating lease liabilities $ 378,055 $ 301,557
Weighted average remaining lease term 8 years 7 months 6 days 9 years 1 month 6 days
Weighted average discount rate 5.80% 5.80%
v3.26.1
Leases - Narrative (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2026
USD ($)
tranche
Mar. 31, 2025
USD ($)
Mar. 31, 2026
USD ($)
tranche
Mar. 31, 2025
USD ($)
Jun. 30, 2025
USD ($)
Lessee, Lease, Description [Line Items]          
ROU assets obtained in exchange for operating lease commitments $ 834 $ 110,145 $ 94,907 $ 128,617  
Operating lease, liabilities $ 378,055   $ 378,055   $ 301,557
Vernon, California          
Lessee, Lease, Description [Line Items]          
Operating lease agreement, number of tranches | tranche 3   3    
ROU assets obtained in exchange for operating lease commitments     $ 284,000    
Operating lease, liabilities $ 294,900   $ 294,900    
v3.26.1
Leases - Schedule of Operating Lease, Lease Income (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Leases [Abstract]        
Sublease income $ 10,524 $ 1,300 $ 29,181 $ 1,300
v3.26.1
Leases - Schedule of Future Total Minimum Sublicense Payments (Details)
$ in Thousands
Mar. 31, 2026
USD ($)
Fiscal Year:  
Remainder of 2026 $ 9,492
2027 38,348
2028 39,499
2029 40,684
2030 41,904
2031 and beyond 241,533
Total Sublicense receipts - Lessor $ 411,460
v3.26.1
Leases - Schedule of Maturities of Operating Lease Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Jun. 30, 2025
Leases [Abstract]    
Remainder of 2026 $ 14,123  
2027 55,980  
2028 55,498  
2029 55,890  
2030 57,437  
2031 and beyond 251,685  
Total future lease payments 490,613  
Less: Imputed interest (112,558)  
Present value of operating lease liabilities 378,055 $ 301,557
Current portion 32,703 21,189
Long-term portion $ 345,352 $ 280,368
v3.26.1
Related Party Transactions - Narrative (Details)
$ in Millions
Oct. 09, 2025
USD ($)
Mar. 31, 2026
USD ($)
Jun. 30, 2025
USD ($)
Mar. 01, 2020
May 01, 2019
Oct. 31, 2018
USD ($)
financialInstitution
Charles Liang            
Related Party Transaction [Line Items]            
Number of financial institutions, margin loans | financialInstitution           2
Ablecom | Management | Steve Liang and Other Family Members            
Related Party Transaction [Line Items]            
Ownership percentage   35.00%        
Ablecom | Management | Charles Liang and Wife            
Related Party Transaction [Line Items]            
Ownership percentage   10.50%        
Chien-Tsun Chang, Spouse of Steve Liang | Related Party | Charles Liang            
Related Party Transaction [Line Items]            
Principal (in millions)           $ 12.9
Interest rate, stated percentage       25.00% 85.00% 80.00%
Unsecured debt (prior year approximately)   $ 0.0 $ 16.8      
Repayments of unsecured debt $ 16.9          
v3.26.1
Related Party Transactions - Dealings with Ablecom Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Jun. 30, 2025
Related Party Transaction [Line Items]          
Purchase commitments, total $ 10,100.0   $ 10,100.0    
Related Party          
Related Party Transaction [Line Items]          
Purchase commitments, total $ 228.6   $ 228.6    
Ablecom | Related Party          
Related Party Transaction [Line Items]          
Product sold percent 94.00% 95.00% 95.50% 95.20%  
Credit facility, maximum borrowing capacity $ 10.0   $ 10.0    
Credit facility, payment term     30 days    
Ablecom | Related Party | Non-Cancellable Purchase Obligation          
Related Party Transaction [Line Items]          
Purchase commitments, total $ 49.3   $ 49.3   $ 30.6
v3.26.1
Related Party Transactions - Dealings with Compuware Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Nov. 19, 2025
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Jun. 30, 2025
Related Party Transaction [Line Items]            
Purchase commitments, total   $ 10,100.0   $ 10,100.0    
Related Party            
Related Party Transaction [Line Items]            
Purchase commitments, total   $ 228.6   $ 228.6    
Related Party | Compuware | Power Supplies Purchased Benchmark | Customer Concentration Risk            
Related Party Transaction [Line Items]            
Concentration risk percentage   92.40% 93.70% 94.00% 94.80%  
Compuware | Related Party            
Related Party Transaction [Line Items]            
Credit facility, maximum borrowing capacity $ 200.0          
Credit facility, payment term 90 days          
Compuware | Related Party | Non-Cancellable Purchase Obligation            
Related Party Transaction [Line Items]            
Purchase commitments, total   $ 179.3   $ 179.3   $ 118.3
v3.26.1
Related Party Transactions - Dealings with Leadtek Research Inc Narrative (Details)
3 Months Ended 9 Months Ended
Mar. 31, 2026
USD ($)
Mar. 31, 2025
USD ($)
Mar. 31, 2026
USD ($)
Mar. 31, 2025
USD ($)
Dec. 31, 2025
Oct. 31, 2023
board_member
Related Party Transaction [Line Items]            
Cash payment for property, plant, and equipment     $ 133,769,000 $ 104,536,000    
Related Party            
Related Party Transaction [Line Items]            
Cash payment for property, plant, and equipment     9,366,000 10,508,000    
Leadtek            
Related Party Transaction [Line Items]            
Number of board of directors served | board_member           2
Number of board of directors | board_member           7
Leadtek | Related Party            
Related Party Transaction [Line Items]            
Cash payment for property, plant, and equipment     0 0    
Leadtek | Servers | Related Party            
Related Party Transaction [Line Items]            
Sale of services $ 400,000 $ 200,000 1,200,000 500,000    
Leadtek | Graphic Cards | Related Party            
Related Party Transaction [Line Items]            
Cash payment for property, plant, and equipment $ 0 $ 0 $ 0.0 $ 500,000    
Leadtek | Ablecom and Compuware            
Related Party Transaction [Line Items]            
Ownership percentage         29.00% 30.00%
v3.26.1
Related Party Transactions - Dealings with Investment in a Corporate Venture Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Jun. 30, 2025
Dec. 23, 2025
Oct. 31, 2016
Related Party Transaction [Line Items]              
Cost of sales $ 9,224,334 $ 4,159,695 $ 25,658,675 $ 14,329,311      
Corporate Venture              
Related Party Transaction [Line Items]              
Cost of sales   4,200 8,100 9,000      
Related Party              
Related Party Transaction [Line Items]              
Cost of sales 202,840 $ 115,519 549,962 $ 491,680      
Corporate Venture              
Related Party Transaction [Line Items]              
Equity method investment, ownership percentage             30.00%
Equity method investment, ownership percentage, divested           30.00%  
Corporate Venture | Related Party              
Related Party Transaction [Line Items]              
Impairment on investments         $ 6,700    
Accounts receivable $ 0   $ 0   $ 100    
Corporate Venture | Investor in China              
Related Party Transaction [Line Items]              
Equity method investment, ownership percentage             70.00%
v3.26.1
Related Party Transactions - Other Transactions Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Jun. 30, 2025
Related Party Transaction [Line Items]          
Net sales $ 10,243,014,000 $ 4,599,913,000 $ 27,943,295,000 $ 16,215,131,000  
Cost of sales 9,224,334,000 4,159,695,000 25,658,675,000 14,329,311,000  
Accounts payable, related parties 3,686,991,000   3,686,991,000   $ 1,281,977,000
Accounts receivable, after allowance for credit loss, current 8,413,396,000   8,413,396,000   2,203,942,000
Related Party          
Related Party Transaction [Line Items]          
Net sales 4,879,000 7,647,000 23,940,000 33,799,000  
Cost of sales 202,840,000 115,519,000 549,962,000 491,680,000  
Accounts payable, related parties 134,052,000   134,052,000   129,752,000
Accounts receivable, after allowance for credit loss, current 633,000   633,000   393,000
Green Earth | Related Party          
Related Party Transaction [Line Items]          
Net sales 0 0 0 0  
Cost of sales 0 $ 0 0 0  
Chargebacks       $ 0  
Accounts payable, related parties 0   0   0
Accounts receivable, after allowance for credit loss, current $ 0   $ 0   $ 0
v3.26.1
Related Party Transactions - Schedule of Related Party Transactions (Details) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Jun. 30, 2025
Related Party Transaction [Line Items]          
Accounts receivable $ 8,413,396,000   $ 8,413,396,000   $ 2,203,942,000
Other receivables 761,190,000   761,190,000   247,426,000
Other assets 643,369,000   643,369,000   604,871,000
Accounts payable 3,686,991,000   3,686,991,000   1,281,977,000
Accrued liabilities 830,007,000   830,007,000   565,637,000
Other long-term liabilities 412,361,000   412,361,000   326,528,000
Net sales 10,243,014,000 $ 4,599,913,000 27,943,295,000 $ 16,215,131,000  
Cost of sales 9,224,334,000 4,159,695,000 25,658,675,000 14,329,311,000  
Research and Development 215,659,000 162,857,000 569,734,000 453,329,000  
Changes in accounts receivable     (6,209,831,000) 94,782,000  
Changes in prepaid expenses and other assets     (381,738,000) (284,356,000)  
Changes in accounts payable     2,406,930,000 (811,690,000)  
Changes in accrued liabilities     232,916,000 52,714,000  
Changes in other long-term liabilities     20,193,000 5,414,000  
Cash payment for property, plant, and equipment     133,769,000 104,536,000  
Unpaid property, plant, and equipment     16,778,000 18,283,000  
Related Party          
Related Party Transaction [Line Items]          
Accounts receivable 633,000   633,000   393,000
Other receivables 28,714,000   28,714,000   13,745,000
Other assets 59,000   59,000   0
Accounts payable 134,052,000   134,052,000   129,752,000
Accrued liabilities 1,330,000   1,330,000   1,044,000
Other long-term liabilities 494,000   494,000   608,000
Net sales 4,879,000 7,647,000 23,940,000 33,799,000  
Cost of sales 202,840,000 115,519,000 549,962,000 491,680,000  
Purchase of fixed assets 4,450,000 7,777,000 8,078,000 15,279,000  
Research and Development 2,199,000 1,431,000 5,299,000 5,078,000  
Sales and marketing 1,119,000 0 1,815,000 (6,000)  
Changes in accounts receivable     (240,000) 5,878,000  
Changes in prepaid expenses and other assets     (15,028,000) (2,782,000)  
Changes in accounts payable     4,300,000 (49,991,000)  
Changes in accrued liabilities     286,000 571,000  
Changes in other long-term liabilities     (114,000) 729,000  
Cash payment for property, plant, and equipment     9,366,000 10,508,000  
Unpaid property, plant, and equipment     2,591,000 7,111,000  
Ablecom | Related Party          
Related Party Transaction [Line Items]          
Accounts receivable 1,000   1,000   1,000
Other receivables 1,344,000   1,344,000   1,059,000
Other assets 59,000   59,000   0
Accounts payable 88,323,000   88,323,000   55,460,000
Accrued liabilities 689,000   689,000   753,000
Other long-term liabilities 251,000   251,000   114,000
Net sales 315,000 3,000 403,000 10,000  
Cost of sales 126,145,000 50,147,000 307,907,000 252,426,000  
Purchase of fixed assets 4,444,000 7,777,000 7,923,000 14,908,000  
Research and Development 1,754,000 971,000 4,161,000 3,958,000  
Sales and marketing 0 0 0 0  
Changes in accounts receivable     0 0  
Changes in prepaid expenses and other assets     (344,000) 577,000  
Changes in accounts payable     32,863,000 (48,270,000)  
Changes in accrued liabilities     (64,000) 487,000  
Changes in other long-term liabilities     137,000 227,000  
Cash payment for property, plant, and equipment     9,217,000 10,137,000  
Unpaid property, plant, and equipment     2,584,000 7,111,000  
Compuware | Related Party          
Related Party Transaction [Line Items]          
Accounts receivable 430,000   430,000   285,000
Other receivables 27,370,000   27,370,000   12,686,000
Other assets 0   0   0
Accounts payable 45,729,000   45,729,000   74,292,000
Accrued liabilities 641,000   641,000   291,000
Other long-term liabilities 243,000   243,000   494,000
Net sales 4,181,000 3,278,000 14,184,000 24,318,000  
Cost of sales 76,695,000 65,372,000 242,055,000 238,720,000  
Purchase of fixed assets 6,000 0 155,000 371,000  
Research and Development 445,000 460,000 1,138,000 1,120,000  
Sales and marketing 1,104,000 0 1,739,000 0  
Changes in accounts receivable     (145,000) 48,000  
Changes in prepaid expenses and other assets     (14,684,000) (3,359,000)  
Changes in accounts payable     (28,563,000) (1,491,000)  
Changes in accrued liabilities     350,000 84,000  
Changes in other long-term liabilities     (251,000) 502,000  
Cash payment for property, plant, and equipment     149,000 371,000  
Unpaid property, plant, and equipment     7,000 0  
Corporate Venture | Related Party          
Related Party Transaction [Line Items]          
Accounts receivable 0   0   30,000
Other receivables 0   0   0
Other assets 0   0   0
Accounts payable 0   0   0
Accrued liabilities 0   0   0
Other long-term liabilities 0   0   0
Net sales 0 4,201,000 8,147,000 8,977,000  
Cost of sales 0 0 0 0  
Purchase of fixed assets 0 0 0 0  
Research and Development 0 0 0 0  
Sales and marketing 0 0 0 0  
Changes in accounts receivable     30,000 4,990,000  
Changes in prepaid expenses and other assets     0 0  
Changes in accounts payable     0 0  
Changes in accrued liabilities     0 0  
Changes in other long-term liabilities     0 0  
Cash payment for property, plant, and equipment     0 0  
Unpaid property, plant, and equipment     0 0  
Leadtek | Related Party          
Related Party Transaction [Line Items]          
Accounts receivable 202,000   202,000   77,000
Other receivables 0   0   0
Other assets 0   0   0
Accounts payable 0   0   0
Accrued liabilities 0   0   0
Other long-term liabilities 0   0   0
Net sales 383,000 165,000 1,206,000 494,000  
Cost of sales 0 0 0 534,000  
Purchase of fixed assets 0 0 0 0  
Research and Development 0 0 0 0  
Sales and marketing 0 0 0 0  
Changes in accounts receivable     (125,000) 840,000  
Changes in prepaid expenses and other assets     0 0  
Changes in accounts payable     0 (230,000)  
Changes in accrued liabilities     0 0  
Changes in other long-term liabilities     0 0  
Cash payment for property, plant, and equipment     0 0  
Unpaid property, plant, and equipment     0 0  
Green Earth | Related Party          
Related Party Transaction [Line Items]          
Accounts receivable 0   0   0
Accounts payable 0   0   $ 0
Net sales 0 0 0 0  
Cost of sales 0 0 0 0  
Purchase of fixed assets 0 0 0 0  
Research and Development 0 0 0 0  
Sales and marketing $ 15,000 $ 0 $ 76,000 $ (6,000)  
v3.26.1
Stock-based Compensation and Stockholders' Equity - Preferred Stock and Common Stock - Narrative (Details)
Mar. 31, 2026
vote
$ / shares
shares
Jun. 30, 2025
vote
$ / shares
shares
Share-Based Payment Arrangement [Abstract]    
Preferred stock, shares authorized (in shares) 10,000,000 10,000,000
Preferred stock, par value (in dollars per share) | $ / shares $ 0.001 $ 0.001
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, shares authorized (in shares) 1,000,000,000 1,000,000,000
Common stock, par value (in dollars per share) | $ / shares $ 0.001 $ 0.001
Number of votes per common stock share | vote 1 1
v3.26.1
Stock-based Compensation and Stockholders' Equity - Equity Incentive Plan and Offerings of Common Stock Narrative (Details) - shares
1 Months Ended 9 Months Ended
Jun. 05, 2020
Jun. 30, 2025
Jan. 31, 2024
May 31, 2022
Mar. 31, 2026
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares reserved for outstanding awards (in shares)   34,848,133     35,420,914
2020 Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares authorized (in shares) 50,000,000        
Shares reserved for future issuance (in shares) 10,450,000        
Additional shares authorized (in shares)   18,000,000 15,000,000 20,000,000  
Authorized shares available for future issuance (in shares)         7,654,346
2016 Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares reserved for outstanding awards (in shares) 72,460,000        
Employee Stock Option | 2020 Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Percentage of fair market value 110.00%        
Ownership percentage threshold for employee owned incentive stock options to qualify for exercise price per share 10.00%        
Stock option expected life (in years) 10 years        
Employee Stock Options and Restricted Stock Units | 2020 Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period (in years) 4 years        
Employee Stock Options and Restricted Stock Units | Tranche One | 2020 Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock option and restricted stock units vesting rights, percentage 25.00%        
Vesting period after one year 1 year        
Employee Stock Options and Restricted Stock Units | Share-Based Compensation, Tranche Two and Thereafter | 2020 Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock option and restricted stock units vesting rights, percentage         6.25%
v3.26.1
Stock-based Compensation and Stockholders' Equity - Determining Fair Value Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Weighted average fair value of options (in dollars per share) $ 21.70 $ 18.97 $ 33.98 $ 26.03
Capitalized stock-based compensation $ 0 $ 200,000 $ 0 $ 500,000
Restricted Stock Units (RSUs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Dividend yield 0.00%      
v3.26.1
Stock-based Compensation and Stockholders' Equity - Schedule of Stock Option Valuation Assumptions (Details) - Employee Stock Option
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Risk-free interest rate 3.92%      
Risk-free interest rate, minimum   4.05% 3.68% 3.82%
Risk-free interest rate, maximum   4.39% 4.00% 4.39%
Expected term 5 years 11 months 15 days      
Dividend yield 0.00% 0.00% 0.00% 0.00%
Volatility 77.64%      
Volatility, minimum   73.06% 76.16% 63.67%
Volatility, maximum   95.28% 92.16% 95.28%
Minimum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expected term   3 years 3 years 5 months 8 days 3 years
Maximum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expected term   5 years 11 months 23 days 5 years 11 months 15 days 5 years 11 months 23 days
v3.26.1
Stock-based Compensation and Stockholders' Equity - Schedule of Stock-based Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense before taxes $ 125,934 $ 84,704 $ 305,558 $ 230,840
Income tax impact (28,713) (22,433) (70,373) (57,442)
Stock-based compensation expense, net 97,221 62,271 235,185 173,398
Cost of sales        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense before taxes 11,522 7,060 25,400 17,713
Research and development        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense before taxes 83,115 54,254 200,090 141,590
Sales and marketing        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense before taxes 12,276 9,923 33,700 27,245
General and administrative        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense before taxes $ 19,021 $ 13,467 $ 46,368 $ 44,292
v3.26.1
Stock-based Compensation and Stockholders' Equity - Stock Option and RSU Narrative (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Nov. 30, 2023
tranche
$ / shares
shares
Mar. 31, 2026
USD ($)
$ / shares
Mar. 31, 2025
USD ($)
Mar. 31, 2026
USD ($)
$ / shares
shares
Mar. 31, 2025
USD ($)
Mar. 02, 2024
$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Grants in period (in shares) | shares       3,178,597    
Stock-based compensation expense before taxes   $ 125,934 $ 84,704 $ 305,558 $ 230,840  
Total pretax intrinsic value of options exercised   10,800 46,800 50,500 162,600  
2023 CEO Performance Award            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Grants in period (in shares) | shares 5,000,000          
Number of vesting tranches | tranche 5          
Stock-based compensation expense before taxes   900 $ 900 2,900 $ 12,400  
Unrecognized compensation cost related to non-vested stock-based awards   $ 2,600   $ 2,600    
Unrecognized compensation cost related to non-vested stock based awards, period for recognition (in years)       9 months    
2023 CEO Performance Award | Milestone One            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share price milestone (in dollars per share) | $ / shares $ 45.00 $ 45.00   $ 45.00   $ 45.00
2023 CEO Performance Award | Milestone Five            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share price milestone (in dollars per share) | $ / shares $ 110.00 $ 110.00   $ 110.00    
Employee Stock Option            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Unrecognized compensation cost related to non-vested stock-based awards   $ 237,200   $ 237,200    
Unrecognized compensation cost related to non-vested stock based awards, period for recognition (in years)       2 years 7 months 2 days    
Restricted Stock Units (RSUs)            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Unrecognized compensation cost related to non-vested stock-based awards   $ 689,400   $ 689,400    
Unrecognized compensation cost related to non-vested stock based awards, period for recognition (in years)       2 years 5 months 23 days    
v3.26.1
Stock-based Compensation and Stockholders' Equity - Schedule of Operational and Stock Price Milestones (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Aug. 26, 2025
USD ($)
Apr. 22, 2025
USD ($)
Feb. 27, 2025
USD ($)
May 05, 2024
day
$ / shares
Apr. 01, 2024
day
$ / shares
Mar. 02, 2024
day
$ / shares
Mar. 31, 2026
USD ($)
$ / shares
Mar. 31, 2025
USD ($)
Mar. 31, 2026
USD ($)
$ / shares
Mar. 31, 2025
USD ($)
Nov. 30, 2023
$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Net sales             $ 10,243,014 $ 4,599,913 $ 27,943,295 $ 16,215,131  
Milestone One | 2023 CEO Performance Award                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Net sales     $ 13,000,000           $ 13,000,000    
Share price milestone (in dollars per share) | $ / shares           $ 45.00 $ 45.00   $ 45.00   $ 45.00
Market price milestone, number of trading days | day           60          
Milestone Two | 2023 CEO Performance Award                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Net sales   $ 15,000,000             $ 15,000,000    
Share price milestone (in dollars per share) | $ / shares         $ 60.00   60.00   $ 60.00    
Market price milestone, number of trading days | day         60            
Milestone Three | 2023 CEO Performance Award                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Net sales   17,000,000             $ 17,000,000    
Share price milestone (in dollars per share) | $ / shares         $ 75.00   75.00   $ 75.00    
Market price milestone, number of trading days | day         60            
Milestone Four | 2023 CEO Performance Award                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Net sales   $ 19,000,000             $ 19,000,000    
Share price milestone (in dollars per share) | $ / shares       $ 90.00     90.00   $ 90.00    
Market price milestone, number of trading days | day       60              
Milestone Five | 2023 CEO Performance Award                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Net sales $ 21,000,000               $ 21,000,000    
Share price milestone (in dollars per share) | $ / shares             $ 110.00   $ 110.00   $ 110.00
v3.26.1
Stock-based Compensation and Stockholders' Equity - Schedule of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Options Outstanding        
Balance at beginning of period (in shares)     34,848,133  
Granted (in shares)     3,178,597  
Exercised (in shares)     (1,630,182)  
Forfeited/Cancelled (in shares)     (975,634)  
Balance at end of period (in shares) 35,420,914   35,420,914  
Options exercisable (in shares) 24,885,340   24,885,340  
Weighted Average Exercise Price per Share        
Balance at beginning of period (in dollars per share)     $ 22.47  
Granted (in dollars per share)     49.37  
Exercised (in dollars per share)     8.17  
Forfeited/Cancelled (in dollars per share)     37.45  
Balance at end of period (in dollars per share) $ 25.13   25.13  
Options exercisable (in dollars per share) 17.48   17.48  
Weighted Average Grant-Date Fair Value per Share        
Granted (in dollars per share) $ 21.70 $ 18.97 $ 33.98 $ 26.03
Weighted Average Remaining Contractual Term (in Years)        
Weighted average remaining contractual term, options outstanding (in years)     6 years 5 months 26 days  
Weighted average remaining contractual term, options exercisable (in years)     5 years 7 months 17 days  
Aggregate Intrinsic Value (in thousands)        
Aggregate intrinsic value, options outstanding $ 322,574   $ 322,574  
Aggregate intrinsic value, options exercisable $ 309,416   $ 309,416  
Employee Stock Option        
Weighted Average Grant-Date Fair Value per Share        
Granted (in dollars per share)     $ 33.98  
v3.26.1
Stock-based Compensation and Stockholders' Equity - Schedule of RSU Activity (Details) - Restricted Stock Units (RSUs)
9 Months Ended
Mar. 31, 2026
$ / shares
shares
Time-Based RSUs Outstanding  
Balance at beginning of period (in shares) | shares 20,428,647
Granted (in shares) | shares 8,120,018
Released (in shares) | shares (8,117,534)
Forfeited (in shares) | shares (1,402,029)
Balance at end of period (in shares) | shares 19,029,102
Weighted Average Grant-Date Fair Value per Share  
Balance at beginning of period (in dollars per share) | $ / shares $ 34.22
Granted (in dollars per share) | $ / shares 45.07
Released (in dollars per share) | $ / shares 28.50
Forfeited (in dollars per share) | $ / shares 40.15
Balance at end of period (in dollars per share) | $ / shares $ 40.85
v3.26.1
Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Income Tax Disclosure [Abstract]        
Income tax provision $ 126,887 $ 5,843 $ 266,199 $ 137,544
Effective tax rate 20.80% 5.10% 20.20% 13.90%
Expected decrease in unrecognized tax benefits over next twelve months $ 4,100   $ 4,100  
v3.26.1
Commitments and Contingencies (Details)
Apr. 07, 2026
indvidual
Mar. 31, 2026
USD ($)
Jun. 30, 2025
USD ($)
Purchase Commitment, Excluding Long-term Commitment [Line Items]      
Purchase commitments, total   $ 10,100,000,000  
Purchase obligation, loss accrued   4,100,000 $ 0
Related Party      
Purchase Commitment, Excluding Long-term Commitment [Line Items]      
Purchase commitments, total   $ 228,600,000  
Subsequent Event      
Purchase Commitment, Excluding Long-term Commitment [Line Items]      
Litigation, number of employed or associated employees internally investigated | indvidual 3